
<html lang="en"     class="pb-page"  data-request-id="c91e4869-430a-4171-b296-78c906139a59"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2008.51.issue-6;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm7013309;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Brivanib Alaninate ((S)-((R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), A Novel Prodrug of Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinase Inhibitor (BMS-540215)" /></meta><meta name="dc.Creator" content="Zhen-wei  Cai" /></meta><meta name="dc.Creator" content="Yongzheng  Zhang" /></meta><meta name="dc.Creator" content="Robert M.  Borzilleri" /></meta><meta name="dc.Creator" content="Ligang  Qian" /></meta><meta name="dc.Creator" content="Stephanie  Barbosa" /></meta><meta name="dc.Creator" content="Donna  Wei" /></meta><meta name="dc.Creator" content="Xiaoping  Zheng" /></meta><meta name="dc.Creator" content="Lawrence  Wu" /></meta><meta name="dc.Creator" content="Junying  Fan" /></meta><meta name="dc.Creator" content="Zhongping  Shi" /></meta><meta name="dc.Creator" content="Barri S.  Wautlet" /></meta><meta name="dc.Creator" content="Steve  Mortillo" /></meta><meta name="dc.Creator" content="Robert  Jeyaseelan, Sr." /></meta><meta name="dc.Creator" content="Daniel W.  Kukral" /></meta><meta name="dc.Creator" content="Amrita  Kamath" /></meta><meta name="dc.Creator" content="Punit  Marathe" /></meta><meta name="dc.Creator" content="Celia  D’Arienzo" /></meta><meta name="dc.Creator" content="George  Derbin" /></meta><meta name="dc.Creator" content="Joel C.  Barrish" /></meta><meta name="dc.Creator" content="Jeffrey A.  Robl" /></meta><meta name="dc.Creator" content="John T.  Hunt" /></meta><meta name="dc.Creator" content="Louis J.  Lombardo" /></meta><meta name="dc.Creator" content="Joseph  Fargnoli" /></meta><meta name="dc.Creator" content="Rajeev S.  Bhide" /></meta><meta name="dc.Description" content="A series of amino acid ester prodrugs of the dual VEGFR-2/FGFR-1 kinase inhibitor 1 (BMS-540215) was prepared in an effort to improve the aqueous solubility and oral bioavailability of the parent c..." /></meta><meta name="Description" content="A series of amino acid ester prodrugs of the dual VEGFR-2/FGFR-1 kinase inhibitor 1 (BMS-540215) was prepared in an effort to improve the aqueous solubility and oral bioavailability of the parent c..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 21, 2008" /></meta><meta name="dc.Type" content="rapid-communication" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm7013309" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm7013309" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm7013309" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm7013309" /></link>
        
    
    

<title>Discovery of Brivanib Alaninate ((S)-((R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), A Novel Prodrug of Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinase Inhibitor (BMS-540215) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm7013309" /></meta><meta property="og:title" content="Discovery of Brivanib Alaninate ((S)-((R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), A Novel Prodrug of Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinase Inhibitor (BMS-540215)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/large/jm-2007-013309_0006.jpeg" /></meta><meta property="og:description" content=" A series of amino acid ester prodrugs of the dual VEGFR-2/FGFR-1 kinase inhibitor 1 (BMS-540215) was prepared in an effort to improve the aqueous solubility and oral bioavailability of the parent compound. These prodrugs were evaluated for their ability to liberate parent drug 1 in in vitro and in vivo systems. The l-alanine prodrug 8 (also known as brivanib alaninate/BMS-582664) was selected as a development candidate and is presently in phase II clinical trials." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm7013309"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm7013309">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm7013309&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm7013309&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm7013309&amp;href=/doi/10.1021/jm7013309" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 1976-1980</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm701248t" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Brief Article</span></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Brivanib Alaninate ((<i>S</i>)-((<i>R</i>)-1-(4-(4-Fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), A Novel Prodrug of Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinase Inhibitor (BMS-540215)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhen-wei++Cai">Zhen-wei Cai</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yongzheng++Zhang">Yongzheng Zhang</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+M.++Borzilleri">Robert M. Borzilleri</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ligang++Qian">Ligang Qian</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephanie++Barbosa">Stephanie Barbosa</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donna++Wei">Donna Wei</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoping++Zheng">Xiaoping Zheng</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence++Wu">Lawrence Wu</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Junying++Fan">Junying Fan</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhongping++Shi">Zhongping Shi</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barri+S.++Wautlet">Barri S. Wautlet</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steve++Mortillo">Steve Mortillo</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Jeyaseelan%2C++Sr.">Robert Jeyaseelan, Sr.</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+W.++Kukral">Daniel W. Kukral</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amrita++Kamath">Amrita Kamath</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Punit++Marathe">Punit Marathe</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Celia++D%E2%80%99Arienzo">Celia D’Arienzo</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=George++Derbin">George Derbin</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel+C.++Barrish">Joel C. Barrish</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+A.++Robl">Jeffrey A. Robl</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+T.++Hunt">John T. Hunt</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louis+J.++Lombardo">Louis J. Lombardo</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Fargnoli">Joseph Fargnoli</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rajeev+S.++Bhide">Rajeev S. Bhide</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: (609) 252-5627 . Fax: (609) 252-6601. E-mail: <a href="/cdn-cgi/l/email-protection#ee94868b80998b87c08d8f87ae8c839dc08d8183"><span class="__cf_email__" data-cfemail="2b51434e455c4e4205484a426b49465805484446">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Department of Chemistry.</div><div class="corresp-fn" id="afn2">#Department of Process Discovery.</div><div class="corresp-fn" id="afn3">‡Department of Discovery Biology.</div><div class="corresp-fn" id="afn4">§Department of Pharmaceutical Candidate Optimization.</div><div class="corresp-fn" id="afn5">⊥Department of Exploratory Biopharm. and Stability.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm7013309&amp;href=/doi/10.1021%2Fjm7013309" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 1976–1980</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 21, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 October 2007</li><li><span class="item_label"><b>Published</b> online</span>21 February 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 March 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm7013309" title="DOI URL">https://doi.org/10.1021/jm7013309</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1976%26pageCount%3D5%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZhen-wei%2BCai%252C%2BYongzheng%2BZhang%252C%2BRobert%2BM.%2BBorzilleri%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D6%26contentID%3Djm7013309%26title%3DDiscovery%2Bof%2BBrivanib%2BAlaninate%2B%2528%2528S%2529-%2528%2528R%2529-1-%25284-%25284-Fluoro-2-methyl-1H-indol-5-yloxy%2529-5-methylpyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-6-yloxy%2529propan-2-yl%25292-aminopropanoate%2529%252C%2BA%2BNovel%2BProdrug%2Bof%2BDual%2BVascular%2BEndothelial%2BGrowth%2BFactor%2BReceptor-2%2Band%2BFibroblast%2BGrowth%2BFactor%2BReceptor-1%2BKinase%2BInhibitor%2B%2528BMS-540215%2529%26numPages%3D5%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1980%26publicationDate%3DMarch%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm7013309"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3223</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">102</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm7013309" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Brivanib Alaninate ((S)-((R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), A Novel Prodrug of Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinase Inhibitor (BMS-540215)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhen-wei&quot;,&quot;last_name&quot;:&quot;Cai&quot;},{&quot;first_name&quot;:&quot;Yongzheng&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;M. Borzilleri&quot;},{&quot;first_name&quot;:&quot;Ligang&quot;,&quot;last_name&quot;:&quot;Qian&quot;},{&quot;first_name&quot;:&quot;Stephanie&quot;,&quot;last_name&quot;:&quot;Barbosa&quot;},{&quot;first_name&quot;:&quot;Donna&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Xiaoping&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Junying&quot;,&quot;last_name&quot;:&quot;Fan&quot;},{&quot;first_name&quot;:&quot;Zhongping&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Barri&quot;,&quot;last_name&quot;:&quot;S. Wautlet&quot;},{&quot;first_name&quot;:&quot;Steve&quot;,&quot;last_name&quot;:&quot;Mortillo&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Jeyaseelan&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;W. Kukral&quot;},{&quot;first_name&quot;:&quot;Amrita&quot;,&quot;last_name&quot;:&quot;Kamath&quot;},{&quot;first_name&quot;:&quot;Punit&quot;,&quot;last_name&quot;:&quot;Marathe&quot;},{&quot;first_name&quot;:&quot;Celia&quot;,&quot;last_name&quot;:&quot;D’Arienzo&quot;},{&quot;first_name&quot;:&quot;George&quot;,&quot;last_name&quot;:&quot;Derbin&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;C. Barrish&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;A. Robl&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;T. Hunt&quot;},{&quot;first_name&quot;:&quot;Louis&quot;,&quot;last_name&quot;:&quot;J. Lombardo&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Fargnoli&quot;},{&quot;first_name&quot;:&quot;Rajeev&quot;,&quot;last_name&quot;:&quot;S. Bhide&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;1976-1980&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm7013309&quot;},&quot;abstract&quot;:&quot;A series of amino acid ester prodrugs of the dual VEGFR-2/FGFR-1 kinase inhibitor 1 (BMS-540215) was prepared in an effort to improve the aqueous solubility and oral bioavailability of the parent compound. These prodrugs were evaluated for their ability to liberate parent drug 1 in in vitro and in vivo systems. The l-alanine prodrug 8 (also known as brivanib alaninate/BMS-582664) was selected as a development candidate and is presently in phase II clinical trials.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7013309&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7013309" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7013309&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7013309" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7013309&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7013309" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm7013309&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7013309&amp;href=/doi/10.1021/jm7013309" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm7013309" /></input><a href="/doi/pdf/10.1021/jm7013309" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (243 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm7013309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm7013309%26sid%3Dliteratum%253Aachs%26pmid%3D18288793%26genre%3Darticle%26aulast%3DCai%26date%3D2008%26atitle%3DDiscovery%2Bof%2BBrivanib%2BAlaninate%2B%2528%2528S%2529-%2528%2528R%2529-1-%25284-%25284-Fluoro-2-methyl-1H-indol-5-yloxy%2529-5-methylpyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-6-yloxy%2529propan-2-yl%25292-aminopropanoate%2529%252C%2BA%2BNovel%2BProdrug%2Bof%2BDual%2BVascular%2BEndothelial%2BGrowth%2BFactor%2BReceptor-2%2Band%2BFibroblast%2BGrowth%2BFactor%2BReceptor-1%2BKinase%2BInhibitor%2B%2528BMS-540215%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D6%26spage%3D1976%26epage%3D1980%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/medium/jm-2007-013309_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/large/jm-2007-013309_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7013309&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of amino acid ester prodrugs of the dual VEGFR-2/FGFR-1 kinase inhibitor <b>1</b> (BMS-540215) was prepared in an effort to improve the aqueous solubility and oral bioavailability of the parent compound. These prodrugs were evaluated for their ability to liberate parent drug <b>1</b> in in vitro and in vivo systems. The <span class="smallcaps smallerCapital">l</span>-alanine prodrug <b>8</b> (also known as brivanib alaninate/BMS-582664) was selected as a development candidate and is presently in phase II clinical trials.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04417" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04417" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Vascular endothelial growth factor (VEGF<a class="ref internalNav" href="#fn1" aria-label="a">a</a>), fibroblast growth factor (FGF), as well as their corresponding tyrosine kinase receptors, VEGFR and FGFR, play a critical role in physiological and pathological angiogenesis, a process of forming new capillaries from existing blood vessels. Angiogenesis is essential for solid tumor growth and metastasis.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Tumor-induced angiogenesis is mediated by VEGF, FGF, and other cytokines such as platelet-derived growth factor (PDGF). Among them, VEGF is known to be one of the most important angiogenic growth factor in the stimulation of tumor progression.<a onclick="showRef(event, 'ref1 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref3">(1, 3)</a> Importantly, the specific binding of VEGF ligand to vascular cell surface expressed protein kinase receptor VEGFR-2 triggers effective downstream cell proliferation signaling pathways and leads to tumor vascularization.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The interruption of VEGFR-2 signaling by binding of a small molecule inhibitor to the VEGFR-2 kinase domain has been shown to inhibit angiogenesis, tumor progression, and dissemination in a number of preclinical and clinical studies.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> This approach has been further validated by the recent FDA approval of the antiangiogenic agents, such as bevacizumab (a monoclonal antibody which targets to the VEGF-A ligand) and small molecule inhibitors, sorafenib and sunitinib (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>), for the treatment of solid tumors.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Similarly, FGFR-1 is also expressed on endothelial cells and is important in cell survival and proliferation underlying blood vessel development and blood vessel stabilization in tumor angiogenesis.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Moreover, the FGFR family of receptors has been associated with a variety of malignant tumors including melanoma,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> glioma,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> pancreatic,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> as well as bladder cancer.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/medium/jm-2007-013309_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/large/jm-2007-013309_0001.jpeg" id="gc1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Examples of VEGFR-2 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/large/jm-2007-013309_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7013309&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As part of our continuing effort to identify selective small-molecule kinase inhibitors for antiangiogenic therapies underlying cancer, we discovered a new class of pyrrolo[2,1-<i>f</i>][1,2,4]triazine-based VEGFR-2 inhibitors. An optimized analog <b>1</b> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) demonstrated potent inhibition against VEGFR-2 and FGFR-1, excellent kinase selectivity, and potent in vivo efficacy versus H3396 and L2987 human lung carcinoma xenografts implanted in athymic mice.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, oral administration of <b>1</b> in rat (at 25 mg/kg) as a micronized suspension produced significantly lower systemic exposure levels of <b>1</b> than those obtained from solution formulations. The low aqueous solubility (<1 μg/mL at pH 6.5) of <b>1</b> presumably contributed to dissolution rate-limited absorption of the compound, particularly at high doses. Efforts to improve the oral bioavailability and increase drug plasma concentrations of <b>1</b> at high doses using different formulation strategies were unsuccessful. To overcome this potential development issue, we decided to investigate a prodrug approach. Amino acid ester prodrugs of alcohols have been used successfully in marketed drugs to improve aqueous solubility.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Herein, we report our prodrug strategy of incorporating a variety of amino acids onto the secondary alcohol group of <b>1</b> through a metabolically labile ester linkage to improve its physicochemical and pharmacokinetic properties.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The fluoroindole-substituted pyrrolotriazine ester <b>4</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) was synthesized in excellent yield by reacting chloroimidate <b>2</b><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> with 4-fluoro-2-methyl-1<i>H</i>-indol-5-ol (<b>3</b>)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> in the presence of potassium carbonate in DMF. Treatment of ester <b>4</b> with methyl magnesium bromide gave rise to the tertiary alcohol <b>5</b>, which underwent BF<sub>3</sub>/OEt<sub>2</sub>/50% H<sub>2</sub>O<sub>2</sub> promoted oxidative rearrangement<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> to afford phenol <b>6</b> in good yield. This approach was used as an effective alternative to the Baeyer–Villiger reaction to prepare the key intermediate <b>6</b> from the corresponding aldehyde.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Base-catalyzed epoxide opening of <i>R</i>-(+)-propylene oxide with <b>6</b> in ethanol at elevated temperature afforded compound <b>1</b> in an enantiomeric excess of >99% ee. The addition of lithium chloride to the reaction mixture enhanced the rate of epoxide ring opening presumably due to chelation of the lithium ion with the epoxide oxygen. The ester prodrugs were generally prepared in excellent yield by coupling alcohol <b>1</b> with commercially available Cbz-protected amino acids or the carboxylic acids bearing a tertiary amine in the presence of HATU (2-(3<i>H</i>-[1,2,3]triazolo[4,5-<i>b</i>]pyridin-3-yl)-1,1,3,3-tetramethylisouronium hexafluorophosphate), DIPEA, and DMAP in DMF to give esters <b>7</b>–<b>15</b> and <b>16</b>–<b>20</b>, respectively. In the case of <b>7</b>–<b>15</b>, the final products were obtained after deprotection of the Cbz group via a palladium-catalyzed hydrogen transfer reaction with ammonium formate. No racemization of the chiral amino esters occurred during the chemical transformations based on an assessment of their enantiomeric purities in the synthesis of <span class="smallcaps smallerCapital">l</span>-alanine ester <b>8</b> and its enantiomeric isomer <span class="smallcaps smallerCapital">d</span>-alanine ester <b>9</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/medium/jm-2007-013309_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/large/jm-2007-013309_0002.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/large/jm-2007-013309_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7013309&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF, 16 h; (b) MeMgBr, THF, 0 °C, 2–5 h, 75% yield over two steps; (c) H<sub>2</sub>O<sub>2</sub>, BF<sub>3</sub>/OEt<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −15 °C to −25 °C, 1 h, 66%; (d) <i>R</i>-(+)- propylene oxide, LiCl, NEt<sub>3</sub> (cat.), EtOH, 3 h, 81%; (e) CbzNHCR<sup>1</sup>R<sup>2</sup>COOH (<b>7</b>–<b>15</b>) or R<sup>3</sup>CO<sub>2</sub>H (<b>16</b>–<b>20</b>), HATU, DIPEA, DMAP (cat.), THF, 5 h, 51–94%; (f) HCOO<sup>−</sup>NH<sub>4</sub><sup>+</sup>, Pd/C, DMF, 69–99%.</p></p></figure><div class="NLM_p last"><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: VEGFR-2, vascular endothelial growth factor receptor-2; FGFR-1, fibroblast growth factor receptor-1; PDGF, platelet-derived growth factor; Cbz, benzyloxycarbonyl; AUC, area under curve; DIPEA, diisopropylethylamine; DMAP, 4-dimethylaminopyridine; HATU, 2-(3<i>H</i>-[1,2,3]triazolo[4,5-<i>b</i>]pyridin-3-yl)-1,1,3,3-tetramethylisouronium hexafluorophosphate; PEG, poly(ethylene glycol); TGI, tumor growth inhibition; CYP450, cytochrome P450 enzyme.</p></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> In Vitro Assessment of Prodrugs</h3><div class="NLM_p">A number of specific and nonspecific esterases found in the stomach, intestines, liver, and plasma are capable of hydrolyzing amino ester linkages. Our desire was to identify prodrugs of high chemical stability that displayed rapid and quantitative conversion to parent to maximize drug exposure and minimize unproductive metabolism. The prodrugs were initially evaluated to determine their stability in human and mouse liver S9 fractions and in plasma. Generally, the ester prodrugs tested were moderately stable to ester cleavage in mouse plasma, and very stable to ester cleavage in human plasma (data not shown), suggesting metabolic conversion to <b>1</b> in the liver would be necessary. No attempts were made to fully evaluate and rank the conversion of prodrugs to <b>1</b> in human plasma since all prodrugs appeared to show the remarkably low conversion. Thus, the assay for determining the rate of conversion of prodrugs to parent <b>1</b> in liver S9 fraction was considered to be the primary screening method. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> illustrates the influence of the structure of the pro-moiety on the hydrolytic rate. Prodrugs with α-substitution of less hindered groups on amino acids such as <b>7</b> (glycinate), <b>8</b> (<span class="smallcaps smallerCapital">l</span>-alaninate), <b>9</b> (<span class="smallcaps smallerCapital">d</span>-alaninate), and <b>13</b> (<span class="smallcaps smallerCapital">l</span>-leucinate) exhibited complete conversion to parent <b>1</b> in both human and mouse liver S9 fractions within the 5 min incubation time, with no additional major metabolites detected. Compound <b>10</b> (α,α-dimethylglycinate) bearing chemical disubstitution on the α-carbon, also served as an excellent substrate for esterase and was readily hydrolyzed under the assay conditions. The use of more hindered amino acids, such as compounds, <b>11</b> (<span class="smallcaps smallerCapital">l</span>-valinate), <b>12</b> (<span class="smallcaps smallerCapital">d</span>-valinate), <b>14</b> (<span class="smallcaps smallerCapital">l</span>-isoleucinate), and <b>15</b> (<span class="smallcaps smallerCapital">l</span>-phenylalanine), provided lower rates of conversion to parent drug <b>1</b>. <i>N</i>,<i>N</i>-Dimethylglycinate <b>16</b> displayed a low rate of conversion in mouse and moderate rate of conversion in human liver S9 fractions. The 2-morpholinoacetate <b>17</b> gave a moderate rate of conversion both in mouse and human liver S9 fraction. Substituted benzoic acid prodrugs <b>18</b>–<b>20</b>, in general, demonstrated lower hydrolytic conversion rates.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Prodrug Stability in Liver S9 Fraction (5 Min Incubation)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/medium/jm-2007-013309_0003.gif" alt="" id="gr4" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/medium/jm-2007-013309_0004.gif" alt="" id="gr5" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for a description of assay conditions.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">Data are expressed as a mean of at least of two determinations (variation < 20%).</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Pharmacokinetics and Pharmaceutical Properties</h3><div class="NLM_p">Four prodrugs (<b>7</b>, <b>8</b>, <b>10</b>, and <b>13</b>) that demonstrated rapid conversion to parent <b>1</b> in human and mouse liver S9 fraction were assessed in oral exposure studies in mice (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). All compounds were administered as a 70:30 PEG70/water solution at 50 and 200 mg/kg doses, and the plasma concentrations of <b>1</b> were determined at 0.5, 1, and 4 h time points. Parent drug <b>1</b> demonstrated the lowest systemic exposure at 50 mg/kg and no further increase in circulating plasma levels at the high dose of 200 mg/kg. In contrast, prodrugs <b>7</b>, <b>8</b>, <b>10</b>, and <b>13</b> produced higher exposure levels of <b>1</b>, where the AUC increased proportionally with dose at levels of 50 and 200 mg/kg. These data demonstrated efficient in vivo conversion of these four prodrugs to <b>1</b> in mice and suggested our prodrug strategy could serve to overcome the pharmaceutics issues associated with <b>1</b>. Among the four prodrugs tested, <b>10</b> gave slightly lower levels of exposure of <b>1</b> relative to the other three natural amino acid prodrugs (<b>7</b>, <b>8</b>, and <b>13</b>) and was not further pursued.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Oral Exposure of Various Compounds in Mice<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="4" align="center" valign="middle" char=".">plasma concentration of <b>1</b></th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" valign="bottom">cmpd</th><th class="rowsep1" align="center" valign="bottom" char=".">dose (mg/kg)</th><th class="rowsep1" align="center" valign="bottom"><i>C</i><sub>max</sub> (μM)</th><th class="rowsep1" align="center" valign="bottom">AUC (0–4 h; μM·hr)</th><th class="rowsep1" align="center" valign="bottom" char=".">AUC fold increase<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top"><td rowspan="2" align="left"><b>1</b></td><td align="char" char=".">50</td><td align="left">12 ± 6</td><td align="left">45 ± 16</td><td align="char" char="."> </td></tr><tr valign="top"><td align="char" char=".">200</td><td align="left">14 ± 10</td><td align="left">52 ± 14</td><td align="char" char=".">1.2</td></tr><tr valign="top"><td rowspan="2" align="left"><b>7</b></td><td align="char" char=".">50</td><td align="left">21 ± 3</td><td align="left">69 ± 26</td><td align="char" char="."> </td></tr><tr valign="top"><td align="char" char=".">200</td><td align="left">126 ± 15</td><td align="left">303 ± 63</td><td align="char" char=".">4.4</td></tr><tr valign="top"><td rowspan="2" align="left"><b>8</b></td><td align="char" char=".">50</td><td align="left">21 ± 5</td><td align="left">69 ± 16</td><td align="char" char="."> </td></tr><tr valign="top"><td align="char" char=".">200</td><td align="left">78 ± 20</td><td align="left">276 ± 74</td><td align="char" char=".">4.0</td></tr><tr valign="top"><td rowspan="2" align="left"><b>10</b></td><td align="char" char=".">50</td><td align="left">15 ± 6</td><td align="left">46 ± 16</td><td align="char" char="."> </td></tr><tr valign="top"><td align="char" char=".">200</td><td align="left">66 ± 29</td><td align="left">213 ± 107</td><td align="char" char=".">4.6</td></tr><tr valign="top"><td rowspan="2" align="left"><b>13</b></td><td align="char" char=".">50</td><td align="left">31 ± 4</td><td align="left">113 ± 26</td><td align="char" char="."> </td></tr><tr valign="top"><td align="char" char=".">200</td><td align="left">152 ± 17</td><td align="left">451 ± 37</td><td align="char" char=".">4.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Average of three female mice for each dose group.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">Vehicle: PEG400/water (70:30).</p></div><div class="footnote" id="tbl2-fn3"><sup>c</sup><p class="last">For assay condition, see ref <a class="ref internalNav" href="#ref16" aria-label="16">16</a>.</p></div><div class="footnote" id="tbl2-fn4"><sup>d</sup><p class="last">AUC (200 mpk)/AUC (50 mpk).</p></div></div></div><div class="NLM_p">When evaluated in a cytochrome P450 panel to assess the potential for drug−drug interactions, compounds <b>7</b>, <b>8</b>, and <b>13</b> were found to be more potent inhibitors of these metabolizing enzymes than parent <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Although no circulating prodrug was observed for any of these compounds in the mouse oral exposure assay, analogues with modest activity were desirable since it was difficult to rule out the possibility of incomplete conversion of prodrug to parent drug in the clinical setting. Compound <b>7</b> was a highly potent inhibitor of the CYP2C9 isoform (IC<sub>50</sub> = 63 nM), and demonstrated submicromolar potency versus CYP3A4 and CYP2C19. Compound <b>13</b> also demonstrated submicromolar activity versus the CYP3A4 isoform. Overall, compound <b>8</b> showed the most favorable CYP inhibition profile. The risk of drug−drug interactions was further mitigated by the demonstration that compound <b>8</b> was rapidly converted to parent <b>1</b> in human intestinal microsomes (18% remaining of <b>8</b> after 10 min of incubation).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibition of Human CYP Isozymes by Various Prodrugs<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#tbl3-fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#tbl3-fn3" aria-label="c">c</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="6" align="center" valign="middle" char=".">IC<sub>50</sub> for CYP inhibition (μM)</th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" valign="bottom">cmpd</th><th class="rowsep1" align="center" valign="bottom" char=".">1A2</th><th class="rowsep1" align="center" valign="bottom" char=".">2C9</th><th class="rowsep1" align="center" valign="bottom" char=".">2C19</th><th class="rowsep1" align="center" valign="bottom" char=".">2D6</th><th class="rowsep1" align="center" valign="bottom" char=".">3A4 (BFC)</th><th class="rowsep1" align="center" valign="bottom" char=".">3A4 (BzRes)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b></td><td align="char" char=".">>40</td><td align="char" char=".">>40</td><td align="char" char=".">>40</td><td align="char" char=".">>40</td><td align="char" char=".">18</td><td align="char" char=".">>40</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="char" char=".">3.7</td><td align="char" char=".">0.063</td><td align="char" char=".">0.16</td><td align="char" char=".">12</td><td align="char" char=".">0.16</td><td align="char" char=".">0.31</td></tr><tr valign="top"><td align="left"><b>8</b></td><td align="char" char=".">>40</td><td align="char" char=".">9.7</td><td align="char" char=".">2.1</td><td align="char" char=".">24</td><td align="char" char=".">0.51</td><td align="char" char=".">1.6</td></tr><tr valign="top"><td align="left"><b>13</b></td><td align="char" char=".">34</td><td align="char" char=".">2.7</td><td align="char" char=".">1.8</td><td align="char" char=".">24</td><td align="char" char=".">0.095</td><td align="char" char=".">0.37</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Data are expressed as a mean of at least two measurements.</p></div><div class="footnote" id="tbl3-fn2"><sup>b</sup><p class="last">Highest test concentration: 40 μM.</p></div><div class="footnote" id="tbl3-fn3"><sup>c</sup><p class="last">For assay condition, see ref <a class="ref internalNav" href="#ref16" aria-label="16">16</a>.</p></div></div></div><div class="NLM_p last">Prodrug <b>8</b> also exhibited high solid state stability (only 0.3% degradation at 50 °C with desiccant over a period of 12 weeks) and acceptable solution state stability up to pH 6.5. The compound was extremely stable at pH 4.2 in buffer solution at 37 °C, with less than 1% of prodrug degrading to parent <b>1</b> over a 24 h period. Furthermore, <b>8</b> possessed high aqueous solubility (73 mg/mL at pH 5.8). Based on its promising results in the above studies, <b>8</b> was selected for in vivo evaluation in tumor xenograft studies.</div></div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vivo Antitumor Activity of 8</h3><div class="NLM_p">The in vivo antitumor activity of <b>8</b> was evaluated in a L2987 nonsmall cell lung tumor xenografts assay in athymic mice (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Once daily oral administration of <b>8</b> for 14 consecutive days inhibited the growth of the established tumor (80–100 mm<sup>3</sup> size) in a dose-dependent manner. At 80 and 107 mg/kg doses, essentially complete tumor stasis was observed throughout the dosing period, with a percent tumor growth inhibition (%TGI) of 85 and 97%, respectively. No overt toxicity was observed in either cohort of animals, suggesting good safety margins in mice for this compound. This result supported the concept that prodrug <b>8</b> could provide an effective means to improve the pharmaceutical and pharmacokinetic properties of <b>1</b> for clinical development.</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/medium/jm-2007-013309_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/large/jm-2007-013309_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. In vivo antitumor activity of <b>8</b> vs L2987 xenografts in athymic mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/large/jm-2007-013309_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7013309&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04384" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04384" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The synthesis and biological evaluation of a series of amino ester prodrugs of <b>1</b> are reported. In vitro assessment of the conversion of various prodrugs to <b>1</b> in liver S9 fraction and serum and in vivo evaluation of their oral exposure in mice led to the identification of compounds <b>7</b>, <b>8</b>, and <b>13</b> as potential lead prodrugs. Evaluation of inhibition of human CYP enzymes by these compounds revealed that prodrug <b>8</b> possessed favorable CYP profile and least likelihood for drug−drug interactions. Further studies showed that <b>8</b> demonstrated excellent pharmaceutical properties and significant antitumor activity against L2987 human lung carcinoma xenografts. Based on these results, <b>8</b> was selected for advancement into preclinical toxicity studies to support clinical development of this interesting drug candidate.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06248" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06248" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Preparation of 2-(4-(4-Fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yl)propan-2-ol (5)</h4><div class="NLM_p">To a solution of freshly prepared chloroimidate <b>2</b><a onclick="showRef(event, 'ref14 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref18">(14, 18)</a> (167.8 g, 0.7 mol) in DMF (1.1 L) was added K<sub>2</sub>CO<sub>3</sub> (267 g, 2.1 mol) and 4-fluoro-2-methyl-1<i>H</i>-indol-5-ol <b>3</b><a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (109.5 g, 0.7 mol). The reaction mixture was stirred at rt for 16 h and then cooled to 0 °C. The mixture was diluted with water and extracted with EtOAc. The organic layer was washed with water, 10% aqueous LiCl, and water. The organic extract was concentrated in vacuo, and the residue was coevaporated with toluene to give crude <b>4</b>. MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 369.4 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.15 (s, 1H), 7.90 (s, 1H), 7.08 (d, 1H, <i>J</i> = 8.25 Hz), 6.98 (dd, 1H), 6.34 (s, 1H), 4.39 (q, 2H, <i>J</i> = 7.15 Hz), 2.87 (s, 3H), 2.45 (s, 3H), 1.41 (t, 3H, <i>J</i> = 7.15 Hz).</div><div class="NLM_p last">To a mixture of compound <b>4</b> and LiCl (140 g) in THF (1.1 L) at 0 °C was added MeMgBr (1 M in toluene, 2.8 mol) at a rate so as to maintain internal temperature below 5 °C. The resulting mixture was stirred at 0 °C for 2 h and 15 °C for 3 h. The mixture was recooled to 5 °C, and additional MeMgBr (0.14 mol) was added. The mixture was stirred at 15 °C for another 1.5 h. The mixture was extracted with EtOAc and 15% aqueous NH<sub>4</sub>Cl. The organic extract was concentrated. The residue was dissolved in dichloromethane (DCM) and passed through a short pad of silica gel, eluting with DCM, 5% EtOAc in DCM. The filtrate was concentrated to give a white solid that was recrystallized from EtOAc/heptane afforded <b>5</b> (186 g, 75% yield). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 355.4 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.00 (s, br, 1H), 7.83 (s, 1H), 7.68 (s, 1H), 7.08 (d, 1H, <i>J</i> = 8.60 Hz), 6.97 (dd, 1H), 6.35 (s, 1H), 2.78 (s, 3H), 2.46 (s, 3H), 1.80 (s, OH), 1.70 (s, 6H).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 4-(4-Fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-ol (6)</h4><div class="NLM_p last">To a solution of BF<sub>3</sub>/OEt<sub>2</sub> (120 mL, 0.948 mol) in DCM (200 mL) at 0 °C was added H<sub>2</sub>O<sub>2</sub> (50% aqueous solution, 4.6 mL, 0.079 mol). The mixture was stirred at 0 °C for 30 min and then cooled to −20 °C. To this mixture was added a solution of <b>5</b> (20 g, 0.0564 mol) in DCM (400 mL) via cannula at a rate so as to keep the reaction temperature between −15 to −25 °C. The resulting mixture was stirred at −15 °C for 40 min. The reaction was quenched with 20% aq Na<sub>2</sub>SO<sub>3</sub> (200 mL) and 33% aq ethanolamine (300 mL) and stirred below 0 °C for 2 h. The organic layer was then separated, and the aqueous layer was extracted with EtOAc. The combined extracts were washed with 5% aq citric acid, 10% aq NaHCO<sub>3</sub>, water, and brine, dried, and then concentrated to give an orange foam. The crude material was dissolved in THF and loaded to a Florisil column, eluting with 30% EtOAc/heptane. The desired fractions were concentrated in vacuo and recrystallized from EtOAc/heptane. The solid was collected and washed with heptane to afford <b>6</b> (9.1 g, 52% yield) as an off-white solid. The filtrate was further purified on silica gel using 40% EtOAc/heptane to give additional product <b>6</b> (2.5 g, 14% yield). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 313.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.34 (s, 1H), 9.60 (br s, 1H), 7.85 (s, 1H), 7.51 (s, 1H), 7.13 (d, 1H, <i>J</i> = 8.7 Hz), 6.98 (t, 1H, <i>J</i> = 8.7 Hz), 6.24 (s, 1H), 2.41 (s, 3H), 2.39 (s, 3H).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (<i>R</i>)-1-(4-(4-Fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propan-2-ol (1)</h4><div class="NLM_p last">A mixture of <b>6</b> (7.5 g, 24 mmol), <i>R</i>-(+)-propylene oxide (120 mmol), LiCl (3.02 g, 72 mmol), and NEt<sub>3</sub> (300 μL) in EtOH (50 mL) was heated in a sealed tube at 70 °C for 3 h. The solvent was reduced to about 10 mL and the residue was poured into water. The precipitate was collected by filtration and washed with water. The crude solid was dissolved in 5% EtOH/DCM and passed through a short pad of silica gel, eluting with 20% EtOAc/DCM. The filtrate was concentrated, and the solid residue was triturated with 30% EtOH/heptane to afford <b>1</b> (7.2 g, 81% yield) as an off-white solid. MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 371.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.72 (s, 1H), 7.61 (s, 1H), 7.10 (d, 1H, <i>J</i> = 8.80 Hz), 6.90 (t, 1H, <i>J</i> = 7.15 Hz), 6.23 (s, 1H), 4.12–4.20 (m, 1H), 3.92 (d, 2H, <i>J</i> = 6.55 Hz), 2.48 (s, 3H), 2.43 (s, 3H), 1.29 (d, 3H, <i>J</i> = 6.6 Hz). Mp 208–210 °C. Anal. (C<sub>19</sub>H<sub>19</sub>FN<sub>4</sub>O<sub>3</sub>): C, H, N, F.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> General Procedure for the synthesis of <i>N</i>-Cbz-Protected Compounds 7–15 and 16–20</h4><div class="NLM_p last">A mixture of <b>1</b> (1 equiv, 0.16 mmol), the appropriate <i>N</i>-CbzNHCR<sup>1</sup>R<sup>2</sup>COOH or R<sup>3</sup>COOH (2.5 equiv, 0.4 mmol), HATU (253 mg, 0.4 mmol), DIPEA (103 mg, 0.8 mmol), and DMAP (5 mg) in DMF (1 mL) was stirred overnight. The volatiles were removed in vacuo, and the residue was purified by flash column chromatography or preparative HPLC conditions to afford <i>N</i>-Cbz-protected compounds <b>7</b>–<b>15</b> and <b>16</b>–<b>20</b>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> General Procedure for the Synthesis of Compounds 7–15</h4><div class="NLM_p last">A mixture of the appropriate <i>N</i>-Cbz-protected derivatives <b>7</b>–<b>15</b> (1 equiv, 0.11 mmol), Pd/C (10%, 6 mg), and ammonium formate (200 mg) in DMF (1.5 mL) was stirred at RT for 0.5 to 2 h (the reaction was monitored by HPLC for completion). The mixture was diluted with ethyl acetate and filtered through a pad of celite<sup></sup>. The filtrate was washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, and passed through a pad of silica gel, eluting with EtOAc. The filtrate was concentrated and if necessary further purified by prep-HPLC conditions. The desired fraction was lyophilized with HCl (1 N in water) to afford the title compounds <b>7</b>–<b>15</b> as HCl salts.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Pharmacology</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Incubation with Liver S9 Fractions</h4><div class="NLM_p last">The in vitro metabolism of prodrugs was investigated in incubations with S9 subcellular fractions from mouse (CD-1) and human liver homogenates. Incubation of prodrugs was done in duplicate with S9 fractions from each species. The rate of metabolism was measured under the following conditions: prodrug, 20 μM final concentration (400 μM stock solutions in 4% DMSO/96% water; final incubation solutions contained 0.2% DMSO); 20 μL of S9 per 200 μL incubation, final protein concentration 2 mg/mL; MgCl<sub>2</sub>, 10 mM; pH 7.4 sodium phosphate buffer, 60 mM. Incubations were performed in 96-well plates at 37 °C under an atmosphere of 5% CO<sub>2</sub>. Incubations were initiated by the addition of S9 and were quenched at various times (0, 10, or 30 min) by the addition of an equal volume (0.2 mL) of acetonitrile to each well. Plates were sealed, vortexed, and centrifuged to pellet-precipitated proteins, and the supernatants were transferred to clean plates or HPLC vials. Samples were analyzed using a LC/MS/MS assay.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Stability of Prodrug 8 in Human Intestinal Microsomes</h4><div class="NLM_p last">The in vitro metabolism of <b>8</b> was investigated in incubations (in duplicate) with human intestinal microsomes. The rate of oxidative metabolism was measured under the following conditions: <b>8</b>, 10 μM final concentration for intestinal microsomes (100 μM stock solutions in 2% DMSO/19.5% acetonitrile/80% water; final incubation solutions contained 0.05% DMSO, 1.95% acetonitrile); final protein concentration, 1 mg/mL; NADPH, 0.9 mg/mL; pH 7.4 sodium phosphate buffer, 56 mM. Incubations were performed in 96-well plates at 37 °C under an atmosphere of 5% CO<sub>2</sub>. Incubations were initiated by the addition of NADPH and were quenched at various times (0, 10, or 30 min) by the addition of an equal volume (0.2 mL) of acetonitrile to each well. Plates were sealed, vortexed, and centrifuged to pellet-precipitated proteins, and the supernatants were transferred to clean plates or HPLC vials. Samples were analyzed using a LC/MS/MS assay.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24"><a href="/doi/suppl/10.1021/jm7013309">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Characterization data for chiral purity determination of <b>1</b>, <b>8</b>, and <b>9</b>, prodrugs <b>7</b>–<b>20</b>, and a table of reaction yields and HPLC analysis data for key compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm7013309/suppl_file/jm7013309-file002.pdf">jm7013309-file002.pdf (177.13 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm7013309" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhen-wei Cai</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fe84969b90899b97d09d9f97be9c938dd09d9193"><span class="__cf_email__" data-cfemail="5f25373a31283a36713c3e361f3d322c713c3032">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongzheng Zhang</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert M. Borzilleri</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ligang Qian</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephanie Barbosa</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donna Wei</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoping Zheng</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence Wu</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Junying Fan</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhongping Shi</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barri S. Wautlet</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steve Mortillo</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Jeyaseelan</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel W. Kukral</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amrita Kamath</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Punit Marathe</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Celia D’Arienzo</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">George Derbin</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel C. Barrish</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey A. Robl</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John T. Hunt</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louis J. Lombardo</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Fargnoli</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajeev S. Bhide</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, Post Office Box 4000, Princeton, New Jersey 08543-4000</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank the Discovery Analytical Sciences Department at BMS for obtaining high resolution MS analyses and enantiomeric excess determinations.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46462" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46462" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 18 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Klagsbrun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moses, M. A.</span><span> </span><span class="NLM_article-title">Molecular angiogenesis</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_elocation-id">R217–224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&author=M.+Klagsbrunauthor=M.+A.+Moses&title=Molecular+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlagsbrun%26aufirst%3DM.%26aulast%3DMoses%26aufirst%3DM.%2BA.%26atitle%3DMolecular%2520angiogenesis%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Folkman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shing, Y.</span><span> </span><span class="NLM_article-title">Angiogenesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">10931</span><span class="NLM_x">–</span> <span class="NLM_lpage">10934</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=10931-10934&author=J.+Folkmanauthor=Y.+Shing&title=Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26aulast%3DShing%26aufirst%3DY.%26atitle%3DAngiogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D10931%26epage%3D10934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Folkman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klagsbrun, M.</span><span> </span><span class="NLM_article-title">Angiogenic factors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">235</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1987&pages=442-447&author=J.+Folkmanauthor=M.+Klagsbrun&title=Angiogenic+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26aulast%3DKlagsbrun%26aufirst%3DM.%26atitle%3DAngiogenic%2520factors%26jtitle%3DScience%26date%3D1987%26volume%3D235%26spage%3D442%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Carmeliet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">Angiogenesis in cancer and other diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1038%2F35025220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=11001068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVSls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=249-257&author=P.+Carmelietauthor=R.+K.+Jain&title=Angiogenesis+in+cancer+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in cancer and other diseases</span></div><div class="casAuthors">Carmeliet, Peter; Jain, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">6801</span>),
    <span class="NLM_cas:pages">249-257</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 75 refs.  Pathol. angiogenesis is a hallmark of cancer and various ischemic and inflammatory diseases.  Concd. efforts in this area of research are leading to the discovery of a growing no. of pro- and anti-angiogenic mols., some of which are already in clin. trials.  The complex interactions among these mols. and how they affect vascular structure and function in different environments are now beginning to be elucidated.  This integrated understanding is leading to the development of a no. of exciting and bold approaches to treat cancer and other diseases.  But owing to several unanswered questions, caution is needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPQMelW0OMYbVg90H21EOLACvtfcHk0lgy_Ps6zeUmzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVSls74%253D&md5=703cbcdbd32292a9238f0394220c853c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F35025220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35025220%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DAngiogenesis%2520in%2520cancer%2520and%2520other%2520diseases%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D249%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ellis, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidler, I. J.</span><span> </span><span class="NLM_article-title">Angiogenesis and metastasis</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">32A</span><span class="NLM_x">, </span> <span class="NLM_fpage">2451</span><span class="NLM_x">–</span> <span class="NLM_lpage">2460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32A&publication_year=1996&pages=2451-2460&author=L.+M.+Ellisauthor=I.+J.+Fidler&title=Angiogenesis+and+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DL.%2BM.%26aulast%3DFidler%26aufirst%3DI.%2BJ.%26atitle%3DAngiogenesis%2520and%2520metastasis%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1996%26volume%3D32A%26spage%3D2451%26epage%3D2460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Folkman, J.</span><span> </span><span class="NLM_article-title">Angiogenesis-dependent diseases</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1016%2FS0093-7754%2801%2990021-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=11740806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A280%3ADC%252BD3MnptlOguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=536-542&author=J.+Folkman&title=Angiogenesis-dependent+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis-dependent diseases</span></div><div class="casAuthors">Folkman J</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">536-42</span>
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    </div><div class="casAbstract">There is accumulating evidence that leukemias and other hematologic diseases are angiogenesis-dependent.  Therefore, angiogenesis inhibitors may be useful adjuncts to conventional therapies in the treatment of these diseases.  When all conventional therapy has failed, an angiogenesis inhibitor may be successfully used alone, as has been demonstrated in the treatment of multiple myeloma by thalidomide.  The experimental and clinical evidence that the efficacy of thalidomide against multiple myeloma is mediated in part by its antiangiogenic activity is presented here.  In current clinical trials throughout the United States, angiogenesis inhibitors are being used against cancer in combination with conventional chemotherapy or radiotherapy.  Angiogenesis inhibitors are also being used in combination with each other.  This practice may increase as different angiogenesis inhibitors become more widely available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcxNoAnTF920EgZCMqtRBifW6udTcc2eaood6RVTZIAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MnptlOguw%253D%253D&md5=e5d99cc1a7ff1b7e3ee6fcdb07671b45</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2FS0093-7754%2801%2990021-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0093-7754%252801%252990021-1%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DAngiogenesis-dependent%2520diseases%26jtitle%3DSemin.%2520Oncol.%26date%3D2001%26volume%3D28%26spage%3D536%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ferrara, N.</span><span> </span><span class="NLM_article-title">VEGF and the quest for tumor angiogenesis factors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1038%2Fnrc909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=12360282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVGrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=795-803&author=N.+Ferrara&title=VEGF+and+the+quest+for+tumor+angiogenesis+factors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Timeline: VEGF and the quest for tumor angiogenesis factors</span></div><div class="casAuthors">Ferrara, Napoleone</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">795-803</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The ability of tumors to induce new blood-vessel formation has been a major focus of cancer research over the past few decades, and vascular endothelial growth factor (VEGF) is now known to be central to this process.  The quest for VEGF and other factors that promote tumor angiogenesis was initiated many decades ago, and a long and complicated path has led to the development of inhibitors of these mols. as anticancer agents.  How did this field begin, and how have we arrived at our present understanding of the role of VEGF in tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFHN1T3vtAELVg90H21EOLACvtfcHk0lhHi0uqZZOiyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVGrtbk%253D&md5=b0f6d2bde63351fae496d743a9a7e4bf</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1038%2Fnrc909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc909%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DVEGF%2520and%2520the%2520quest%2520for%2520tumor%2520angiogenesis%2520factors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D795%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Risau, W.</span><span> </span><span class="NLM_article-title">Mechanism of angiogenesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=249-257&author=W.+Risau&title=Mechanism+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRisau%26aufirst%3DW.%26atitle%3DMechanism%2520of%2520angiogenesis%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D249%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Baka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clamp, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayson, G. C.</span><span> </span><span class="NLM_article-title">A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1517%2F14728222.10.6.867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=17105373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Smt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=867-876&author=S.+Bakaauthor=A.+R.+Clampauthor=G.+C.+Jayson&title=A+review+of+the+latest+clinical+compounds+to+inhibit+VEGF+in+pathological+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis</span></div><div class="casAuthors">Baka, Sofia; Clamp, Andrew R.; Jayson, Gordon C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">867-876</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Angiogenesis plays an important role in the formation of new blood vessels and is crucial for tumor development and progression.  Imbalance between pro- and antiangiogenesis factors regulates the biol. process of angiogenesis.  The best characterized of the proangiogenic factors and the most potent is vascular endothelial growth factor (VEGF).  The binding of VEGF to one of its transmembrane tyrosine kinase receptors, which are predominantly found on endothelial cells, results in receptor dimerization, activation and autophosphorylation of the tyrosine kinase domain.  This triggers a cascade of complex downstream signalling pathways.  Several strategies targeting the VEGF signalling pathway have been developed.  These include neutralizing antibodies to VEGF (bevacizumab) or VEGF receptors (VEGFRs) (DC101), sol. VEGFR/VEGFR hybrids (VEGF-Trap), and tyrosine kinase inhibitors of VEGFRs (BAY43-9006, SU11248, ZD6474, AZD2171, PTK/ZK and others).  Several of these agents are now being investigated in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozY3D8lNZOqLVg90H21EOLACvtfcHk0lhHi0uqZZOiyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Smt7zO&md5=3cba31f6365fd5ef2749fe401c4a0406</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1517%2F14728222.10.6.867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.10.6.867%26sid%3Dliteratum%253Aachs%26aulast%3DBaka%26aufirst%3DS.%26aulast%3DClamp%26aufirst%3DA.%2BR.%26aulast%3DJayson%26aufirst%3DG.%2BC.%26atitle%3DA%2520review%2520of%2520the%2520latest%2520clinical%2520compounds%2520to%2520inhibit%2520VEGF%2520in%2520pathological%2520angiogenesis%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2006%26volume%3D10%26spage%3D867%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. A.</span><span> </span><span class="NLM_article-title">Antiangiogenic agents targeting vascular endothethial growth factor and its receptors in clinical development</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1447</span><span class="NLM_x">–</span> <span class="NLM_lpage">1465</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1517%2F13543784.11.10.1447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=12387705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFOhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=1447-1465&author=L.+Sepp-Lorenzinoauthor=K.+A.+Thomas&title=Antiangiogenic+agents+targeting+vascular+endothethial+growth+factor+and+its+receptors+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development</span></div><div class="casAuthors">Sepp-Lorenzino, Laura; Thomas, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1447-1465</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  There is ample therapeutic opportunity for the use of antiangiogenic inhibitors in the clinic, as there are several human diseases that are dependent upon angiogenesis.  However, no disease has attracted as much attention as a target for antiangiogenic therapy as malignant disorders.  There is a vast amt. of literature acting as proof-of-principle for the use of angiogenic inhibitors as effective agents for blocking tumor-induced angiogenesis and subverting tumor growth and disease dissemination.  One of the unique attractions of targeting tumor angiogenesis is that vascular endothelial cells are a genetically stable population in which acquisition of therapeutic resistance might be less efficient than in genetically unstable tumor cells [2,3].  This review covers inhibitors that target the tumor angiogenic agent vascular endothelial growth factor and its receptors as one such antiangiogenic approach.  Many agents in this class are in clin. trials with limited reports of toxicity and some early evidence of clin. benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqBbAXNb4_cLVg90H21EOLACvtfcHk0lgUbLVabWJa_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFOhtrw%253D&md5=c2faa232a13b86a261649d6aa9840e97</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1517%2F13543784.11.10.1447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.11.10.1447%26sid%3Dliteratum%253Aachs%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DK.%2BA.%26atitle%3DAntiangiogenic%2520agents%2520targeting%2520vascular%2520endothethial%2520growth%2520factor%2520and%2520its%2520receptors%2520in%2520clinical%2520development%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D1447%26epage%3D1465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Klebl, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, G.</span><span> </span><span class="NLM_article-title">Second-generation kinase inhibitors</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1517%2F14728222.9.5.975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=16185153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVartbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=975-993&author=B.+M.+Kleblauthor=G.+Muller&title=Second-generation+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation kinase inhibitors</span></div><div class="casAuthors">Klebl, Bert M.; Mueller, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">975-993</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  An increasing no. of kinase inhibitor candidates are entering clin. development, representing an important change in the pharmaceutical industry; notably, the development of small-mol. kinase inhibitors for signal transduction therapies.  Today, kinase inhibitors garner substantial attention in cancer research.  Over the last few years, three distinct small-mol. kinase inhibitors reached the market for treatment of chronic myeloid leukemia, gastrointestinal stromal tumors, and non-small cell lung cancers.  These three drugs, imatinib, gefitinib and erlotinib, act on a distinct subset of dysregulated, and often cancer-relevant kinases.  Imatinib, gefitinib and erlotinib are considered the front-runners of targeted kinase inhibitor drugs.  The entire research field gains tremendous insights through the ongoing research and clin. trials with these three drugs and with fast following first-generation kinase inhibitors, many of which are in different phases of clin. development.  In addn., novel chemogenomic and chemoproteomic technologies are emanating from the current kinase research area, focussing efforts on the generation of spectrum-selective inhibitors for anticancer therapies as opposed to the monospecific inhibitors for the remaining therapeutic areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJli31wX5cJbVg90H21EOLACvtfcHk0lgUbLVabWJa_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVartbfN&md5=81c46202984d0fe908b7315008839b03</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1517%2F14728222.9.5.975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.9.5.975%26sid%3Dliteratum%253Aachs%26aulast%3DKlebl%26aufirst%3DB.%2BM.%26aulast%3DMuller%26aufirst%3DG.%26atitle%3DSecond-generation%2520kinase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2005%26volume%3D9%26spage%3D975%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span> </span><span class="NLM_article-title">Protein tyrosine kinase inhibitors as anticancer agents</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1517%2F13543776.14.1.35" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVequrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=35-53&author=C.+T.+Supuranauthor=A.+Scozzafava&title=Protein+tyrosine+kinase+inhibitors+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine kinase inhibitors as anticancer agents</span></div><div class="casAuthors">Supuran, Claudiu T.; Scozzafava, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-53</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  There are > 700 protein kinases and 100 protein phosphatases encoded within the human genome.  By catalyzing protein phosphorylation and dephosphorylation, they play a pivotal role in intracellular signaling and in the regulation of signal transduction pathways.  Activation of oncogenes coding for such proteins can lead to the prodn. of kinases that are continually active in the absence of a normal stimulus, leading to increased cell proliferation and/or decreased apoptosis.  Receptor and nonreceptor protein tyrosine kinases (PTKs) are essential enzymes in cellular signaling processes that regulate cell growth, differentiation, migration and metab.  Their inhibition by specific inhibitors was recently shown to constitute a new modality for cancer treatment.  A patent literature review comprising the years 2000-2003 is presented here, as the major drug houses are currently involved in the design and development of novel types of such compds. with applications as antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorjQ5uLqMRpbVg90H21EOLACvtfcHk0lgUbLVabWJa_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVequrg%253D&md5=0433a3e496ac1961f4602f7dd6ca7dfb</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1517%2F13543776.14.1.35&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.14.1.35%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DScozzafava%26aufirst%3DA.%26atitle%3DProtein%2520tyrosine%2520kinase%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2004%26volume%3D14%26spage%3D35%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kiselyov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakin, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkachenko, S. E.</span><span> </span><span class="NLM_article-title">VEGF/VEGFR signaling as a target for inhibiting angiogenesis</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=83-107&author=A.+Kiselyovauthor=K.+V.+Balakinauthor=S.+E.+Tkachenko&title=VEGF%2FVEGFR+signaling+as+a+target+for+inhibiting+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiselyov%26aufirst%3DA.%26aulast%3DBalakin%26aufirst%3DK.%2BV.%26aulast%3DTkachenko%26aufirst%3DS.%2BE.%26atitle%3DVEGF%252FVEGFR%2520signaling%2520as%2520a%2520target%2520for%2520inhibiting%2520angiogenesis%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D16%26spage%3D83%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Herbst, R. S.</span><span> </span><span class="NLM_article-title">Therapeutic options to target angiogenesis in human malignancies</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1517%2F14728214.11.4.635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=17064223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWltbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=635-650&author=R.+S.+Herbst&title=Therapeutic+options+to+target+angiogenesis+in+human+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic options to target angiogenesis in human malignancies</span></div><div class="casAuthors">Herbst, Roy S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">635-650</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The crit. role of angiogenesis in tumor growth and metastasis is now well established in the literature.  Growing tumors stimulate neovascularization through the secretion of pro-angiogenic growth factors, in particular, basic fibroblast growth factor and VEGF.  Several lines of evidence have implicated VEGF in tumorigenesis, and understanding the role of VEGF in tumor angiogenesis has facilitated the development of novel targeting agents that specifically interfere with angiogenesis.  Different approaches to disrupting tumor-induced angiogenesis encompass tyrosine kinase inhibitor, monoclonal antibodies, small-mol. inhibitors and transcription inhibitors.  However, monoclonal antibody and tyrosine kinase inhibitors are the most advanced drug classes currently being investigated in clin. trials.  So far, three anti-VEGF inhibitors, bevacizumab, sunitinib and sorafenib, have been approved for the treatment of solid human malignancies including colorectal cancer, gastrointestinal stromal tumors and renal cell carcinoma.  Other antiangiogenic drugs are being investigated in various types of cancer.  This review summarizes the current literature on the use of these agents to interfere with VEGF, VEGF receptor, the matrix breakdown or other mechanisms involved in angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCCi5NM8VbsLVg90H21EOLACvtfcHk0lhHZ4fIE74Bqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWltbfL&md5=d66cd5be7b8293bb797f68b7fb6d5d1a</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1517%2F14728214.11.4.635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.11.4.635%26sid%3Dliteratum%253Aachs%26aulast%3DHerbst%26aufirst%3DR.%2BS.%26atitle%3DTherapeutic%2520options%2520to%2520target%2520angiogenesis%2520in%2520human%2520malignancies%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2006%26volume%3D11%26spage%3D635%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Presta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DellʼEra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnati, M.</span><span> </span><span class="NLM_article-title">Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1016%2Fj.cytogfr.2005.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=15863032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=159-178&author=M.+Prestaauthor=P.+Dell%CA%BCEraauthor=S.+Mitolaauthor=E.+Moroniauthor=R.+Roncaauthor=M.+Rusnati&title=Fibroblast+growth+factor%2Ffibroblast+growth+factor+receptor+system+in+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis</span></div><div class="casAuthors">Presta, Marco; Dell'Era, Patrizia; Mitola, Stefania; Moroni, Emanuela; Ronca, Roberto; Rusnati, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-178</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Fibroblast growth factors (FGFs) are a family of heparin-binding growth factors.  FGFs exert their pro-angiogenic activity by interacting with various endothelial cell surface receptors, including tyrosine kinase receptors, heparan-sulfate proteoglycans, and integrins.  Their activity is modulated by a variety of free and extracellular matrix-assocd. mols.  Also, the cross-talk among FGFs, vascular endothelial growth factors (VEGFs), and inflammatory cytokines/chemokines may play a role in the modulation of blood vessel growth in different pathol. conditions, including cancer.  Indeed, several exptl. evidences point to a role for FGFs in tumor growth and angiogenesis.  This review will focus on the relevance of the FGF/FGF receptor system in adult angiogenesis and its contribution to tumor vascularization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ2Z-3PisajLVg90H21EOLACvtfcHk0lhHZ4fIE74Bqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOns7c%253D&md5=9f7ce0832577f97591b7a5c3c120ff12</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cytogfr.2005.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cytogfr.2005.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DPresta%26aufirst%3DM.%26aulast%3DDell%25CA%25BCEra%26aufirst%3DP.%26aulast%3DMitola%26aufirst%3DS.%26aulast%3DMoroni%26aufirst%3DE.%26aulast%3DRonca%26aufirst%3DR.%26aulast%3DRusnati%26aufirst%3DM.%26atitle%3DFibroblast%2520growth%2520factor%252Ffibroblast%2520growth%2520factor%2520receptor%2520system%2520in%2520angiogenesis%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2005%26volume%3D16%26spage%3D159%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ozen, M. A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medrano, E. E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittmann, M. A. C.</span><span> </span><span class="NLM_article-title">Inhibition of proliferation and survival of melanoma cells by adenoviral-mediated expression of dominant negative fibroblast growth factor receptor</span> <span class="citation_source-journal">Melanoma Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1097%2F00008390-200402000-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=15091189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1agtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=13-21&issue=1&author=M.+A.+C.+Ozenauthor=E.+E.+B.+Medranoauthor=M.+A.+C.+Ittmann&title=Inhibition+of+proliferation+and+survival+of+melanoma+cells+by+adenoviral-mediated+expression+of+dominant+negative+fibroblast+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of proliferation and survival of melanoma cells by adenoviral-mediated expression of dominant negative fibroblast growth factor receptor</span></div><div class="casAuthors">Ozen, Mustafa; Medrano, Estela E.; Ittmann, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Melanoma Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-21</span>CODEN:
                <span class="NLM_cas:coden">MREEEH</span>;
        ISSN:<span class="NLM_cas:issn">0960-8931</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Melanoma is the most deadly cutaneous malignancy; its incidence has risen significantly over the last 30 yr and there is no effective treatment for advanced melanoma.  Autocrine expression of fibroblast growth factors (FGFs) is a common event in malignant melanoma.  We therefore sought to inhibit the proliferation and survival of melanoma cells as an approach to melanoma therapy by disrupting FGF signaling via adenoviral-mediated expression of a dominant neg. FGF receptor.  We tested three melanoma cell lines (A375, IIB and UCD) that express FGF2 and respond to exogenous FGF2 with increased proliferation.  In all three cell lines, there was a significant decrease in net proliferation, and in two (A375 and UCD) an increase in cell death, assocd. with expression of the dominant neg. FGF receptor.  In these two cell lines, expression of the dominant neg. FGF receptor resulted in the accumulation of p21 (WAF1/cip1), decreased cell division cycle-2 (cdc2) kinase activity, an increase in the percentage of cells in the G2 phase of the cell cycle, and inhibition of cytokinesis, with accumulation of binucleated cells.  These studies reveal that inhibition of FGF signaling can markedly decrease the net proliferation of melanoma cells by a novel mechanism involving a decrease in cdc2 kinase activity, an increase in p21 expression, inhibition of G2 progression, inhibition of cytokinesis and increased cell death.  In contrast, disruption of FGF signaling had only slight effects on normal melanocytes.  Disruption of FGF signaling via the expression of the dominant neg. FGF receptor is, therefore, a potential therapeutic approach in human melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcsEa7XwD8LbVg90H21EOLACvtfcHk0lhHZ4fIE74Bqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1agtrs%253D&md5=017f21e66536bbf7113a99c73185835d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1097%2F00008390-200402000-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008390-200402000-00003%26sid%3Dliteratum%253Aachs%26aulast%3DOzen%26aufirst%3DM.%2BA.%2BC.%26aulast%3DMedrano%26aufirst%3DE.%2BE.%2BB.%26aulast%3DIttmann%26aufirst%3DM.%2BA.%2BC.%26atitle%3DInhibition%2520of%2520proliferation%2520and%2520survival%2520of%2520melanoma%2520cells%2520by%2520adenoviral-mediated%2520expression%2520of%2520dominant%2520negative%2520fibroblast%2520growth%2520factor%2520receptor%26jtitle%3DMelanoma%2520Res.%26date%3D2004%26volume%3D14%26issue%3D1%26spage%3D13%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Auguste, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gürsel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemière, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuevas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carceller, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">and Bikfalvi, A.</span><span> </span><span class="NLM_article-title">Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">–</span> <span class="NLM_lpage">1726</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=1717-1726&author=P.+Augusteauthor=D.+B.+G%C3%BCrselauthor=S.+Lemi%C3%A8reauthor=D.+Reimersauthor=P.+Cuevasauthor=F.+Carcellerauthor=J.+P.+Di+Santoauthor=A.+and+Bikfalvi&title=Inhibition+of+fibroblast+growth+factor%2Ffibroblast+growth+factor+receptor+activity+in+glioma+cells+impedes+tumor+growth+by+both+angiogenesis-dependent+and+-independent+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAuguste%26aufirst%3DP.%26aulast%3DG%25C3%25BCrsel%26aufirst%3DD.%2BB.%26aulast%3DLemi%25C3%25A8re%26aufirst%3DS.%26aulast%3DReimers%26aufirst%3DD.%26aulast%3DCuevas%26aufirst%3DP.%26aulast%3DCarceller%26aufirst%3DF.%26aulast%3DDi%2BSanto%26aufirst%3DJ.%2BP.%26aulast%3Dand%2BBikfalvi%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520fibroblast%2520growth%2520factor%252Ffibroblast%2520growth%2520factor%2520receptor%2520activity%2520in%2520glioma%2520cells%2520impedes%2520tumor%2520growth%2520by%2520both%2520angiogenesis-dependent%2520and%2520-independent%2520mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D1717%26epage%3D1726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kornmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beger, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korc, M.</span><span> </span><span class="NLM_article-title">Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis</span> <span class="citation_source-journal">Pancreas</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=169-175&author=M.+Kornmannauthor=H.+G.+Begerauthor=M.+Korc&title=Role+of+fibroblast+growth+factors+and+their+receptors+in+pancreatic+cancer+and+chronic+pancreatitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKornmann%26aufirst%3DM.%26aulast%3DBeger%26aufirst%3DH.%2BG.%26aulast%3DKorc%26aufirst%3DM.%26atitle%3DRole%2520of%2520fibroblast%2520growth%2520factors%2520and%2520their%2520receptors%2520in%2520pancreatic%2520cancer%2520and%2520chronic%2520pancreatitis%26jtitle%3DPancreas%26date%3D1998%26volume%3D17%26spage%3D169%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frebourg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfister, C.</span><span> </span><span class="NLM_article-title">Molecular profiling of bladder tumors based on the detection of FGFR3 and TP53 mutations</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">2686</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1016%2Fj.juro.2006.07.132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=17085196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlantbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=2686-9&author=A.+Lamyauthor=F.+Gobetauthor=M.+Laurentauthor=F.+Blanchardauthor=C.+Varinauthor=C.+Moulinauthor=A.+Andreouauthor=T.+Frebourgauthor=C.+Pfister&title=Molecular+profiling+of+bladder+tumors+based+on+the+detection+of+FGFR3+and+TP53+mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular profiling of bladder tumors based on the detection of FGFR3 and TP53 mutations</span></div><div class="casAuthors">Lamy, A.; Gobet, F.; Laurent, M.; Blanchard, F.; Varin, C.; Moulin, C.; Andreou, A.; Frebourg, T.; Pfister, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">6, Pt. 1</span>),
    <span class="NLM_cas:pages">2686-2689</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Purpose: On a routine basis we performed systematic mol. screening for FGFR3 and TP53 mutations in 121 bladder tumors.  We then specifically analyzed the predictive value of the recurrence of FGFR3 and TP53 genotypes in superficial lesions.  Materials and Methods: The FGFR3 gene was analyzed by direct sequencing of exons 7, 10 and 15, whereas TP53 status was detd. using the p53 functional assay in yeast.  Results: We identified a missense FGFR3 mutation in 66% of pTa, 26% of pT1 and 12% of pT2 tumors.  Of activating FGFR3 mutations 54% and 85% were found in low G1 and intermediate G2 grade tumors, resp., but in only 20% of high grade G3 tumors.  We detected inactivating TP53 mutations in 10% of pTa, 42% of pT1 and 58% of pT2 tumors.  Moreover, TP53 mutations were found only in 23% of grade G1 and 3% of grade G2 tumors but in 44% of high grade G3 tumors.  When the 2 genotypes were combined, we obsd. that 58% of pTa tumors had the (mutant FGFR3, WT TP53) genotype, whereas 58% of invasive lesions harbored the inverse genotype (WT FGFR3, mutant TP53).  The (mutant FGFR3, WT TP53) genotype and the (WT FGFR3, mutant TP53) genotype were detected in 23% and 38% of pT1G3 tumors, resp.  In the subgroup of 92 patients with superficial pTa-T1 bladder tumors we did not find that the TP53 or FGFR3 genotype alone or combined had a predictive value for tumor recurrence.  Conclusions: Our data again represent solid proof for the pivotal role of FGFR3 and TP53 mutations in superficial and invasive bladder tumors, resp.  However, other mol. markers should be identified for borderline pT1G3 bladder tumors, which are probably at the crossroads of these 2 distinct mol. pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2xIzAcPgkU7Vg90H21EOLACvtfcHk0li4b5Y7DVIYdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlantbvJ&md5=d16e6a583df615ef20baeab6c3f3b851</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2006.07.132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2006.07.132%26sid%3Dliteratum%253Aachs%26aulast%3DLamy%26aufirst%3DA.%26aulast%3DGobet%26aufirst%3DF.%26aulast%3DLaurent%26aufirst%3DM.%26aulast%3DBlanchard%26aufirst%3DF.%26aulast%3DVarin%26aufirst%3DC.%26aulast%3DMoulin%26aufirst%3DC.%26aulast%3DAndreou%26aufirst%3DA.%26aulast%3DFrebourg%26aufirst%3DT.%26aulast%3DPfister%26aufirst%3DC.%26atitle%3DMolecular%2520profiling%2520of%2520bladder%2520tumors%2520based%2520on%2520the%2520detection%2520of%2520FGFR3%2520and%2520TP53%2520mutations%26jtitle%3DJ.%2520Urol.%26date%3D2006%26volume%3D176%26spage%3D2686%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bhide, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaseelan Sr., R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukral, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DʼArienzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derbin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span> </span><span class="NLM_article-title">Discovery and preclinical studies of (<i>R</i>)-1-(4-(4-fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propanol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2143</span><span class="NLM_x">–</span> <span class="NLM_lpage">2146</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051106d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2143-2146&author=R.+S.+Bhideauthor=Z.-W.+Caiauthor=Y.-Z.+Zhangauthor=L.+Qianauthor=D.+Weiauthor=S.+Barbosaauthor=L.+J.+Lombardoauthor=R.+M.+Borzilleriauthor=X.+Zhengauthor=L.+I.+Wuauthor=J.+C.+Barrishauthor=S.-H.+Kimauthor=K.+Leavittauthor=A.+Mathurauthor=L.+Leithauthor=S.+Chaoauthor=B.+Wautletauthor=S.+Mortilloauthor=R.+Jayaseelan+Sr.author=D.+Kukralauthor=J.+Huntauthor=A.+Kamathauthor=A.+Furaauthor=V.+Vyasauthor=P.+Maratheauthor=C.+D%CA%BCArienzoauthor=G.+Derbinauthor=J.+Fargnoli&title=Discovery+and+preclinical+studies+of+%28R%29-1-%284-%284-fluoro-2-methyl-1H-indol-5-yloxy%29-5-methylpyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazin-6-yloxy%29propanol+%28BMS-540215%29%2C+an+in+vivo+active+potent+VEGFR-2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm051106d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051106d%26sid%3Dliteratum%253Aachs%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DZhang%26aufirst%3DY.-Z.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DBarbosa%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%2BI.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DLeavitt%26aufirst%3DK.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DLeith%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DS.%26aulast%3DWautlet%26aufirst%3DB.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DJayaseelan%2BSr.%26aufirst%3DR.%26aulast%3DKukral%26aufirst%3DD.%26aulast%3DHunt%26aufirst%3DJ.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DD%25CA%25BCArienzo%26aufirst%3DC.%26aulast%3DDerbin%26aufirst%3DG.%26aulast%3DFargnoli%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520preclinical%2520studies%2520of%2520%2528R%2529-1-%25284-%25284-fluoro-2-methyl-1H-indol-5-yloxy%2529-5-methylpyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-6-yloxy%2529propanol%2520%2528BMS-540215%2529%252C%2520an%2520in%2520vivo%2520active%2520potent%2520VEGFR-2%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2143%26epage%3D2146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hu, L.</span><span> </span><span class="NLM_article-title">Prodrug approaches to drug delivery</span>. In  <span class="citation_source-book">Drug Delivery Principles and Applications</span>. <span class="NLM_contrib-group">Wang, B.; Siahaan, T.; Soltero, R. A.</span>, Eds.; <span class="NLM_publisher-name">John Wiley & Son, Inc.</span>: <span class="NLM_publisher-loc">New Jersey</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">125</span>#x2013; <span class="NLM_lpage">165</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=125-165&author=L.+Hu&title=Drug+Delivery+Principles+and+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DL.%26atitle%3DProdrug%2520approaches%2520to%2520drug%2520delivery%26btitle%3DDrug%2520Delivery%2520Principles%2520and%2520Applications%26aulast%3DWang%26aufirst%3DB.%26pub%3DJohn%2520Wiley%2520%2526%2520Son%252C%2520Inc%26date%3D2005%26spage%3D125%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goyal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R. S.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-<i>f</i>][1,2,4]triazine based VEGFR-2 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1433</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1429-1433&author=R.+M.+Borzilleriauthor=Z.-W.+Caiauthor=C.+Ellisauthor=J.+Fargnoliauthor=A.+Furaauthor=T.+Gerhardtauthor=B.+Goyalauthor=J.+T.+Huntauthor=S.+Mortilloauthor=L.+Qianauthor=J.+Tokarskiauthor=V.+Vyasauthor=B.+Wautletauthor=X.+Zhengauthor=R.+S.+Bhide&title=Synthesis+and+SAR+of+4-%283-hydroxyphenylamino%29pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+based+VEGFR-2+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DEllis%26aufirst%3DC.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DGerhardt%26aufirst%3DT.%26aulast%3DGoyal%26aufirst%3DB.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DTokarski%26aufirst%3DJ.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DWautlet%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-%25283-hydroxyphenylamino%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520based%2520VEGFR-2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1429%26epage%3D1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kabalka, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayana, C.</span><span> </span><span class="NLM_article-title">Sodium perborate: A convenient reagent for benzylic hydroperoxide rearrangement</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">7667</span><span class="NLM_x">–</span> <span class="NLM_lpage">7668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1993&pages=7667-7668&author=G.+W.+Kabalkaauthor=N.+K.+Reddyauthor=C.+Narayana&title=Sodium+perborate%3A+A+convenient+reagent+for+benzylic+hydroperoxide+rearrangement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKabalka%26aufirst%3DG.%2BW.%26aulast%3DReddy%26aufirst%3DN.%2BK.%26aulast%3DNarayana%26aufirst%3DC.%26atitle%3DSodium%2520perborate%253A%2520A%2520convenient%2520reagent%2520for%2520benzylic%2520hydroperoxide%2520rearrangement%26jtitle%3DTetrahedron%2520Lett.%26date%3D1993%26volume%3D34%26spage%3D7667%26epage%3D7668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukral, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of orally active 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)-pyrrolo[2,1-<i>f</i>][1,2,4]triazines as dual vascular endothelial growth factor receptor-2 (VEGFR-2) and fibroblast growth factor receptor-1 (FGFR-1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3991</span><span class="NLM_x">–</span> <span class="NLM_lpage">4008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0501275" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3991-4008&author=R.+M.+Borzilleriauthor=X.+Zhengauthor=L.+Qianauthor=C.+Ellisauthor=Z.-W.+Caiauthor=B.+Wautletauthor=S.+Mortilloauthor=R.+Jeyaseelanauthor=D.+Kukralauthor=A.+Furaauthor=A.+Kamathauthor=V.+Vyasauthor=J.+Tokarskiauthor=J.+C.+Barrishauthor=J.+T.+Huntauthor=L.+J.+Lombardoauthor=J.+Fargnoliauthor=R.+Bhide&title=Design%2C+synthesis%2C+and+evaluation+of+orally+active+4-%282%2C4-difluoro-5-%28methoxycarbamoyl%29phenylamino%29-pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazines+as+dual+vascular+endothelial+growth+factor+receptor-2+%28VEGFR-2%29+and+fibroblast+growth+factor+receptor-1+%28FGFR-1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm0501275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0501275%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DEllis%26aufirst%3DC.%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DWautlet%26aufirst%3DB.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKukral%26aufirst%3DD.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DTokarski%26aufirst%3DJ.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBhide%26aufirst%3DR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520orally%2520active%25204-%25282%252C4-difluoro-5-%2528methoxycarbamoyl%2529phenylamino%2529-pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%2520as%2520dual%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520%2528VEGFR-2%2529%2520and%2520fibroblast%2520growth%2520factor%2520receptor-1%2520%2528FGFR-1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3991%26epage%3D4008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><div class="note"><p class="first last">For detailed in vivo assay condition, see <a class="ref internalNav" href="#ref16" aria-label="Experimental Section in ref 16">Experimental Section in ref 16</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+detailed+in+vivo+assay+condition%2C+see+Experimental+Section+in+ref+16."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Chen, B.-C.; Zhao, R.; Sundeen, J. E.; Leftheris, K.; Hynes, J.; Wrobleski, S. T.</span><span> </span><span class="NLM_article-title">Process for preparing pyrrolotriazine kinase inhibitors</span>. U.S. patent application, US 2004157846,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=B.-C.+Chen&author=R.+Zhao&author=J.+E.+Sundeen&author=K.+Leftheris&author=J.+Hynes&author=S.+T.+Wrobleski&title=Process+for+preparing+pyrrolotriazine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.-C.%26atitle%3DProcess%2520for%2520preparing%2520pyrrolotriazine%2520kinase%2520inhibitors%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 102 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Debasmita Saha, Anupreet Kharbanda, Wei Yan, Naga Rajiv Lakkaniga, Brendan Frett, <span class="NLM_string-name hlFld-ContribAuthor">Hong-Yu Li</span>. </span><span class="cited-content_cbyCitation_article-title">The Exploration of Chirality for Improved Druggability within the Human Kinome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (2)
                                     , 441-469. <a href="https://doi.org/10.1021/acs.jmedchem.9b00640" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00640</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00640%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BExploration%252Bof%252BChirality%252Bfor%252BImproved%252BDruggability%252Bwithin%252Bthe%252BHuman%252BKinome%26aulast%3DSaha%26aufirst%3DDebasmita%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D15042019%26date%3D09102019%26date%3D24092019%26volume%3D63%26issue%3D2%26spage%3D441%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Murugaiah A. M. Subbaiah, Sandhya Mandlekar, Sridhar Desikan, Thangeswaran Ramar, Lakshumanan Subramani, Mathiazhagan Annadurai, Salil D. Desai, Sarmistha Sinha, Susan M. Jenkins, Mark R. Krystal, Murali Subramanian, Srikanth Sridhar, Shweta Padmanabhan, Priyadeep Bhutani, Rambabu Arla, Shashyendra Singh, Jaydeep Sinha, Megha Thakur, John F. Kadow, <span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor Atazanavir. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3553-3574. <a href="https://doi.org/10.1021/acs.jmedchem.9b00002" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacokinetic%252BEvaluation%252Bof%252BPhosphate%252Band%252BAmino%252BAcid%252BEster%252BProdrugs%252Bfor%252BImproving%252Bthe%252BOral%252BBioavailability%252Bof%252Bthe%252BHIV-1%252BProtease%252BInhibitor%252BAtazanavir%26aulast%3DA.%2BM.%2BSubbaiah%26aufirst%3DMurugaiah%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D01012019%26date%3D02042019%26volume%3D62%26issue%3D7%26spage%3D3553%26epage%3D3574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhanni  Gu</span>, <span class="hlFld-ContribAuthor ">Shuni  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">José Luis  Aceña</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, and <span class="hlFld-ContribAuthor ">Hong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (2)
                                     , 422-518. <a href="https://doi.org/10.1021/acs.chemrev.5b00392" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00392%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DNext%252BGeneration%252Bof%252BFluorine-Containing%252BPharmaceuticals%25252C%252BCompounds%252BCurrently%252Bin%252BPhase%252BII%2525E2%252580%252593III%252BClinical%252BTrials%252Bof%252BMajor%252BPharmaceutical%252BCompanies%25253A%252BNew%252BStructural%252BTrends%252Band%252BTherapeutic%252BAreas%26aulast%3DZhou%26aufirst%3DYu%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D06072015%26date%3D12012016%26date%3D27012016%26volume%3D116%26issue%3D2%26spage%3D422%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul C.  Lobben</span>, <span class="hlFld-ContribAuthor ">Evan  Barlow</span>, <span class="hlFld-ContribAuthor ">James S.  Bergum</span>, <span class="hlFld-ContribAuthor ">Alan  Braem</span>, <span class="hlFld-ContribAuthor ">Shih-Ying  Chang</span>, <span class="hlFld-ContribAuthor ">Frank  Gibson</span>, <span class="hlFld-ContribAuthor ">Nathaniel  Kopp</span>, <span class="hlFld-ContribAuthor ">Chiajen  Lai</span>, <span class="hlFld-ContribAuthor ">Thomas L.  LaPorte</span>, <span class="hlFld-ContribAuthor ">David K.  Leahy</span>, <span class="hlFld-ContribAuthor ">Jale  Müslehiddinoğlu</span>, <span class="hlFld-ContribAuthor ">Fernando  Quiroz</span>, <span class="hlFld-ContribAuthor ">Dimitri  Skliar</span>, <span class="hlFld-ContribAuthor ">Lori  Spangler</span>, <span class="hlFld-ContribAuthor ">Sushil  Srivastava</span>, <span class="hlFld-ContribAuthor ">Daniel  Wasser</span>, <span class="hlFld-ContribAuthor ">John  Wasylyk</span>, <span class="hlFld-ContribAuthor ">Robert  Wethman</span>, and <span class="hlFld-ContribAuthor ">Zhongmin  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Control Strategy for the Manufacture of Brivanib Alaninate, a Novel Pyrrolotriazine VEGFR/FGFR Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2015,</strong> <em>19 </em>
                                    (8)
                                     , 900-907. <a href="https://doi.org/10.1021/op500126u" title="DOI URL">https://doi.org/10.1021/op500126u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op500126u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop500126u%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DControl%252BStrategy%252Bfor%252Bthe%252BManufacture%252Bof%252BBrivanib%252BAlaninate%25252C%252Ba%252BNovel%252BPyrrolotriazine%252BVEGFR%25252FFGFR%252BInhibitor%26aulast%3DLobben%26aufirst%3DPaul%2BC.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D15042014%26date%3D29052014%26date%3D21082015%26date%3D15052014%26volume%3D19%26issue%3D8%26spage%3D900%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaan A.  Pesti</span>, <span class="hlFld-ContribAuthor ">Thomas  LaPorte</span>, <span class="hlFld-ContribAuthor ">John E.  Thornton</span>, <span class="hlFld-ContribAuthor ">Lori  Spangler</span>, <span class="hlFld-ContribAuthor ">Frederic  Buono</span>, <span class="hlFld-ContribAuthor ">Gerard  Crispino</span>, <span class="hlFld-ContribAuthor ">Frank  Gibson</span>, <span class="hlFld-ContribAuthor ">Paul  Lobben</span>, and <span class="hlFld-ContribAuthor ">Christos G.  Papaioannou</span>  . </span><span class="cited-content_cbyCitation_article-title">Commercial Synthesis of a Pyrrolotriazine–Fluoroindole Intermediate to Brivanib Alaninate: Process Development Directed toward Impurity Control. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2014,</strong> <em>18 </em>
                                    (1)
                                     , 89-102. <a href="https://doi.org/10.1021/op400242j" title="DOI URL">https://doi.org/10.1021/op400242j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op400242j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop400242j%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DCommercial%252BSynthesis%252Bof%252Ba%252BPyrrolotriazine%2525E2%252580%252593Fluoroindole%252BIntermediate%252Bto%252BBrivanib%252BAlaninate%25253A%252BProcess%252BDevelopment%252BDirected%252Btoward%252BImpurity%252BControl%26aulast%3DPesti%26aufirst%3DJaan%2BA.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D01092013%26date%3D10122013%26date%3D17012014%26date%3D02122013%26volume%3D18%26issue%3D1%26spage%3D89%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Musumeci</span>, <span class="hlFld-ContribAuthor ">Marco  Radi</span>, <span class="hlFld-ContribAuthor ">Chiara  Brullo</span>, and <span class="hlFld-ContribAuthor ">Silvia  Schenone</span>  . </span><span class="cited-content_cbyCitation_article-title">Vascular Endothelial Growth Factor (VEGF) Receptors: Drugs and New Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (24)
                                     , 10797-10822. <a href="https://doi.org/10.1021/jm301085w" title="DOI URL">https://doi.org/10.1021/jm301085w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301085w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301085w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DVascular%252BEndothelial%252BGrowth%252BFactor%252B%252528VEGF%252529%252BReceptors%25253A%252BDrugs%252Band%252BNew%252BInhibitors%26aulast%3DMusumeci%26aufirst%3DFrancesca%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D25072012%26date%3D06112012%26date%3D27122012%26date%3D25102012%26volume%3D55%26issue%3D24%26spage%3D10797%26epage%3D10822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason G.  Kettle</span>, <span class="hlFld-ContribAuthor ">Simon  Brown</span>, <span class="hlFld-ContribAuthor ">Claire  Crafter</span>, <span class="hlFld-ContribAuthor ">Barry R.  Davies</span>, <span class="hlFld-ContribAuthor ">Phillippa  Dudley</span>, <span class="hlFld-ContribAuthor ">Gary  Fairley</span>, <span class="hlFld-ContribAuthor ">Paul  Faulder</span>, <span class="hlFld-ContribAuthor ">Shaun  Fillery</span>, <span class="hlFld-ContribAuthor ">Hannah  Greenwood</span>, <span class="hlFld-ContribAuthor ">Janet  Hawkins</span>, <span class="hlFld-ContribAuthor ">Michael  James</span>, <span class="hlFld-ContribAuthor ">Keith  Johnson</span>, <span class="hlFld-ContribAuthor ">Clare D.  Lane</span>, <span class="hlFld-ContribAuthor ">Martin  Pass</span>, <span class="hlFld-ContribAuthor ">Jennifer H.  Pink</span>, <span class="hlFld-ContribAuthor ">Helen  Plant</span>, and <span class="hlFld-ContribAuthor ">Sabina C.  Cosulich</span>  . </span><span class="cited-content_cbyCitation_article-title">Diverse Heterocyclic Scaffolds as Allosteric Inhibitors of AKT. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (3)
                                     , 1261-1273. <a href="https://doi.org/10.1021/jm201394e" title="DOI URL">https://doi.org/10.1021/jm201394e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201394e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201394e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiverse%252BHeterocyclic%252BScaffolds%252Bas%252BAllosteric%252BInhibitors%252Bof%252BAKT%26aulast%3DKettle%26aufirst%3DJason%2BG.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D17102011%26date%3D27012012%26date%3D09022012%26date%3D16012012%26volume%3D55%26issue%3D3%26spage%3D1261%26epage%3D1273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>, <span class="hlFld-ContribAuthor ">Nadine C.  Becknell</span>, <span class="hlFld-ContribAuthor ">Allison L.  Zulli</span>, <span class="hlFld-ContribAuthor ">Ted L.  Underiner</span>, <span class="hlFld-ContribAuthor ">Thelma S.  Angeles</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Mark S.  Albom</span>, <span class="hlFld-ContribAuthor ">Hong  Chang</span>, <span class="hlFld-ContribAuthor ">Sheila J.  Miknyoczki</span>, <span class="hlFld-ContribAuthor ">Kathryn  Hunter</span>, <span class="hlFld-ContribAuthor ">Susan  Jones-Bolin</span>, <span class="hlFld-ContribAuthor ">Hugh  Zhao</span>, <span class="hlFld-ContribAuthor ">Edward R.  Bacon</span>, <span class="hlFld-ContribAuthor ">John P.  Mallamo</span>, <span class="hlFld-ContribAuthor ">Mark A.  Ator</span>, and <span class="hlFld-ContribAuthor ">Bruce A.  Ruggeri</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (2)
                                     , 903-913. <a href="https://doi.org/10.1021/jm201449n" title="DOI URL">https://doi.org/10.1021/jm201449n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201449n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201449n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BProfile%252Bof%252Bthe%252Bpan-Vascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor%25252FTyrosine%252BKinase%252Bwith%252BImmunoglobulin%252Band%252BEpidermal%252BGrowth%252BFactor-Like%252BHomology%252BDomains%252B2%252B%252528VEGF-R%25252FTIE-2%252529%252BInhibitor%252B11-%2525282-Methylpropyl%252529-12%25252C13-dihydro-2-methyl-8-%252528pyrimidin-2-ylamino%252529-4H-indazolo%25255B5%25252C4-a%25255Dpyrrolo%25255B3%25252C4-c%25255Dcarbazol-4-one%252B%252528CEP-11981%252529%25253A%252BA%252BNovel%252BOncology%252BTherapeutic%252BAgent%26aulast%3DHudkins%26aufirst%3DRobert%2BL.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D26102011%26date%3D06012012%26date%3D26012012%26date%3D12122011%26volume%3D55%26issue%3D2%26spage%3D903%26epage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hidehisa  Iwata</span>, <span class="hlFld-ContribAuthor ">Shinichi  Imamura</span>, <span class="hlFld-ContribAuthor ">Akira  Hori</span>, <span class="hlFld-ContribAuthor ">Mark S.  Hixon</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Kimura</span>, and <span class="hlFld-ContribAuthor ">Hiroshi  Miki</span>  . </span><span class="cited-content_cbyCitation_article-title">Biochemical Characterization of TAK-593, a Novel VEGFR/PDGFR Inhibitor with a Two-Step Slow Binding Mechanism. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2011,</strong> <em>50 </em>
                                    (5)
                                     , 738-751. <a href="https://doi.org/10.1021/bi101777f" title="DOI URL">https://doi.org/10.1021/bi101777f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi101777f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi101777f%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DBiochemical%252BCharacterization%252Bof%252BTAK-593%25252C%252Ba%252BNovel%252BVEGFR%25252FPDGFR%252BInhibitor%252Bwith%252Ba%252BTwo-Step%252BSlow%252BBinding%252BMechanism%26aulast%3DIwata%26aufirst%3DHidehisa%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D05112010%26date%3D14122010%26date%3D10012011%26date%3D08022011%26date%3D23122010%26volume%3D50%26issue%3D5%26spage%3D738%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason G.  Kettle</span> and <span class="hlFld-ContribAuthor ">Richard A.  Ward</span>. </span><span class="cited-content_cbyCitation_article-title">Toward the Comprehensive Systematic Enumeration and Synthesis of Novel Kinase Inhibitors Based on a 4-Anilinoquinazoline Binding Mode. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2010,</strong> <em>50 </em>
                                    (4)
                                     , 525-533. <a href="https://doi.org/10.1021/ci9004767" title="DOI URL">https://doi.org/10.1021/ci9004767</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci9004767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci9004767%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DToward%252Bthe%252BComprehensive%252BSystematic%252BEnumeration%252Band%252BSynthesis%252Bof%252BNovel%252BKinase%252BInhibitors%252BBased%252Bon%252Ba%252B4-Anilinoquinazoline%252BBinding%252BMode%26aulast%3DKettle%26aufirst%3DJason%2BG.%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D10%252012%25202009%26date%3D09022010%26date%3D26042010%26volume%3D50%26issue%3D4%26spage%3D525%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhong</span>, <span class="hlFld-ContribAuthor ">Yueshan  Li</span>, <span class="hlFld-ContribAuthor ">Liang  Xiong</span>, <span class="hlFld-ContribAuthor ">Wenjing  Wang</span>, <span class="hlFld-ContribAuthor ">Ming  Wu</span>, <span class="hlFld-ContribAuthor ">Ting  Yuan</span>, <span class="hlFld-ContribAuthor ">Wei  Yang</span>, <span class="hlFld-ContribAuthor ">Chenyu  Tian</span>, <span class="hlFld-ContribAuthor ">Zhuang  Miao</span>, <span class="hlFld-ContribAuthor ">Tianqi  Wang</span>, <span class="hlFld-ContribAuthor ">Shengyong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2021,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-021-00572-w" title="DOI URL">https://doi.org/10.1038/s41392-021-00572-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-021-00572-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-021-00572-w%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DSmall%252Bmolecules%252Bin%252Btargeted%252Bcancer%252Btherapy%25253A%252Badvances%25252C%252Bchallenges%25252C%252Band%252Bfuture%252Bperspectives%26aulast%3DZhong%26aufirst%3DLei%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yihong  Wan</span>, <span class="hlFld-ContribAuthor ">Wenyu  Wu</span>, <span class="hlFld-ContribAuthor ">Yuanda  Wan</span>, <span class="hlFld-ContribAuthor ">Liren  Li</span>, <span class="hlFld-ContribAuthor ">Jiawen  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Chen</span>, <span class="hlFld-ContribAuthor ">Shuwen  Liu</span>, <span class="hlFld-ContribAuthor ">Xingang  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Brivanib alaninate inhibited dengue virus proliferation through VEGFR2/AMPK pathway. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>170 </em>, 105721. <a href="https://doi.org/10.1016/j.phrs.2021.105721" title="DOI URL">https://doi.org/10.1016/j.phrs.2021.105721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2021.105721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2021.105721%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DBrivanib%252Balaninate%252Binhibited%252Bdengue%252Bvirus%252Bproliferation%252Bthrough%252BVEGFR2%25252FAMPK%252Bpathway%26aulast%3DWan%26aufirst%3DYihong%26date%3D2021%26volume%3D170%26spage%3D105721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olga  Nigro</span>, <span class="hlFld-ContribAuthor ">Claudio  Chini</span>, <span class="hlFld-ContribAuthor ">Ilaria  Proserpio</span>. </span><span class="cited-content_cbyCitation_article-title">Molecularly targeted therapy for advanced gastrointestinal noncolorectal cancer treatment: how to choose? Past, present, future. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Drugs</span><span> <strong>2021,</strong> <em>32 </em>
                                    (6)
                                     , 593-601. <a href="https://doi.org/10.1097/CAD.0000000000001071" title="DOI URL">https://doi.org/10.1097/CAD.0000000000001071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/CAD.0000000000001071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FCAD.0000000000001071%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Drugs%26atitle%3DMolecularly%252Btargeted%252Btherapy%252Bfor%252Badvanced%252Bgastrointestinal%252Bnoncolorectal%252Bcancer%252Btreatment%25253A%252Bhow%252Bto%252Bchoose%25253F%252BPast%25252C%252Bpresent%25252C%252Bfuture%26aulast%3DNigro%26aufirst%3DOlga%26date%3D2021%26date%3D2021%26volume%3D32%26issue%3D6%26spage%3D593%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Limin  An</span>, <span class="hlFld-ContribAuthor ">Haotian  Liao</span>, <span class="hlFld-ContribAuthor ">Kefei  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy and Safety of Second-line Treatments in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: A Meta-analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical and Translational Hepatology</span><span> <strong>2021,</strong> <em>000 </em>
                                    (000)
                                     , 000-000. <a href="https://doi.org/10.14218/JCTH.2021.00054" title="DOI URL">https://doi.org/10.14218/JCTH.2021.00054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14218/JCTH.2021.00054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14218%2FJCTH.2021.00054%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520and%2520Translational%2520Hepatology%26atitle%3DEfficacy%252Band%252BSafety%252Bof%252BSecond-line%252BTreatments%252Bin%252BPatients%252Bwith%252BAdvanced%252BHepatocellular%252BCarcinoma%252Bafter%252BSorafenib%252BFailure%25253A%252BA%252BMeta-analysis%26aulast%3DAn%26aufirst%3DLimin%26date%3D2021%26date%3D2021%26volume%3D000%26issue%3D000%26spage%3D000%26epage%3D000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Liang</span>, <span class="hlFld-ContribAuthor ">Juelan  Wang</span>, <span class="hlFld-ContribAuthor ">Liyun  Zhao</span>, <span class="hlFld-ContribAuthor ">Jun  Hou</span>, <span class="hlFld-ContribAuthor ">Yonghe  Hu</span>, <span class="hlFld-ContribAuthor ">Jianyou  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances of dual FGFR inhibitors as a novel therapy for cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113205. <a href="https://doi.org/10.1016/j.ejmech.2021.113205" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113205%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bof%252Bdual%252BFGFR%252Binhibitors%252Bas%252Ba%252Bnovel%252Btherapy%252Bfor%252Bcancer%26aulast%3DLiang%26aufirst%3DQi%26date%3D2021%26volume%3D214%26spage%3D113205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sravani  Sana</span>, <span class="hlFld-ContribAuthor ">Velma Ganga  Reddy</span>, <span class="hlFld-ContribAuthor ">Sonal  Bhandari</span>, <span class="hlFld-ContribAuthor ">T. Srinivasa  Reddy</span>, <span class="hlFld-ContribAuthor ">Ramya  Tokala</span>, <span class="hlFld-ContribAuthor ">Akash P.  Sakla</span>, <span class="hlFld-ContribAuthor ">Suresh K.  Bhargava</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112457. <a href="https://doi.org/10.1016/j.ejmech.2020.112457" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112457%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploration%252Bof%252Bcarbamide%252Bderived%252Bpyrimidine-thioindole%252Bconjugates%252Bas%252Bpotential%252BVEGFR-2%252Binhibitors%252Bwith%252Banti-angiogenesis%252Beffect%26aulast%3DSana%26aufirst%3DSravani%26date%3D2020%26volume%3D200%26spage%3D112457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robin L.  Jones</span>, <span class="hlFld-ContribAuthor ">Mark J.  Ratain</span>, <span class="hlFld-ContribAuthor ">Peter J.  O'Dwyer</span>, <span class="hlFld-ContribAuthor ">Lillian L.  Siu</span>, <span class="hlFld-ContribAuthor ">Jacek  Jassem</span>, <span class="hlFld-ContribAuthor ">Jacques  Medioni</span>, <span class="hlFld-ContribAuthor ">Maja  DeJonge</span>, <span class="hlFld-ContribAuthor ">Charles  Rudin</span>, <span class="hlFld-ContribAuthor ">Michael  Sawyer</span>, <span class="hlFld-ContribAuthor ">David  Khayat</span>, <span class="hlFld-ContribAuthor ">Ahmad  Awada</span>, <span class="hlFld-ContribAuthor ">Judith M.P.G.M.  de Vos-Geelen</span>, <span class="hlFld-ContribAuthor ">T.R. Jeffry  Evans</span>, <span class="hlFld-ContribAuthor ">Jennifer  Obel</span>, <span class="hlFld-ContribAuthor ">Bruce  Brockstein</span>, <span class="hlFld-ContribAuthor ">Jacques  DeGreve</span>, <span class="hlFld-ContribAuthor ">Jean-Francois  Baurain</span>, <span class="hlFld-ContribAuthor ">Robert  Maki</span>, <span class="hlFld-ContribAuthor ">David  D'Adamo</span>, <span class="hlFld-ContribAuthor ">Mark  Dickson</span>, <span class="hlFld-ContribAuthor ">Samir  Undevia</span>, <span class="hlFld-ContribAuthor ">David  Geary</span>, <span class="hlFld-ContribAuthor ">Linda  Janisch</span>, <span class="hlFld-ContribAuthor ">Philippe L.  Bedard</span>, <span class="hlFld-ContribAuthor ">Albiruni R.  Abdul Razak</span>, <span class="hlFld-ContribAuthor ">Rebecca  Kristeleit</span>, <span class="hlFld-ContribAuthor ">Joanna  Vitfell-Rasmussen</span>, <span class="hlFld-ContribAuthor ">Ian  Walters</span>, <span class="hlFld-ContribAuthor ">Stan B.  Kaye</span>, <span class="hlFld-ContribAuthor ">Gary  Schwartz</span>. </span><span class="cited-content_cbyCitation_article-title">Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Cancer</span><span> <strong>2019,</strong> <em>120 </em>, 132-139. <a href="https://doi.org/10.1016/j.ejca.2019.07.024" title="DOI URL">https://doi.org/10.1016/j.ejca.2019.07.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejca.2019.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejca.2019.07.024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Cancer%26atitle%3DPhase%252BII%252Brandomised%252Bdiscontinuation%252Btrial%252Bof%252Bbrivanib%252Bin%252Bpatients%252Bwith%252Badvanced%252Bsolid%252Btumours%26aulast%3DJones%26aufirst%3DRobin%2BL.%26date%3D2019%26volume%3D120%26spage%3D132%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mossenta</span>, <span class="hlFld-ContribAuthor ">Busato</span>, <span class="hlFld-ContribAuthor ">Baboci</span>, <span class="hlFld-ContribAuthor ">Cintio</span>, <span class="hlFld-ContribAuthor ">Toffoli</span>, <span class="hlFld-ContribAuthor ">Bo</span>. </span><span class="cited-content_cbyCitation_article-title">New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (8)
                                     , 1086. <a href="https://doi.org/10.3390/cancers11081086" title="DOI URL">https://doi.org/10.3390/cancers11081086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11081086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11081086%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DNew%252BInsight%252Binto%252BTherapies%252BTargeting%252BAngiogenesis%252Bin%252BHepatocellular%252BCarcinoma%26aulast%3DMossenta%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D8%26spage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhaskar Venkata Kameswara Subrahmanya  Lakkakula</span>, <span class="hlFld-ContribAuthor ">Batoul  Farran</span>, <span class="hlFld-ContribAuthor ">Saikrishna  Lakkakula</span>, <span class="hlFld-ContribAuthor ">Sujatha  Peela</span>, <span class="hlFld-ContribAuthor ">Nagendra Sastry  Yarla</span>, <span class="hlFld-ContribAuthor ">Pallaval Veera  Bramhachari</span>, <span class="hlFld-ContribAuthor ">Mohammad Amjad  Kamal</span>, <span class="hlFld-ContribAuthor ">Madhu Sudhana  Saddala</span>, <span class="hlFld-ContribAuthor ">Ganji Purnachandra  Nagaraju</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule tyrosine kinase inhibitors and pancreatic cancer—Trials and troubles. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2019,</strong> <em>56 </em>, 149-167. <a href="https://doi.org/10.1016/j.semcancer.2018.09.011" title="DOI URL">https://doi.org/10.1016/j.semcancer.2018.09.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2018.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2018.09.011%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DSmall%252Bmolecule%252Btyrosine%252Bkinase%252Binhibitors%252Band%252Bpancreatic%252Bcancer%2525E2%252580%252594Trials%252Band%252Btroubles%26aulast%3DLakkakula%26aufirst%3DBhaskar%2BVenkata%2BKameswara%2BSubrahmanya%26date%3D2019%26volume%3D56%26spage%3D149%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sahin  Lacin</span>, <span class="hlFld-ContribAuthor ">Asif  Rashid</span>, <span class="hlFld-ContribAuthor ">Yun Shin  Chun</span>, <span class="hlFld-ContribAuthor ">Bruno Calazans  Odisio</span>, <span class="hlFld-ContribAuthor ">Eugene J.  Koay</span>, <span class="hlFld-ContribAuthor ">Reham  Abdel-Wahab</span>, <span class="hlFld-ContribAuthor ">Ahmed O.  Kaseb</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 207-234. <a href="https://doi.org/10.1007/978-3-030-18890-0_13" title="DOI URL">https://doi.org/10.1007/978-3-030-18890-0_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-18890-0_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-18890-0_13%26sid%3Dliteratum%253Aachs%26atitle%3DHepatocellular%252BCarcinoma%26aulast%3DLacin%26aufirst%3DSahin%26date%3D2019%26date%3D2019%26spage%3D207%26epage%3D234%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DTextbook%252Bof%252BGastrointestinal%252BOncology%26aulast%3DYalcin%26aufirst%3DSuayib%26date%3D2019%26volume%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Hao  Qiang</span>, <span class="hlFld-ContribAuthor ">Dandan  Huang</span>, <span class="hlFld-ContribAuthor ">Xinzhou  Bi</span>, <span class="hlFld-ContribAuthor ">Wenlong  Huang</span>, <span class="hlFld-ContribAuthor ">Hai  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 814-831. <a href="https://doi.org/10.1016/j.ejmech.2018.09.050" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.050%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploration%252Bof%252Bnovel%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine%252Bderivatives%252Bwith%252Bimproved%252Banticancer%252Befficacy%252Bas%252Bdual%252Binhibitors%252Bof%252Bc-Met%25252FVEGFR-2%26aulast%3DShi%26aufirst%3DWei%26date%3D2018%26volume%3D158%26spage%3D814%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stella  Cascioferro</span>, <span class="hlFld-ContribAuthor ">Barbara  Parrino</span>, <span class="hlFld-ContribAuthor ">Virginia  Spanò</span>, <span class="hlFld-ContribAuthor ">Anna  Carbone</span>, <span class="hlFld-ContribAuthor ">Alessandra  Montalbano</span>, <span class="hlFld-ContribAuthor ">Paola  Barraja</span>, <span class="hlFld-ContribAuthor ">Patrizia  Diana</span>, <span class="hlFld-ContribAuthor ">Girolamo  Cirrincione</span>. </span><span class="cited-content_cbyCitation_article-title">An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>142 </em>, 328-375. <a href="https://doi.org/10.1016/j.ejmech.2017.08.009" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.009%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Boverview%252Bon%252Bthe%252Brecent%252Bdevelopments%252Bof%252B1%25252C2%25252C4-triazine%252Bderivatives%252Bas%252Banticancer%252Bcompounds%26aulast%3DCascioferro%26aufirst%3DStella%26date%3D2017%26volume%3D142%26spage%3D328%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jarkko  Rautio</span>, <span class="hlFld-ContribAuthor ">Jussi  Kärkkäinen</span>, <span class="hlFld-ContribAuthor ">Kenneth B.  Sloan</span>. </span><span class="cited-content_cbyCitation_article-title">Prodrugs – Recent approvals and a glimpse of the pipeline. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2017,</strong> <em>109 </em>, 146-161. <a href="https://doi.org/10.1016/j.ejps.2017.08.002" title="DOI URL">https://doi.org/10.1016/j.ejps.2017.08.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2017.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2017.08.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DProdrugs%252B%2525E2%252580%252593%252BRecent%252Bapprovals%252Band%252Ba%252Bglimpse%252Bof%252Bthe%252Bpipeline%26aulast%3DRautio%26aufirst%3DJarkko%26date%3D2017%26volume%3D109%26spage%3D146%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.S.  Perera</span>, <span class="hlFld-ContribAuthor ">Eleonora  Jovcheva</span>, <span class="hlFld-ContribAuthor ">Laurence  Mevellec</span>, <span class="hlFld-ContribAuthor ">Jorge  Vialard</span>, <span class="hlFld-ContribAuthor ">Desiree  De Lange</span>, <span class="hlFld-ContribAuthor ">Tinne  Verhulst</span>, <span class="hlFld-ContribAuthor ">Caroline  Paulussen</span>, <span class="hlFld-ContribAuthor ">Kelly  Van De Ven</span>, <span class="hlFld-ContribAuthor ">Peter  King</span>, <span class="hlFld-ContribAuthor ">Eddy  Freyne</span>, <span class="hlFld-ContribAuthor ">David C.  Rees</span>, <span class="hlFld-ContribAuthor ">Matthew  Squires</span>, <span class="hlFld-ContribAuthor ">Gordon  Saxty</span>, <span class="hlFld-ContribAuthor ">Martin  Page</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Murray</span>, <span class="hlFld-ContribAuthor ">Ron  Gilissen</span>, <span class="hlFld-ContribAuthor ">George  Ward</span>, <span class="hlFld-ContribAuthor ">Neil T.  Thompson</span>, <span class="hlFld-ContribAuthor ">David R.  Newell</span>, <span class="hlFld-ContribAuthor ">Na  Cheng</span>, <span class="hlFld-ContribAuthor ">Liang  Xie</span>, <span class="hlFld-ContribAuthor ">Jennifer  Yang</span>, <span class="hlFld-ContribAuthor ">Suso J.  Platero</span>, <span class="hlFld-ContribAuthor ">Jayaprakash D.  Karkera</span>, <span class="hlFld-ContribAuthor ">Christopher  Moy</span>, <span class="hlFld-ContribAuthor ">Patrick  Angibaud</span>, <span class="hlFld-ContribAuthor ">Sylvie  Laquerre</span>, <span class="hlFld-ContribAuthor ">Matthew V.  Lorenzi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2017,</strong> <em>16 </em>
                                    (6)
                                     , 1010-1020. <a href="https://doi.org/10.1158/1535-7163.MCT-16-0589" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-16-0589</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-16-0589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-16-0589%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DDiscovery%252Band%252BPharmacological%252BCharacterization%252Bof%252BJNJ-42756493%252B%252528Erdafitinib%252529%25252C%252Ba%252BFunctionally%252BSelective%252BSmall-Molecule%252BFGFR%252BFamily%252BInhibitor%26aulast%3DPerera%26aufirst%3DTimothy%2BP.S.%26date%3D2017%26date%3D2017%26volume%3D16%26issue%3D6%26spage%3D1010%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rut  Porta</span>, <span class="hlFld-ContribAuthor ">Roberto  Borea</span>, <span class="hlFld-ContribAuthor ">Andreia  Coelho</span>, <span class="hlFld-ContribAuthor ">Shahanavaj  Khan</span>, <span class="hlFld-ContribAuthor ">António  Araújo</span>, <span class="hlFld-ContribAuthor ">Pablo  Reclusa</span>, <span class="hlFld-ContribAuthor ">Tindara  Franchina</span>, <span class="hlFld-ContribAuthor ">Nele  Van Der Steen</span>, <span class="hlFld-ContribAuthor ">Peter  Van Dam</span>, <span class="hlFld-ContribAuthor ">Jose  Ferri</span>, <span class="hlFld-ContribAuthor ">Rafael  Sirera</span>, <span class="hlFld-ContribAuthor ">Aung  Naing</span>, <span class="hlFld-ContribAuthor ">David  Hong</span>, <span class="hlFld-ContribAuthor ">Christian  Rolfo</span>. </span><span class="cited-content_cbyCitation_article-title">FGFR a promising druggable target in cancer: Molecular biology and new drugs. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Oncology/Hematology</span><span> <strong>2017,</strong> <em>113 </em>, 256-267. <a href="https://doi.org/10.1016/j.critrevonc.2017.02.018" title="DOI URL">https://doi.org/10.1016/j.critrevonc.2017.02.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.critrevonc.2017.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.critrevonc.2017.02.018%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Oncology%252FHematology%26atitle%3DFGFR%252Ba%252Bpromising%252Bdruggable%252Btarget%252Bin%252Bcancer%25253A%252BMolecular%252Bbiology%252Band%252Bnew%252Bdrugs%26aulast%3DPorta%26aufirst%3DRut%26date%3D2017%26volume%3D113%26spage%3D256%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Yu</span>, <span class="hlFld-ContribAuthor ">Yanyan  Yang</span>, <span class="hlFld-ContribAuthor ">Yan  Liu</span>, <span class="hlFld-ContribAuthor ">Yinfeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong  Xu</span>, <span class="hlFld-ContribAuthor ">Mengpeng  Li</span>, <span class="hlFld-ContribAuthor ">Murugavel  Ponnusamy</span>, <span class="hlFld-ContribAuthor ">Kun  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Xun  Wang</span>, <span class="hlFld-ContribAuthor ">Pei-Feng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">A FGFR1 inhibitor patent review: progress since 2010. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (4)
                                     , 439-454. <a href="https://doi.org/10.1080/13543776.2017.1272574" title="DOI URL">https://doi.org/10.1080/13543776.2017.1272574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1272574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1272574%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252BFGFR1%252Binhibitor%252Bpatent%252Breview%25253A%252Bprogress%252Bsince%252B2010%26aulast%3DYu%26aufirst%3DTao%26date%3D2017%26date%3D2016%26volume%3D27%26issue%3D4%26spage%3D439%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helmut  Popper</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Pathology of Lung Tumors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 611-638. <a href="https://doi.org/10.1007/978-3-662-50491-8_19" title="DOI URL">https://doi.org/10.1007/978-3-662-50491-8_19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-662-50491-8_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-662-50491-8_19%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%252BPathology%252Bof%252BLung%252BTumors%26aulast%3DPopper%26aufirst%3DHelmut%26date%3D2017%26date%3D2016%26spage%3D611%26epage%3D638%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DPathology%252Bof%252BLung%252BDisease%26aulast%3DPopper%26aufirst%3DHelmut%26date%3D2017%26volume%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Niu</span>, <span class="hlFld-ContribAuthor ">Duo  Hong</span>, <span class="hlFld-ContribAuthor ">Teng-Chuang  Ma</span>, <span class="hlFld-ContribAuthor ">Xiao-Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Jin-Hang  Han</span>, <span class="hlFld-ContribAuthor ">Jun  Sun</span>, <span class="hlFld-ContribAuthor ">Ke  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Short-term and long-term efficacy of 7 targeted therapies for the treatment of advanced hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Medicine</span><span> <strong>2016,</strong> <em>95 </em>
                                    (49)
                                     , e5591. <a href="https://doi.org/10.1097/MD.0000000000005591" title="DOI URL">https://doi.org/10.1097/MD.0000000000005591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/MD.0000000000005591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FMD.0000000000005591%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicine%26atitle%3DShort-term%252Band%252Blong-term%252Befficacy%252Bof%252B7%252Btargeted%252Btherapies%252Bfor%252Bthe%252Btreatment%252Bof%252Badvanced%252Bhepatocellular%252Bcarcinoma%26aulast%3DNiu%26aufirst%3DMeng%26date%3D2016%26volume%3D95%26issue%3D49%26spage%3De5591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Massimiliano  Berretta</span>, <span class="hlFld-ContribAuthor ">Luca  Rinaldi</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Di Benedetto</span>, <span class="hlFld-ContribAuthor ">Arben  Lleshi</span>, <span class="hlFld-ContribAuthor ">Vallì  De Re</span>, <span class="hlFld-ContribAuthor ">Gaetano  Facchini</span>, <span class="hlFld-ContribAuthor ">Paolo  De Paoli</span>, <span class="hlFld-ContribAuthor ">Raffaele  Di Francia</span>. </span><span class="cited-content_cbyCitation_article-title">Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2016,</strong> <em>7 </em><a href="https://doi.org/10.3389/fphar.2016.00428" title="DOI URL">https://doi.org/10.3389/fphar.2016.00428</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2016.00428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2016.00428%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DAngiogenesis%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatocellular%252BCarcinoma%26aulast%3DBerretta%26aufirst%3DMassimiliano%26date%3D2016%26date%3D2016%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Pia  Brizzi</span>, <span class="hlFld-ContribAuthor ">Daniele  Pignataro</span>, <span class="hlFld-ContribAuthor ">Marco  Tampellini</span>, <span class="hlFld-ContribAuthor ">Giorgio Vittorio  Scagliotti</span>, <span class="hlFld-ContribAuthor ">Massimo  Di Maio</span>. </span><span class="cited-content_cbyCitation_article-title">Systemic treatment of hepatocellular carcinoma: why so many failures in the development of new drugs?. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2016,</strong> <em>16 </em>
                                    (10)
                                     , 1053-1062. <a href="https://doi.org/10.1080/14737140.2016.1227706" title="DOI URL">https://doi.org/10.1080/14737140.2016.1227706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737140.2016.1227706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737140.2016.1227706%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DSystemic%252Btreatment%252Bof%252Bhepatocellular%252Bcarcinoma%25253A%252Bwhy%252Bso%252Bmany%252Bfailures%252Bin%252Bthe%252Bdevelopment%252Bof%252Bnew%252Bdrugs%25253F%26aulast%3DBrizzi%26aufirst%3DMaria%2BPia%26date%3D2016%26date%3D2016%26volume%3D16%26issue%3D10%26spage%3D1053%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason G.  Kettle</span>, <span class="hlFld-ContribAuthor ">David M.  Wilson</span>. </span><span class="cited-content_cbyCitation_article-title">Standing on the shoulders of giants: a retrospective analysis of kinase drug discovery at AstraZeneca. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2016,</strong> <em>21 </em>
                                    (10)
                                     , 1596-1608. <a href="https://doi.org/10.1016/j.drudis.2016.06.007" title="DOI URL">https://doi.org/10.1016/j.drudis.2016.06.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2016.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2016.06.007%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DStanding%252Bon%252Bthe%252Bshoulders%252Bof%252Bgiants%25253A%252Ba%252Bretrospective%252Banalysis%252Bof%252Bkinase%252Bdrug%252Bdiscovery%252Bat%252BAstraZeneca%26aulast%3DKettle%26aufirst%3DJason%2BG.%26date%3D2016%26volume%3D21%26issue%3D10%26spage%3D1596%26epage%3D1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Fan</span>, <span class="hlFld-ContribAuthor ">Yang  Dai</span>, <span class="hlFld-ContribAuthor ">Jingwei  Shao</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Chen  Wang</span>, <span class="hlFld-ContribAuthor ">Sufen  Cao</span>, <span class="hlFld-ContribAuthor ">Bin  Zhao</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Wenhu  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of pyrazolylaminoquinazoline derivatives as highly potent pan-fibroblast growth factor receptor inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (11)
                                     , 2594-2599. <a href="https://doi.org/10.1016/j.bmcl.2016.04.028" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.04.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.04.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.04.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyrazolylaminoquinazoline%252Bderivatives%252Bas%252Bhighly%252Bpotent%252Bpan-fibroblast%252Bgrowth%252Bfactor%252Breceptor%252Binhibitors%26aulast%3DFan%26aufirst%3DJun%26date%3D2016%26volume%3D26%26issue%3D11%26spage%3D2594%26epage%3D2599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Longqin  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Prodrug Approaches to Drug Delivery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 227-271. <a href="https://doi.org/10.1002/9781118833322.ch12" title="DOI URL">https://doi.org/10.1002/9781118833322.ch12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118833322.ch12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118833322.ch12%26sid%3Dliteratum%253Aachs%26atitle%3DProdrug%252BApproaches%252Bto%252BDrug%252BDelivery%26aulast%3DHu%26aufirst%3DLongqin%26date%3D2016%26date%3D2016%26spage%3D227%26epage%3D271%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DDrug%252BDelivery%26aulast%3DWang%26aufirst%3DBinghe%26date%3D2016%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin  Schmidt</span>, <span class="hlFld-ContribAuthor ">Lan  Wei</span>, <span class="hlFld-ContribAuthor ">Danielle K.  DePeralta</span>, <span class="hlFld-ContribAuthor ">Yujin  Hoshida</span>, <span class="hlFld-ContribAuthor ">Poh Seng  Tan</span>, <span class="hlFld-ContribAuthor ">Xiaochen  Sun</span>, <span class="hlFld-ContribAuthor ">Janelle P.  Sventek</span>, <span class="hlFld-ContribAuthor ">Michael  Lanuti</span>, <span class="hlFld-ContribAuthor ">Kenneth K.  Tanabe</span>, <span class="hlFld-ContribAuthor ">Bryan C.  Fuchs</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular subclasses of hepatocellular carcinoma predict sensitivity to fibroblast growth factor receptor inhibition. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cancer</span><span> <strong>2016,</strong> <em>138 </em>
                                    (6)
                                     , 1494-1505. <a href="https://doi.org/10.1002/ijc.29893" title="DOI URL">https://doi.org/10.1002/ijc.29893</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ijc.29893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fijc.29893%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cancer%26atitle%3DMolecular%252Bsubclasses%252Bof%252Bhepatocellular%252Bcarcinoma%252Bpredict%252Bsensitivity%252Bto%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252Binhibition%26aulast%3DSchmidt%26aufirst%3DBenjamin%26date%3D2016%26date%3D2015%26volume%3D138%26issue%3D6%26spage%3D1494%26epage%3D1505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela Cornelia  Lazăr</span>, <span class="hlFld-ContribAuthor ">Sorina  Tăban</span>, <span class="hlFld-ContribAuthor ">Marioara  Cornianu</span>, <span class="hlFld-ContribAuthor ">Alexandra  Faur</span>, <span class="hlFld-ContribAuthor ">Adrian  Goldiş</span>. </span><span class="cited-content_cbyCitation_article-title">New advances in targeted gastric cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Gastroenterology</span><span> <strong>2016,</strong> <em>22 </em>
                                    (30)
                                     , 6776. <a href="https://doi.org/10.3748/wjg.v22.i30.6776" title="DOI URL">https://doi.org/10.3748/wjg.v22.i30.6776</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3748/wjg.v22.i30.6776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3748%2Fwjg.v22.i30.6776%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Gastroenterology%26atitle%3DNew%252Badvances%252Bin%252Btargeted%252Bgastric%252Bcancer%252Btreatment%26aulast%3DLaz%25C4%2583r%26aufirst%3DDaniela%2BCornelia%26date%3D2016%26volume%3D22%26issue%3D30%26spage%3D6776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yeh Chen  Lee</span>, <span class="hlFld-ContribAuthor ">Michael  Michael</span>, <span class="hlFld-ContribAuthor ">John R  Zalcberg</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of experimental and investigational multikinase inhibitors for the treatment of metastatic colorectal cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2015,</strong> <em>24 </em>
                                    (10)
                                     , 1307-1320. <a href="https://doi.org/10.1517/13543784.2015.1070483" title="DOI URL">https://doi.org/10.1517/13543784.2015.1070483</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2015.1070483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2015.1070483%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DAn%252Boverview%252Bof%252Bexperimental%252Band%252Binvestigational%252Bmultikinase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bmetastatic%252Bcolorectal%252Bcancer%26aulast%3DLee%26aufirst%3DYeh%2BChen%26date%3D2015%26date%3D2015%26volume%3D24%26issue%3D10%26spage%3D1307%26epage%3D1320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rozanne  Arulanandam</span>, <span class="hlFld-ContribAuthor ">Cory  Batenchuk</span>, <span class="hlFld-ContribAuthor ">Fernando A.  Angarita</span>, <span class="hlFld-ContribAuthor ">Kathryn  Ottolino-Perry</span>, <span class="hlFld-ContribAuthor ">Sophie  Cousineau</span>, <span class="hlFld-ContribAuthor ">Amelia  Mottashed</span>, <span class="hlFld-ContribAuthor ">Emma  Burgess</span>, <span class="hlFld-ContribAuthor ">Theresa J.  Falls</span>, <span class="hlFld-ContribAuthor ">Naomi  De Silva</span>, <span class="hlFld-ContribAuthor ">Jovian  Tsang</span>, <span class="hlFld-ContribAuthor ">Grant A.  Howe</span>, <span class="hlFld-ContribAuthor ">Marie-Claude  Bourgeois-Daigneault</span>, <span class="hlFld-ContribAuthor ">David P.  Conrad</span>, <span class="hlFld-ContribAuthor ">Manijeh  Daneshmand</span>, <span class="hlFld-ContribAuthor ">Caroline J.  Breitbach</span>, <span class="hlFld-ContribAuthor ">David H.  Kirn</span>, <span class="hlFld-ContribAuthor ">Leda  Raptis</span>, <span class="hlFld-ContribAuthor ">Subash  Sad</span>, <span class="hlFld-ContribAuthor ">Harold  Atkins</span>, <span class="hlFld-ContribAuthor ">Michael S.  Huh</span>, <span class="hlFld-ContribAuthor ">Jean-Simon  Diallo</span>, <span class="hlFld-ContribAuthor ">Brian D.  Lichty</span>, <span class="hlFld-ContribAuthor ">Carolina S.  Ilkow</span>, <span class="hlFld-ContribAuthor ">Fabrice  Le Boeuf</span>, <span class="hlFld-ContribAuthor ">Christina L.  Addison</span>, <span class="hlFld-ContribAuthor ">J. Andrea  McCart</span>, <span class="hlFld-ContribAuthor ">John C.  Bell</span>. </span><span class="cited-content_cbyCitation_article-title">VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Cancer Cell</span><span> <strong>2015,</strong> <em>28 </em>
                                    (2)
                                     , 210-224. <a href="https://doi.org/10.1016/j.ccell.2015.06.009" title="DOI URL">https://doi.org/10.1016/j.ccell.2015.06.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccell.2015.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccell.2015.06.009%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Cell%26atitle%3DVEGF-Mediated%252BInduction%252Bof%252BPRD1-BF1%25252FBlimp1%252BExpression%252BSensitizes%252BTumor%252BVasculature%252Bto%252BOncolytic%252BVirus%252BInfection%26aulast%3DArulanandam%26aufirst%3DRozanne%26date%3D2015%26volume%3D28%26issue%3D2%26spage%3D210%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujie  Zhao</span>, <span class="hlFld-ContribAuthor ">Alex A.  Adjei</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor. </span><span class="cited-content_cbyCitation_journal-name">The Oncologist</span><span> <strong>2015,</strong> <em>20 </em>
                                    (6)
                                     , 660-673. <a href="https://doi.org/10.1634/theoncologist.2014-0465" title="DOI URL">https://doi.org/10.1634/theoncologist.2014-0465</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1634/theoncologist.2014-0465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1634%2Ftheoncologist.2014-0465%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Oncologist%26atitle%3DTargeting%252BAngiogenesis%252Bin%252BCancer%252BTherapy%25253A%252BMoving%252BBeyond%252BVascular%252BEndothelial%252BGrowth%252BFactor%26aulast%3DZhao%26aufirst%3DYujie%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D6%26spage%3D660%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Enzyme Inhibitor, Part I, Tyrosine Kinases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 117-160. <a href="https://doi.org/10.1002/9781118892572.ch8" title="DOI URL">https://doi.org/10.1002/9781118892572.ch8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118892572.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118892572.ch8%26sid%3Dliteratum%253Aachs%26atitle%3DEnzyme%252BInhibitor%25252C%252BPart%252BI%25252C%252BTyrosine%252BKinases%26date%3D2015%26date%3D2015%26spage%3D117%26epage%3D160%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DAntineoplastic%252BDrugs%26aulast%3DLednicer%26aufirst%3DDaniel%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio  Russo</span>, <span class="hlFld-ContribAuthor ">Antonio  Galvano</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Bronte</span>, <span class="hlFld-ContribAuthor ">Marc  Peeters</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Therapies for Colorectal Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 147-162. <a href="https://doi.org/10.1007/978-1-4939-2047-1_13" title="DOI URL">https://doi.org/10.1007/978-1-4939-2047-1_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-2047-1_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-2047-1_13%26sid%3Dliteratum%253Aachs%26atitle%3DTargeted%252BTherapies%252Bfor%252BColorectal%252BCancer%26aulast%3DRusso%26aufirst%3DAntonio%26date%3D2015%26date%3D2015%26spage%3D147%26epage%3D162%26pub%3DSpringer%2520New%2520York%26atitle%3DTargeted%252BTherapies%252Bfor%252BSolid%252BTumors%26aulast%3DRusso%26aufirst%3DAntonio%26date%3D2015%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyung-Ju  Choi</span>, <span class="hlFld-ContribAuthor ">In Hye  Baik</span>, <span class="hlFld-ContribAuthor ">Sang-Kyu  Ye</span>, <span class="hlFld-ContribAuthor ">Yun-Han  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions. </span><span class="cited-content_cbyCitation_journal-name">Biological & Pharmaceutical Bulletin</span><span> <strong>2015,</strong> <em>38 </em>
                                    (7)
                                     , 986-991. <a href="https://doi.org/10.1248/bpb.b15-00231" title="DOI URL">https://doi.org/10.1248/bpb.b15-00231</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/bpb.b15-00231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fbpb.b15-00231%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520%2526%2520Pharmaceutical%2520Bulletin%26atitle%3DMolecular%252BTargeted%252BTherapy%252Bfor%252BHepatocellular%252BCarcinoma%25253A%252BPresent%252BStatus%252Band%252BFuture%252BDirections%26aulast%3DChoi%26aufirst%3DKyung-Ju%26date%3D2015%26volume%3D38%26issue%3D7%26spage%3D986%26epage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Camillo  Porta</span>, <span class="hlFld-ContribAuthor ">Palma  Giglione</span>, <span class="hlFld-ContribAuthor ">Wanda  Liguigli</span>, <span class="hlFld-ContribAuthor ">Chiara  Paglino</span>. </span><span class="cited-content_cbyCitation_article-title">Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2015,</strong> <em>11 </em>
                                    (1)
                                     , 39-50. <a href="https://doi.org/10.2217/fon.14.208" title="DOI URL">https://doi.org/10.2217/fon.14.208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon.14.208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon.14.208%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DDovitinib%252B%252528CHIR258%25252C%252BTKI258%252529%25253A%252Bstructure%25252C%252Bdevelopment%252Band%252Bpreclinical%252Band%252Bclinical%252Bactivity%26aulast%3DPorta%26aufirst%3DCamillo%26date%3D2015%26volume%3D11%26issue%3D1%26spage%3D39%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gan-Lu  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Hepatology</span><span> <strong>2015,</strong> <em>7 </em>
                                    (5)
                                     , 787. <a href="https://doi.org/10.4254/wjh.v7.i5.787" title="DOI URL">https://doi.org/10.4254/wjh.v7.i5.787</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4254/wjh.v7.i5.787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4254%2Fwjh.v7.i5.787%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Hepatology%26atitle%3DChemotherapy%252Band%252Btarget%252Btherapy%252Bfor%252Bhepatocellular%252Bcarcinoma%25253A%252BNew%252Badvances%252Band%252Bchallenges%26aulast%3DDeng%26aufirst%3DGan-Lu%26date%3D2015%26volume%3D7%26issue%3D5%26spage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antony M.  Latham</span>, <span class="hlFld-ContribAuthor ">Jayakanth  Kankanala</span>, <span class="hlFld-ContribAuthor ">Gareth W.  Fearnley</span>, <span class="hlFld-ContribAuthor ">Matthew C.  Gage</span>, <span class="hlFld-ContribAuthor ">Mark T.  Kearney</span>, <span class="hlFld-ContribAuthor ">Shervanthi  Homer-Vanniasinkam</span>, <span class="hlFld-ContribAuthor ">Stephen B.  Wheatcroft</span>, <span class="hlFld-ContribAuthor ">Colin W. G.  Fishwick</span>, <span class="hlFld-ContribAuthor ">Sreenivasan  Ponnambalam</span>, . </span><span class="cited-content_cbyCitation_article-title">In Silico Design and Biological Evaluation of a Dual Specificity Kinase Inhibitor Targeting Cell Cycle Progression and Angiogenesis. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (11)
                                     , e110997. <a href="https://doi.org/10.1371/journal.pone.0110997" title="DOI URL">https://doi.org/10.1371/journal.pone.0110997</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0110997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0110997%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DIn%252BSilico%252BDesign%252Band%252BBiological%252BEvaluation%252Bof%252Ba%252BDual%252BSpecificity%252BKinase%252BInhibitor%252BTargeting%252BCell%252BCycle%252BProgression%252Band%252BAngiogenesis%26aulast%3DLatham%26aufirst%3DAntony%2BM.%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D11%26spage%3De110997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masatoshi  Kudo</span>, <span class="hlFld-ContribAuthor ">Guohong  Han</span>, <span class="hlFld-ContribAuthor ">Richard S.  Finn</span>, <span class="hlFld-ContribAuthor ">Ronnie T.P.  Poon</span>, <span class="hlFld-ContribAuthor ">Jean-Frederic  Blanc</span>, <span class="hlFld-ContribAuthor ">Lunan  Yan</span>, <span class="hlFld-ContribAuthor ">Jijin  Yang</span>, <span class="hlFld-ContribAuthor ">Ligong  Lu</span>, <span class="hlFld-ContribAuthor ">Won-Young  Tak</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Yu</span>, <span class="hlFld-ContribAuthor ">Joon-Hyeok  Lee</span>, <span class="hlFld-ContribAuthor ">Shi-Ming  Lin</span>, <span class="hlFld-ContribAuthor ">Changping  Wu</span>, <span class="hlFld-ContribAuthor ">Tawesak  Tanwandee</span>, <span class="hlFld-ContribAuthor ">Guoliang  Shao</span>, <span class="hlFld-ContribAuthor ">Ian B.  Walters</span>, <span class="hlFld-ContribAuthor ">Christine  Dela Cruz</span>, <span class="hlFld-ContribAuthor ">Valerie  Poulart</span>, <span class="hlFld-ContribAuthor ">Jian-Hua  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial. </span><span class="cited-content_cbyCitation_journal-name">Hepatology</span><span> <strong>2014,</strong> <em>60 </em>
                                    (5)
                                     , 1697-1707. <a href="https://doi.org/10.1002/hep.27290" title="DOI URL">https://doi.org/10.1002/hep.27290</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hep.27290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhep.27290%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatology%26atitle%3DBrivanib%252Bas%252Badjuvant%252Btherapy%252Bto%252Btransarterial%252Bchemoembolization%252Bin%252Bpatients%252Bwith%252Bhepatocellular%252Bcarcinoma%25253A%252BA%252Brandomized%252Bphase%252BIII%252Btrial%26aulast%3DKudo%26aufirst%3DMasatoshi%26date%3D2014%26date%3D2014%26volume%3D60%26issue%3D5%26spage%3D1697%26epage%3D1707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lan  Wang</span>, <span class="hlFld-ContribAuthor ">Mark  Stanley</span>, <span class="hlFld-ContribAuthor ">Jason W.  Boggs</span>, <span class="hlFld-ContribAuthor ">Terry D.  Crawford</span>, <span class="hlFld-ContribAuthor ">Brandon J.  Bravo</span>, <span class="hlFld-ContribAuthor ">Anthony M.  Giannetti</span>, <span class="hlFld-ContribAuthor ">Seth F.  Harris</span>, <span class="hlFld-ContribAuthor ">Steven R.  Magnuson</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Stephen  Schmidt</span>, <span class="hlFld-ContribAuthor ">Ping  Wu</span>, <span class="hlFld-ContribAuthor ">Weilan  Ye</span>, <span class="hlFld-ContribAuthor ">Stephen E.  Gould</span>, <span class="hlFld-ContribAuthor ">Lesley J.  Murray</span>, <span class="hlFld-ContribAuthor ">Chudi O.  Ndubaku</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (18)
                                     , 4546-4552. <a href="https://doi.org/10.1016/j.bmcl.2014.07.071" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.07.071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.07.071%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFragment-based%252Bidentification%252Band%252Boptimization%252Bof%252Ba%252Bclass%252Bof%252Bpotent%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine%252BMAP4K4%252Binhibitors%26aulast%3DWang%26aufirst%3DLan%26date%3D2014%26volume%3D24%26issue%3D18%26spage%3D4546%26epage%3D4552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marielle  Reataza</span>, <span class="hlFld-ContribAuthor ">David K.  Imagawa</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in managing hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Frontiers of Medicine</span><span> <strong>2014,</strong> <em>8 </em>
                                    (2)
                                     , 175-189. <a href="https://doi.org/10.1007/s11684-014-0332-4" title="DOI URL">https://doi.org/10.1007/s11684-014-0332-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11684-014-0332-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11684-014-0332-4%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520of%2520Medicine%26atitle%3DAdvances%252Bin%252Bmanaging%252Bhepatocellular%252Bcarcinoma%26aulast%3DReataza%26aufirst%3DMarielle%26date%3D2014%26date%3D2014%26volume%3D8%26issue%3D2%26spage%3D175%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ikuo  Nakamura</span>, <span class="hlFld-ContribAuthor ">Kais  Zakharia</span>, <span class="hlFld-ContribAuthor ">Bubu A.  Banini</span>, <span class="hlFld-ContribAuthor ">Dalia S.  Mikhail</span>, <span class="hlFld-ContribAuthor ">Tae Hyo  Kim</span>, <span class="hlFld-ContribAuthor ">Ju Dong  Yang</span>, <span class="hlFld-ContribAuthor ">Catherine D.  Moser</span>, <span class="hlFld-ContribAuthor ">Hassan M.  Shaleh</span>, <span class="hlFld-ContribAuthor ">Sarah R.  Thornburgh</span>, <span class="hlFld-ContribAuthor ">Ian  Walters</span>, <span class="hlFld-ContribAuthor ">Lewis R.  Roberts</span>, . </span><span class="cited-content_cbyCitation_article-title">Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (4)
                                     , e92273. <a href="https://doi.org/10.1371/journal.pone.0092273" title="DOI URL">https://doi.org/10.1371/journal.pone.0092273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0092273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0092273%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DBrivanib%252BAttenuates%252BHepatic%252BFibrosis%252BIn%252BVivo%252Band%252BStellate%252BCell%252BActivation%252BIn%252BVitro%252Bby%252BInhibition%252Bof%252BFGF%25252C%252BVEGF%252Band%252BPDGF%252BSignaling%26aulast%3DNakamura%26aufirst%3DIkuo%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D4%26spage%3De92273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pietro  Ciceri</span>, <span class="hlFld-ContribAuthor ">Susanne  Müller</span>, <span class="hlFld-ContribAuthor ">Alison  O'Mahony</span>, <span class="hlFld-ContribAuthor ">Oleg  Fedorov</span>, <span class="hlFld-ContribAuthor ">Panagis  Filippakopoulos</span>, <span class="hlFld-ContribAuthor ">Jeremy P  Hunt</span>, <span class="hlFld-ContribAuthor ">Elisabeth A  Lasater</span>, <span class="hlFld-ContribAuthor ">Gabriel  Pallares</span>, <span class="hlFld-ContribAuthor ">Sarah  Picaud</span>, <span class="hlFld-ContribAuthor ">Christopher  Wells</span>, <span class="hlFld-ContribAuthor ">Sarah  Martin</span>, <span class="hlFld-ContribAuthor ">Lisa M  Wodicka</span>, <span class="hlFld-ContribAuthor ">Neil P  Shah</span>, <span class="hlFld-ContribAuthor ">Daniel K  Treiber</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">Dual kinase-bromodomain inhibitors for rationally designed polypharmacology. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2014,</strong> <em>10 </em>
                                    (4)
                                     , 305-312. <a href="https://doi.org/10.1038/nchembio.1471" title="DOI URL">https://doi.org/10.1038/nchembio.1471</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nchembio.1471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnchembio.1471%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DDual%252Bkinase-bromodomain%252Binhibitors%252Bfor%252Brationally%252Bdesigned%252Bpolypharmacology%26aulast%3DCiceri%26aufirst%3DPietro%26date%3D2014%26date%3D2014%26volume%3D10%26issue%3D4%26spage%3D305%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard B.  Silverman</span>, <span class="hlFld-ContribAuthor ">Mark W.  Holladay</span>. </span><span class="cited-content_cbyCitation_article-title">Prodrugs and Drug Delivery Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 423-468. <a href="https://doi.org/10.1016/B978-0-12-382030-3.00009-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-382030-3.00009-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-382030-3.00009-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-382030-3.00009-X%26sid%3Dliteratum%253Aachs%26atitle%3DProdrugs%252Band%252BDrug%252BDelivery%252BSystems%26aulast%3DSilverman%26aufirst%3DRichard%2BB.%26date%3D2014%26spage%3D423%26epage%3D468%26pub%3DElsevier%26atitle%3DThe%252BOrganic%252BChemistry%252Bof%252BDrug%252BDesign%252Band%252BDrug%252BAction%26date%3D2014%26volume%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Mortlock</span>, <span class="hlFld-ContribAuthor ">K.  Foote</span>, <span class="hlFld-ContribAuthor ">J.  Kettle</span>, <span class="hlFld-ContribAuthor ">B.  Aquila</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.11033-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.11033-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.11033-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.11033-9%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%252Bin%252BCancer%26aulast%3DMortlock%26aufirst%3DA.%26date%3D2014%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2014%26volume%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea Marin  Marques</span>. </span><span class="cited-content_cbyCitation_article-title">Personalizing medicine for metastatic colorectal cancer: Current developments. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Gastroenterology</span><span> <strong>2014,</strong> <em>20 </em>
                                    (30)
                                     , 10425. <a href="https://doi.org/10.3748/wjg.v20.i30.10425" title="DOI URL">https://doi.org/10.3748/wjg.v20.i30.10425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3748/wjg.v20.i30.10425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3748%2Fwjg.v20.i30.10425%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Gastroenterology%26atitle%3DPersonalizing%252Bmedicine%252Bfor%252Bmetastatic%252Bcolorectal%252Bcancer%25253A%252BCurrent%252Bdevelopments%26aulast%3DMarques%26aufirst%3DAndrea%2BMarin%26date%3D2014%26volume%3D20%26issue%3D30%26spage%3D10425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edwin M  Posadas</span>, <span class="hlFld-ContribAuthor ">Suwicha  Limvorasak</span>, <span class="hlFld-ContribAuthor ">Shaleekha  Sharma</span>, <span class="hlFld-ContribAuthor ">Robert A  Figlin</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting angiogenesis in renal cell carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2013,</strong> <em>14 </em>
                                    (16)
                                     , 2221-2236. <a href="https://doi.org/10.1517/14656566.2013.832202" title="DOI URL">https://doi.org/10.1517/14656566.2013.832202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14656566.2013.832202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14656566.2013.832202%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DTargeting%252Bangiogenesis%252Bin%252Brenal%252Bcell%252Bcarcinoma%26aulast%3DPosadas%26aufirst%3DEdwin%2BM%26date%3D2013%26date%3D2013%26volume%3D14%26issue%3D16%26spage%3D2221%26epage%3D2236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guang  Liang</span>, <span class="hlFld-ContribAuthor ">Gaozhi  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Wei</span>, <span class="hlFld-ContribAuthor ">Yunjie  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaokun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule inhibition of fibroblast growth factor receptors in cancer. </span><span class="cited-content_cbyCitation_journal-name">Cytokine & Growth Factor Reviews</span><span> <strong>2013,</strong> <em>24 </em>
                                    (5)
                                     , 467-475. <a href="https://doi.org/10.1016/j.cytogfr.2013.05.002" title="DOI URL">https://doi.org/10.1016/j.cytogfr.2013.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cytogfr.2013.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cytogfr.2013.05.002%26sid%3Dliteratum%253Aachs%26jtitle%3DCytokine%2520%2526%2520Growth%2520Factor%2520Reviews%26atitle%3DSmall%252Bmolecule%252Binhibition%252Bof%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptors%252Bin%252Bcancer%26aulast%3DLiang%26aufirst%3DGuang%26date%3D2013%26volume%3D24%26issue%3D5%26spage%3D467%26epage%3D475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Josep M.  Llovet</span>, <span class="hlFld-ContribAuthor ">Thomas  Decaens</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Raoul</span>, <span class="hlFld-ContribAuthor ">Eveline  Boucher</span>, <span class="hlFld-ContribAuthor ">Masatoshi  Kudo</span>, <span class="hlFld-ContribAuthor ">Charissa  Chang</span>, <span class="hlFld-ContribAuthor ">Yoon-Koo  Kang</span>, <span class="hlFld-ContribAuthor ">Eric  Assenat</span>, <span class="hlFld-ContribAuthor ">Ho-Yeong  Lim</span>, <span class="hlFld-ContribAuthor ">Valerie  Boige</span>, <span class="hlFld-ContribAuthor ">Philippe  Mathurin</span>, <span class="hlFld-ContribAuthor ">Laetitia  Fartoux</span>, <span class="hlFld-ContribAuthor ">Deng-Yn  Lin</span>, <span class="hlFld-ContribAuthor ">Jordi  Bruix</span>, <span class="hlFld-ContribAuthor ">Ronnie T.  Poon</span>, <span class="hlFld-ContribAuthor ">Morris  Sherman</span>, <span class="hlFld-ContribAuthor ">Jean-Frédéric  Blanc</span>, <span class="hlFld-ContribAuthor ">Richard S.  Finn</span>, <span class="hlFld-ContribAuthor ">Won-Young  Tak</span>, <span class="hlFld-ContribAuthor ">Yee  Chao</span>, <span class="hlFld-ContribAuthor ">Rana  Ezzeddine</span>, <span class="hlFld-ContribAuthor ">David  Liu</span>, <span class="hlFld-ContribAuthor ">Ian  Walters</span>, <span class="hlFld-ContribAuthor ">Joong-Won  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Oncology</span><span> <strong>2013,</strong> <em>31 </em>
                                    (28)
                                     , 3509-3516. <a href="https://doi.org/10.1200/JCO.2012.47.3009" title="DOI URL">https://doi.org/10.1200/JCO.2012.47.3009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1200/JCO.2012.47.3009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1200%2FJCO.2012.47.3009%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Oncology%26atitle%3DBrivanib%252Bin%252BPatients%252BWith%252BAdvanced%252BHepatocellular%252BCarcinoma%252BWho%252BWere%252BIntolerant%252Bto%252BSorafenib%252Bor%252Bfor%252BWhom%252BSorafenib%252BFailed%25253A%252BResults%252BFrom%252Bthe%252BRandomized%252BPhase%252BIII%252BBRISK-PS%252BStudy%26aulast%3DLlovet%26aufirst%3DJosep%2BM.%26date%3D2013%26volume%3D31%26issue%3D28%26spage%3D3509%26epage%3D3516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip J.  Johnson</span>, <span class="hlFld-ContribAuthor ">Shukui  Qin</span>, <span class="hlFld-ContribAuthor ">Joong-Won  Park</span>, <span class="hlFld-ContribAuthor ">Ronnie T.P.  Poon</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Raoul</span>, <span class="hlFld-ContribAuthor ">Philip A.  Philip</span>, <span class="hlFld-ContribAuthor ">Chih-Hung  Hsu</span>, <span class="hlFld-ContribAuthor ">Tsung-Hui  Hu</span>, <span class="hlFld-ContribAuthor ">Jeong  Heo</span>, <span class="hlFld-ContribAuthor ">Jianming  Xu</span>, <span class="hlFld-ContribAuthor ">Ligong  Lu</span>, <span class="hlFld-ContribAuthor ">Yee  Chao</span>, <span class="hlFld-ContribAuthor ">Eveline  Boucher</span>, <span class="hlFld-ContribAuthor ">Kwang-Hyub  Han</span>, <span class="hlFld-ContribAuthor ">Seung-Woon  Paik</span>, <span class="hlFld-ContribAuthor ">Jorge  Robles-Aviña</span>, <span class="hlFld-ContribAuthor ">Masatoshi  Kudo</span>, <span class="hlFld-ContribAuthor ">Lunan  Yan</span>, <span class="hlFld-ContribAuthor ">Abhasnee  Sobhonslidsuk</span>, <span class="hlFld-ContribAuthor ">Dmitry  Komov</span>, <span class="hlFld-ContribAuthor ">Thomas  Decaens</span>, <span class="hlFld-ContribAuthor ">Won-Young  Tak</span>, <span class="hlFld-ContribAuthor ">Long-Bin  Jeng</span>, <span class="hlFld-ContribAuthor ">David  Liu</span>, <span class="hlFld-ContribAuthor ">Rana  Ezzeddine</span>, <span class="hlFld-ContribAuthor ">Ian  Walters</span>, <span class="hlFld-ContribAuthor ">Ann-Lii  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Oncology</span><span> <strong>2013,</strong> <em>31 </em>
                                    (28)
                                     , 3517-3524. <a href="https://doi.org/10.1200/JCO.2012.48.4410" title="DOI URL">https://doi.org/10.1200/JCO.2012.48.4410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1200/JCO.2012.48.4410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1200%2FJCO.2012.48.4410%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Oncology%26atitle%3DBrivanib%252BVersus%252BSorafenib%252BAs%252BFirst-Line%252BTherapy%252Bin%252BPatients%252BWith%252BUnresectable%25252C%252BAdvanced%252BHepatocellular%252BCarcinoma%25253A%252BResults%252BFrom%252Bthe%252BRandomized%252BPhase%252BIII%252BBRISK-FL%252BStudy%26aulast%3DJohnson%26aufirst%3DPhilip%2BJ.%26date%3D2013%26volume%3D31%26issue%3D28%26spage%3D3517%26epage%3D3524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel G.  Liao</span>, <span class="hlFld-ContribAuthor ">Joonil  Jung</span>, <span class="hlFld-ContribAuthor ">Jeremy  Tchaicha</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Wilkerson</span>, <span class="hlFld-ContribAuthor ">Andrey  Sivachenko</span>, <span class="hlFld-ContribAuthor ">Ellen M.  Beauchamp</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, <span class="hlFld-ContribAuthor ">Trevor J.  Pugh</span>, <span class="hlFld-ContribAuthor ">Chandra Sekhar  Pedamallu</span>, <span class="hlFld-ContribAuthor ">D. Neil  Hayes</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Gad  Getz</span>, <span class="hlFld-ContribAuthor ">Kwok-Kin  Wong</span>, <span class="hlFld-ContribAuthor ">Robert I.  Haddad</span>, <span class="hlFld-ContribAuthor ">Matthew  Meyerson</span>, <span class="hlFld-ContribAuthor ">Peter S.  Hammerman</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2013,</strong> <em>73 </em>
                                    (16)
                                     , 5195-5205. <a href="https://doi.org/10.1158/0008-5472.CAN-12-3950" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-12-3950</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-12-3950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-12-3950%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DInhibitor-Sensitive%252BFGFR2%252Band%252BFGFR3%252BMutations%252Bin%252BLung%252BSquamous%252BCell%252BCarcinoma%26aulast%3DLiao%26aufirst%3DRachel%2BG.%26date%3D2013%26date%3D2013%26volume%3D73%26issue%3D16%26spage%3D5195%26epage%3D5205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Zhuo  Chen</span>, <span class="hlFld-ContribAuthor ">Linjiang  Tong</span>, <span class="hlFld-ContribAuthor ">Shaoying  Tan</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Ting  Peng</span>, <span class="hlFld-ContribAuthor ">Kun  Han</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Hua  Xie</span>, <span class="hlFld-ContribAuthor ">Yufang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>65 </em>, 477-486. <a href="https://doi.org/10.1016/j.ejmech.2013.05.002" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.05.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNaphthalimides%252Bexhibit%252Bin%2525C2%2525A0vitro%252Bantiproliferative%252Band%252Bantiangiogenic%252Bactivities%252Bby%252Binhibiting%252Bboth%252Btopoisomerase%252BII%252B%252528topo%252BII%252529%252Band%252Breceptor%252Btyrosine%252Bkinases%252B%252528RTKs%252529%26aulast%3DWang%26aufirst%3DXin%26date%3D2013%26volume%3D65%26spage%3D477%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen L.  Richey</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Hutson</span>. </span><span class="cited-content_cbyCitation_article-title">Angiopoietins and Non–Vascular Endothelial Growth Factor Antiangiogenic Targets in Advanced Renal Cell Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">The Cancer Journal</span><span> <strong>2013,</strong> <em>19 </em>
                                    (4)
                                     , 307-310. <a href="https://doi.org/10.1097/PPO.0b013e31829d5d15" title="DOI URL">https://doi.org/10.1097/PPO.0b013e31829d5d15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/PPO.0b013e31829d5d15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FPPO.0b013e31829d5d15%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Cancer%2520Journal%26atitle%3DAngiopoietins%252Band%252BNon%2525E2%252580%252593Vascular%252BEndothelial%252BGrowth%252BFactor%252BAntiangiogenic%252BTargets%252Bin%252BAdvanced%252BRenal%252BCell%252BCarcinoma%26aulast%3DRichey%26aufirst%3DStephen%2BL.%26date%3D2013%26volume%3D19%26issue%3D4%26spage%3D307%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naoki  Miyamoto</span>, <span class="hlFld-ContribAuthor ">Nozomu  Sakai</span>, <span class="hlFld-ContribAuthor ">Takaharu  Hirayama</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Miwa</span>, <span class="hlFld-ContribAuthor ">Yuya  Oguro</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Oki</span>, <span class="hlFld-ContribAuthor ">Kengo  Okada</span>, <span class="hlFld-ContribAuthor ">Terufumi  Takagi</span>, <span class="hlFld-ContribAuthor ">Hidehisa  Iwata</span>, <span class="hlFld-ContribAuthor ">Yoshiko  Awazu</span>, <span class="hlFld-ContribAuthor ">Seiji  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Toshiyuki  Takeuchi</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Miki</span>, <span class="hlFld-ContribAuthor ">Akira  Hori</span>, <span class="hlFld-ContribAuthor ">Shinichi  Imamura</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N -[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2- b ]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1 H -pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (8)
                                     , 2333-2345. <a href="https://doi.org/10.1016/j.bmc.2013.01.074" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.01.074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.01.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.01.074%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN%252B-%25255B5-%252528%25257B2-%25255B%252528cyclopropylcarbonyl%252529amino%25255Dimidazo%25255B1%25252C2-%252Bb%252B%25255Dpyridazin-6-yl%25257Doxy%252529-2-methylphenyl%25255D-1%25252C3-dimethyl-1%252BH%252B-pyrazole-5-carboxamide%252B%252528TAK-593%252529%25252C%252Ba%252Bhighly%252Bpotent%252BVEGFR2%252Bkinase%252Binhibitor%26aulast%3DMiyamoto%26aufirst%3DNaoki%26date%3D2013%26volume%3D21%26issue%3D8%26spage%3D2333%26epage%3D2345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanhong  Chen</span>, <span class="hlFld-ContribAuthor ">Haoyue  Xiang</span>, <span class="hlFld-ContribAuthor ">Cun  Tan</span>, <span class="hlFld-ContribAuthor ">Yuyuan  Xie</span>, <span class="hlFld-ContribAuthor ">Chunhao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">A tandem copper (II)-promoted synthesis of 2-substituted pyrrolo[2,1-f][1,2,4] triazin-4(3H)-ones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (13)
                                     , 2714-2719. <a href="https://doi.org/10.1016/j.tet.2013.02.004" title="DOI URL">https://doi.org/10.1016/j.tet.2013.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.02.004%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DA%252Btandem%252Bcopper%252B%252528II%252529-promoted%252Bsynthesis%252Bof%252B2-substituted%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255D%252Btriazin-4%2525283H%252529-ones%26aulast%3DChen%26aufirst%3DYanhong%26date%3D2013%26volume%3D69%26issue%3D13%26spage%3D2714%26epage%3D2719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erika  Martinelli</span>, <span class="hlFld-ContribAuthor ">Teresa  Troiani</span>, <span class="hlFld-ContribAuthor ">Floriana  Morgillo</span>, <span class="hlFld-ContribAuthor ">Michele  Orditura</span>, <span class="hlFld-ContribAuthor ">Fernando  De Vita</span>, <span class="hlFld-ContribAuthor ">Giulio  Belli</span>, <span class="hlFld-ContribAuthor ">Fortunato  Ciardiello</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging VEGF-receptor inhibitors for colorectal cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Emerging Drugs</span><span> <strong>2013,</strong> <em>18 </em>
                                    (1)
                                     , 25-37. <a href="https://doi.org/10.1517/14728214.2013.749856" title="DOI URL">https://doi.org/10.1517/14728214.2013.749856</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728214.2013.749856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728214.2013.749856%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Emerging%2520Drugs%26atitle%3DEmerging%252BVEGF-receptor%252Binhibitors%252Bfor%252Bcolorectal%252Bcancer%26aulast%3DMartinelli%26aufirst%3DErika%26date%3D2013%26date%3D2012%26volume%3D18%26issue%3D1%26spage%3D25%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard S.  Finn</span>. </span><span class="cited-content_cbyCitation_article-title">Biologic and Systemic Therapies for the Treatment of Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 363-372. <a href="https://doi.org/10.1007/978-1-4419-0751-6_26" title="DOI URL">https://doi.org/10.1007/978-1-4419-0751-6_26</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4419-0751-6_26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4419-0751-6_26%26sid%3Dliteratum%253Aachs%26atitle%3DBiologic%252Band%252BSystemic%252BTherapies%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatocellular%252BCarcinoma%26aulast%3DFinn%26aufirst%3DRichard%2BS.%26date%3D2013%26date%3D2013%26spage%3D363%26epage%3D372%26pub%3DSpringer%2520New%2520York%26atitle%3DImage-Guided%252BCancer%252BTherapy%26aulast%3DDupuy%26aufirst%3DDamian%2BE.%26date%3D2013%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard A.  Westhouse</span>, <span class="hlFld-ContribAuthor ">Bruce D.  Car</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics and Safety Assessment. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 187-206. <a href="https://doi.org/10.1016/B978-0-12-394296-8.00013-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-394296-8.00013-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-394296-8.00013-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-394296-8.00013-0%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacokinetics%252Band%252BSafety%252BAssessment%26aulast%3DWesthouse%26aufirst%3DRichard%2BA.%26date%3D2013%26spage%3D187%26epage%3D206%26pub%3DElsevier%26atitle%3DCancer%252BImmunotherapy%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haoyue  Xiang</span>, <span class="hlFld-ContribAuthor ">Yanhong  Chen</span>, <span class="hlFld-ContribAuthor ">Qian  He</span>, <span class="hlFld-ContribAuthor ">Yuyuan  Xie</span>, <span class="hlFld-ContribAuthor ">Chunhao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Pot, atom and step economic synthesis: a diversity-oriented approach to construct 2-substituted pyrrolo[2,1-f][1,2,4]triazin-4(3H)-ones. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2013,</strong> <em>3 </em>
                                    (17)
                                     , 5807. <a href="https://doi.org/10.1039/c3ra22909b" title="DOI URL">https://doi.org/10.1039/c3ra22909b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra22909b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra22909b%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DPot%25252C%252Batom%252Band%252Bstep%252Beconomic%252Bsynthesis%25253A%252Ba%252Bdiversity-oriented%252Bapproach%252Bto%252Bconstruct%252B2-substituted%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazin-4%2525283H%252529-ones%26aulast%3DXiang%26aufirst%3DHaoyue%26date%3D2013%26volume%3D3%26issue%3D17%26spage%3D5807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen L  Chan</span>, <span class="hlFld-ContribAuthor ">Tony  Mok</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted therapy for hepatocellular carcinoma: current status and future direction. </span><span class="cited-content_cbyCitation_journal-name">Clinical Investigation</span><span> <strong>2013,</strong> <em>3 </em>
                                    (1)
                                     , 83-93. <a href="https://doi.org/10.4155/cli.12.132" title="DOI URL">https://doi.org/10.4155/cli.12.132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/cli.12.132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fcli.12.132%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Investigation%26atitle%3DTargeted%252Btherapy%252Bfor%252Bhepatocellular%252Bcarcinoma%25253A%252Bcurrent%252Bstatus%252Band%252Bfuture%252Bdirection%26aulast%3DChan%26aufirst%3DStephen%2BL%26date%3D2013%26volume%3D3%26issue%3D1%26spage%3D83%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiachang  Gong</span>, <span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">Eric  Masson</span>, <span class="hlFld-ContribAuthor ">Shariq  Syed</span>, <span class="hlFld-ContribAuthor ">Yuan-Qing  Xia</span>, <span class="hlFld-ContribAuthor ">Daphne  Williams</span>, <span class="hlFld-ContribAuthor ">Janice  Pursley</span>, <span class="hlFld-ContribAuthor ">Mohammed  Jemal</span>, <span class="hlFld-ContribAuthor ">W. Griff  Humphreys</span>, <span class="hlFld-ContribAuthor ">Ramaswamy A.  Iyer</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Chiral Inversion of Brivanib and Its Relevance to Safety and Pharmacology. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2012,</strong> <em>40 </em>
                                    (12)
                                     , 2374-2380. <a href="https://doi.org/10.1124/dmd.112.047340" title="DOI URL">https://doi.org/10.1124/dmd.112.047340</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.112.047340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.112.047340%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DMetabolic%252BChiral%252BInversion%252Bof%252BBrivanib%252Band%252BIts%252BRelevance%252Bto%252BSafety%252Band%252BPharmacology%26aulast%3DGong%26aufirst%3DJiachang%26date%3D2012%26date%3D2012%26volume%3D40%26issue%3D12%26spage%3D2374%26epage%3D2380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter M.  Ellis</span>, <span class="hlFld-ContribAuthor ">Khalid  Al-Saleh</span>. </span><span class="cited-content_cbyCitation_article-title">Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Oncology/Hematology</span><span> <strong>2012,</strong> <em>84 </em>
                                    (1)
                                     , 47-58. <a href="https://doi.org/10.1016/j.critrevonc.2012.02.004" title="DOI URL">https://doi.org/10.1016/j.critrevonc.2012.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.critrevonc.2012.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.critrevonc.2012.02.004%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Oncology%252FHematology%26atitle%3DMultitargeted%252Banti-angiogenic%252Bagents%252Band%252BNSCLC%25253A%252BClinical%252Bupdate%252Band%252Bfuture%252Bdirections%26aulast%3DEllis%26aufirst%3DPeter%2BM.%26date%3D2012%26volume%3D84%26issue%3D1%26spage%3D47%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tina  Chou</span>, <span class="hlFld-ContribAuthor ">Richard S  Finn</span>. </span><span class="cited-content_cbyCitation_article-title">Brivanib: a review of development. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2012,</strong> <em>8 </em>
                                    (9)
                                     , 1083-1090. <a href="https://doi.org/10.2217/fon.12.104" title="DOI URL">https://doi.org/10.2217/fon.12.104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon.12.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon.12.104%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DBrivanib%25253A%252Ba%252Breview%252Bof%252Bdevelopment%26aulast%3DChou%26aufirst%3DTina%26date%3D2012%26volume%3D8%26issue%3D9%26spage%3D1083%26epage%3D1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teresa  Troiani</span>, <span class="hlFld-ContribAuthor ">Erika  Martinelli</span>, <span class="hlFld-ContribAuthor ">Michele  Orditura</span>, <span class="hlFld-ContribAuthor ">Ferdinando  De Vita</span>, <span class="hlFld-ContribAuthor ">Fortunato  Ciardiello</span>, <span class="hlFld-ContribAuthor ">Floriana  Morgillo</span>. </span><span class="cited-content_cbyCitation_article-title">Beyond bevacizumab: new anti-VEGF strategies in colorectal cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2012,</strong> <em>21 </em>
                                    (7)
                                     , 949-959. <a href="https://doi.org/10.1517/13543784.2012.689287" title="DOI URL">https://doi.org/10.1517/13543784.2012.689287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2012.689287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2012.689287%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DBeyond%252Bbevacizumab%25253A%252Bnew%252Banti-VEGF%252Bstrategies%252Bin%252Bcolorectal%252Bcancer%26aulast%3DTroiani%26aufirst%3DTeresa%26date%3D2012%26date%3D2012%26volume%3D21%26issue%3D7%26spage%3D949%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen L.  Chan</span>, <span class="hlFld-ContribAuthor ">Tony  Mok</span>, <span class="hlFld-ContribAuthor ">Brigette B. Y.  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Management of Hepatocellular Carcinoma: Beyond Sorafenib. </span><span class="cited-content_cbyCitation_journal-name">Current Oncology Reports</span><span> <strong>2012,</strong> <em>14 </em>
                                    (3)
                                     , 257-266. <a href="https://doi.org/10.1007/s11912-012-0233-0" title="DOI URL">https://doi.org/10.1007/s11912-012-0233-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11912-012-0233-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11912-012-0233-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Oncology%2520Reports%26atitle%3DManagement%252Bof%252BHepatocellular%252BCarcinoma%25253A%252BBeyond%252BSorafenib%26aulast%3DChan%26aufirst%3DStephen%2BL.%26date%3D2012%26date%3D2012%26volume%3D14%26issue%3D3%26spage%3D257%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen L  Chan</span>, <span class="hlFld-ContribAuthor ">Winnie  Yeo</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted therapy of hepatocellular carcinoma: Present and future. </span><span class="cited-content_cbyCitation_journal-name">Journal of Gastroenterology and Hepatology</span><span> <strong>2012,</strong> <em>27 </em>
                                    (5)
                                     , 862-872. <a href="https://doi.org/10.1111/j.1440-1746.2012.07096.x" title="DOI URL">https://doi.org/10.1111/j.1440-1746.2012.07096.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1440-1746.2012.07096.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1440-1746.2012.07096.x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Gastroenterology%2520and%2520Hepatology%26atitle%3DTargeted%252Btherapy%252Bof%252Bhepatocellular%252Bcarcinoma%25253A%252BPresent%252Band%252Bfuture%26aulast%3DChan%26aufirst%3DStephen%2BL%26date%3D2012%26date%3D2012%26volume%3D27%26issue%3D5%26spage%3D862%26epage%3D872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Máximo  de la Vega</span>, <span class="hlFld-ContribAuthor ">Enrique  Díaz-Cantón</span>, <span class="hlFld-ContribAuthor ">Ricardo H  Alvarez</span>. </span><span class="cited-content_cbyCitation_article-title">Novel targeted agents for the treatment of advanced breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2012,</strong> <em>4 </em>
                                    (7)
                                     , 893-914. <a href="https://doi.org/10.4155/fmc.12.45" title="DOI URL">https://doi.org/10.4155/fmc.12.45</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.12.45&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.12.45%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Btargeted%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Badvanced%252Bbreast%252Bcancer%26aulast%3Dde%2Bla%2BVega%26aufirst%3DM%25C3%25A1ximo%26date%3D2012%26volume%3D4%26issue%3D7%26spage%3D893%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard S.  Finn</span>, <span class="hlFld-ContribAuthor ">Yoon-Koo  Kang</span>, <span class="hlFld-ContribAuthor ">Mary  Mulcahy</span>, <span class="hlFld-ContribAuthor ">Blase N.  Polite</span>, <span class="hlFld-ContribAuthor ">Ho Yeong  Lim</span>, <span class="hlFld-ContribAuthor ">Ian  Walters</span>, <span class="hlFld-ContribAuthor ">Christine  Baudelet</span>, <span class="hlFld-ContribAuthor ">Demetrios  Manekas</span>, <span class="hlFld-ContribAuthor ">Joong-Won  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2012,</strong> <em>18 </em>
                                    (7)
                                     , 2090-2098. <a href="https://doi.org/10.1158/1078-0432.CCR-11-1991" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-11-1991</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-11-1991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-11-1991%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DPhase%252BII%25252C%252BOpen-Label%252BStudy%252Bof%252BBrivanib%252Bas%252BSecond-Line%252BTherapy%252Bin%252BPatients%252Bwith%252BAdvanced%252BHepatocellular%252BCarcinoma%26aulast%3DFinn%26aufirst%3DRichard%2BS.%26date%3D2012%26date%3D2012%26volume%3D18%26issue%3D7%26spage%3D2090%26epage%3D2098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward  Chu</span>. </span><span class="cited-content_cbyCitation_article-title">An Update on the Current and Emerging Targeted Agents in Metastatic Colorectal Cancer. </span><span class="cited-content_cbyCitation_journal-name">Clinical Colorectal Cancer</span><span> <strong>2012,</strong> <em>11 </em>
                                    (1)
                                     , 1-13. <a href="https://doi.org/10.1016/j.clcc.2011.05.005" title="DOI URL">https://doi.org/10.1016/j.clcc.2011.05.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.clcc.2011.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.clcc.2011.05.005%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Colorectal%2520Cancer%26atitle%3DAn%252BUpdate%252Bon%252Bthe%252BCurrent%252Band%252BEmerging%252BTargeted%252BAgents%252Bin%252BMetastatic%252BColorectal%252BCancer%26aulast%3DChu%26aufirst%3DEdward%26date%3D2012%26volume%3D11%26issue%3D1%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jong-Suk  Lee</span>, <span class="hlFld-ContribAuthor ">Youra  Kang</span>, <span class="hlFld-ContribAuthor ">Jong Tae  Kim</span>, <span class="hlFld-ContribAuthor ">Dinesh  Thapa</span>, <span class="hlFld-ContribAuthor ">Eung-Seok  Lee</span>, <span class="hlFld-ContribAuthor ">Jung-Ae  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">The anti-angiogenic and anti-tumor activity of synthetic phenylpropenone derivatives is mediated through the inhibition of receptor tyrosine kinases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2012,</strong> <em>677 </em>
                                    (1-3)
                                     , 22-30. <a href="https://doi.org/10.1016/j.ejphar.2011.12.012" title="DOI URL">https://doi.org/10.1016/j.ejphar.2011.12.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2011.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2011.12.012%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DThe%252Banti-angiogenic%252Band%252Banti-tumor%252Bactivity%252Bof%252Bsynthetic%252Bphenylpropenone%252Bderivatives%252Bis%252Bmediated%252Bthrough%252Bthe%252Binhibition%252Bof%252Breceptor%252Btyrosine%252Bkinases%26aulast%3DLee%26aufirst%3DJong-Suk%26date%3D2012%26volume%3D677%26issue%3D1-3%26spage%3D22%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sumanta Kumar  Pal</span>, <span class="hlFld-ContribAuthor ">Karen  Reckamp</span>, <span class="hlFld-ContribAuthor ">Hua  Yu</span>, <span class="hlFld-ContribAuthor ">Robert A.  Figlin</span>, <span class="hlFld-ContribAuthor ">Robert A.  Figlin</span>, <span class="hlFld-ContribAuthor ">Robert A.  Figlin</span>. </span><span class="cited-content_cbyCitation_article-title">Characterizing and Modulating the Tumor Microenvironment in Renal Cell Carcinoma: Potential Therapeutic Strategies. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 239-252. <a href="https://doi.org/10.1007/978-1-4614-2400-0_11" title="DOI URL">https://doi.org/10.1007/978-1-4614-2400-0_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-2400-0_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-2400-0_11%26sid%3Dliteratum%253Aachs%26atitle%3DCharacterizing%252Band%252BModulating%252Bthe%252BTumor%252BMicroenvironment%252Bin%252BRenal%252BCell%252BCarcinoma%25253A%252BPotential%252BTherapeutic%252BStrategies%26aulast%3DPal%26aufirst%3DSumanta%2BKumar%26date%3D2012%26date%3D2012%26spage%3D239%26epage%3D252%26pub%3DSpringer%2520US%26atitle%3DRenal%252BCell%252BCarcinoma%26aulast%3DFiglin%26aufirst%3DRobert%2BA.%26date%3D2012%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. Lance  Cowey</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Hutson</span>. </span><span class="cited-content_cbyCitation_article-title">Angiopoietins and Other Non-VEGF Antiangiogenic Targets in Advanced Renal Cell Carcinoma. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 135-160. <a href="https://doi.org/10.1007/978-1-4614-2400-0_7" title="DOI URL">https://doi.org/10.1007/978-1-4614-2400-0_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-2400-0_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-2400-0_7%26sid%3Dliteratum%253Aachs%26atitle%3DAngiopoietins%252Band%252BOther%252BNon-VEGF%252BAntiangiogenic%252BTargets%252Bin%252BAdvanced%252BRenal%252BCell%252BCarcinoma%26aulast%3DCowey%26aufirst%3DC.%2BLance%26date%3D2012%26date%3D2012%26spage%3D135%26epage%3D160%26pub%3DSpringer%2520US%26atitle%3DRenal%252BCell%252BCarcinoma%26aulast%3DFiglin%26aufirst%3DRobert%2BA.%26date%3D2012%26volume%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiachang  Gong</span>, <span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">Ramaswamy A.  Iyer</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of the Oxidative and Conjugative Enzymes Involved in the Biotransformation of Brivanib. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2012,</strong> <em>40 </em>
                                    (1)
                                     , 219-226. <a href="https://doi.org/10.1124/dmd.111.042457" title="DOI URL">https://doi.org/10.1124/dmd.111.042457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.111.042457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.111.042457%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DIdentification%252Bof%252Bthe%252BOxidative%252Band%252BConjugative%252BEnzymes%252BInvolved%252Bin%252Bthe%252BBiotransformation%252Bof%252BBrivanib%26aulast%3DGong%26aufirst%3DJiachang%26date%3D2012%26date%3D2011%26volume%3D40%26issue%3D1%26spage%3D219%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dae Dong  Kim</span>, <span class="hlFld-ContribAuthor ">Cathy  Eng</span>. </span><span class="cited-content_cbyCitation_article-title">The Current State of Targeted Agents in Rectal Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Surgical Oncology</span><span> <strong>2012,</strong> <em>2012 </em>, 1-14. <a href="https://doi.org/10.1155/2012/406830" title="DOI URL">https://doi.org/10.1155/2012/406830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2012/406830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2012%2F406830%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Surgical%2520Oncology%26atitle%3DThe%252BCurrent%252BState%252Bof%252BTargeted%252BAgents%252Bin%252BRectal%252BCancer%26aulast%3DKim%26aufirst%3DDae%2BDong%26date%3D2012%26volume%3D2012%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Squires</span>, <span class="hlFld-ContribAuthor ">George  Ward</span>, <span class="hlFld-ContribAuthor ">Gordan  Saxty</span>, <span class="hlFld-ContribAuthor ">Valerio  Berdini</span>, <span class="hlFld-ContribAuthor ">Anne  Cleasby</span>, <span class="hlFld-ContribAuthor ">Peter  King</span>, <span class="hlFld-ContribAuthor ">Patrick  Angibaud</span>, <span class="hlFld-ContribAuthor ">Tim  Perera</span>, <span class="hlFld-ContribAuthor ">Lynsey  Fazal</span>, <span class="hlFld-ContribAuthor ">Douglas  Ross</span>, <span class="hlFld-ContribAuthor ">Charlotte Griffiths  Jones</span>, <span class="hlFld-ContribAuthor ">Andrew  Madin</span>, <span class="hlFld-ContribAuthor ">Rajdeep K.  Benning</span>, <span class="hlFld-ContribAuthor ">Emma  Vickerstaffe</span>, <span class="hlFld-ContribAuthor ">Alistair  O'Brien</span>, <span class="hlFld-ContribAuthor ">Martyn  Frederickson</span>, <span class="hlFld-ContribAuthor ">Michael  Reader</span>, <span class="hlFld-ContribAuthor ">Christopher  Hamlett</span>, <span class="hlFld-ContribAuthor ">Michael A.  Batey</span>, <span class="hlFld-ContribAuthor ">Sharna  Rich</span>, <span class="hlFld-ContribAuthor ">Maria  Carr</span>, <span class="hlFld-ContribAuthor ">Darcey  Miller</span>, <span class="hlFld-ContribAuthor ">Ruth  Feltell</span>, <span class="hlFld-ContribAuthor ">Abarna  Thiru</span>, <span class="hlFld-ContribAuthor ">Susanne  Bethell</span>, <span class="hlFld-ContribAuthor ">Lindsay A.  Devine</span>, <span class="hlFld-ContribAuthor ">Brent L.  Graham</span>, <span class="hlFld-ContribAuthor ">Andrew  Pike</span>, <span class="hlFld-ContribAuthor ">Jose  Cosme</span>, <span class="hlFld-ContribAuthor ">Edward J.  Lewis</span>, <span class="hlFld-ContribAuthor ">Eddy  Freyne</span>, <span class="hlFld-ContribAuthor ">John  Lyons</span>, <span class="hlFld-ContribAuthor ">Julie  Irving</span>, <span class="hlFld-ContribAuthor ">Christopher  Murray</span>, <span class="hlFld-ContribAuthor ">David R.  Newell</span>, <span class="hlFld-ContribAuthor ">Neil T.  Thompson</span>. </span><span class="cited-content_cbyCitation_article-title">Potent, Selective Inhibitors of Fibroblast Growth Factor Receptor Define Fibroblast Growth Factor Dependence in Preclinical Cancer Models. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2011,</strong> <em>10 </em>
                                    (9)
                                     , 1542-1552. <a href="https://doi.org/10.1158/1535-7163.MCT-11-0426" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-11-0426</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-11-0426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-11-0426%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DPotent%25252C%252BSelective%252BInhibitors%252Bof%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252BDefine%252BFibroblast%252BGrowth%252BFactor%252BDependence%252Bin%252BPreclinical%252BCancer%252BModels%26aulast%3DSquires%26aufirst%3DMatthew%26date%3D2011%26date%3D2011%26volume%3D10%26issue%3D9%26spage%3D1542%26epage%3D1552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth  Allen</span>, <span class="hlFld-ContribAuthor ">Ian B.  Walters</span>, <span class="hlFld-ContribAuthor ">Douglas  Hanahan</span>. </span><span class="cited-content_cbyCitation_article-title">Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2011,</strong> <em>17 </em>
                                    (16)
                                     , 5299-5310. <a href="https://doi.org/10.1158/1078-0432.CCR-10-2847" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-10-2847</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-10-2847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-10-2847%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DBrivanib%25252C%252Ba%252BDual%252BFGF%25252FVEGF%252BInhibitor%25252C%252BIs%252BActive%252BBoth%252BFirst%252Band%252BSecond%252BLine%252Bagainst%252BMouse%252BPancreatic%252BNeuroendocrine%252BTumors%252BDeveloping%252BAdaptive%25252FEvasive%252BResistance%252Bto%252BVEGF%252BInhibition%26aulast%3DAllen%26aufirst%3DElizabeth%26date%3D2011%26date%3D2011%26volume%3D17%26issue%3D16%26spage%3D5299%26epage%3D5310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nuggehally R.  Srinivas</span>. </span><span class="cited-content_cbyCitation_article-title">The rationality for using prodrug approach in drug discovery programs for new xenobiotics: opportunities and challenges. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Drug Metabolism and Pharmacokinetics</span><span> <strong>2011,</strong> <em>36 </em>
                                    (2)
                                     , 49-59. <a href="https://doi.org/10.1007/s13318-011-0035-z" title="DOI URL">https://doi.org/10.1007/s13318-011-0035-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13318-011-0035-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13318-011-0035-z%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Drug%2520Metabolism%2520and%2520Pharmacokinetics%26atitle%3DThe%252Brationality%252Bfor%252Busing%252Bprodrug%252Bapproach%252Bin%252Bdrug%252Bdiscovery%252Bprograms%252Bfor%252Bnew%252Bxenobiotics%25253A%252Bopportunities%252Band%252Bchallenges%26aulast%3DSrinivas%26aufirst%3DNuggehally%2BR.%26date%3D2011%26date%3D2011%26volume%3D36%26issue%3D2%26spage%3D49%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaushik  Chanda</span>, <span class="hlFld-ContribAuthor ">Cheng-Ting  Chou</span>, <span class="hlFld-ContribAuthor ">Jin-Ji  Lai</span>, <span class="hlFld-ContribAuthor ">Shu-Fen  Lin</span>, <span class="hlFld-ContribAuthor ">Gorakh S.  Yellol</span>, <span class="hlFld-ContribAuthor ">Chung-Ming  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Traceless synthesis of diketopiperazine fused tetrahydro-β-carbolines on soluble polymer support. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2011,</strong> <em>15 </em>
                                    (2)
                                     , 569-581. <a href="https://doi.org/10.1007/s11030-010-9284-z" title="DOI URL">https://doi.org/10.1007/s11030-010-9284-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-010-9284-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-010-9284-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DTraceless%252Bsynthesis%252Bof%252Bdiketopiperazine%252Bfused%252Btetrahydro-%2525CE%2525B2-carbolines%252Bon%252Bsoluble%252Bpolymer%252Bsupport%26aulast%3DChanda%26aufirst%3DKaushik%26date%3D2011%26date%3D2010%26volume%3D15%26issue%3D2%26spage%3D569%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiachang  Gong</span>, <span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">Janet  Caceres-Cortes</span>, <span class="hlFld-ContribAuthor ">Lisa J.  Christopher</span>, <span class="hlFld-ContribAuthor ">Vinod  Arora</span>, <span class="hlFld-ContribAuthor ">Eric  Masson</span>, <span class="hlFld-ContribAuthor ">Daphne  Williams</span>, <span class="hlFld-ContribAuthor ">Janice  Pursley</span>, <span class="hlFld-ContribAuthor ">Alban  Allentoff</span>, <span class="hlFld-ContribAuthor ">Michael  Lago</span>, <span class="hlFld-ContribAuthor ">Scott B.  Tran</span>, <span class="hlFld-ContribAuthor ">Ramaswamy A.  Iyer</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism and Disposition of [
              14
              C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2011,</strong> <em>39 </em>
                                    (5)
                                     , 891-903. <a href="https://doi.org/10.1124/dmd.110.037341" title="DOI URL">https://doi.org/10.1124/dmd.110.037341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.110.037341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.110.037341%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DMetabolism%252Band%252BDisposition%252Bof%252B%25255B%252B14%252BC%25255DBrivanib%252BAlaninate%252Bafter%252BOral%252BAdministration%252Bto%252BRats%25252C%252BMonkeys%25252C%252Band%252BHumans%26aulast%3DGong%26aufirst%3DJiachang%26date%3D2011%26date%3D2011%26volume%3D39%26issue%3D5%26spage%3D891%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pankaj  Bhargava</span>, <span class="hlFld-ContribAuthor ">Murray O.  Robinson</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Second-Generation VEGFR Tyrosine Kinase Inhibitors: Current Status. </span><span class="cited-content_cbyCitation_journal-name">Current Oncology Reports</span><span> <strong>2011,</strong> <em>13 </em>
                                    (2)
                                     , 103-111. <a href="https://doi.org/10.1007/s11912-011-0154-3" title="DOI URL">https://doi.org/10.1007/s11912-011-0154-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11912-011-0154-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11912-011-0154-3%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Oncology%2520Reports%26atitle%3DDevelopment%252Bof%252BSecond-Generation%252BVEGFR%252BTyrosine%252BKinase%252BInhibitors%25253A%252BCurrent%252BStatus%26aulast%3DBhargava%26aufirst%3DPankaj%26date%3D2011%26date%3D2011%26volume%3D13%26issue%3D2%26spage%3D103%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anil R.  Ekkati</span>, <span class="hlFld-ContribAuthor ">Valsan  Mandiyan</span>, <span class="hlFld-ContribAuthor ">Krishna P.  Ravindranathan</span>, <span class="hlFld-ContribAuthor ">Jae H.  Bae</span>, <span class="hlFld-ContribAuthor ">Joseph  Schlessinger</span>, <span class="hlFld-ContribAuthor ">William L.  Jorgensen</span>. </span><span class="cited-content_cbyCitation_article-title">Aryl extensions of thienopyrimidinones as fibroblast growth factor receptor 1 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2011,</strong> <em>52 </em>
                                    (17)
                                     , 2228-2231. <a href="https://doi.org/10.1016/j.tetlet.2010.12.081" title="DOI URL">https://doi.org/10.1016/j.tetlet.2010.12.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2010.12.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2010.12.081%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAryl%252Bextensions%252Bof%252Bthienopyrimidinones%252Bas%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252B1%252Bkinase%252Binhibitors%26aulast%3DEkkati%26aufirst%3DAnil%2BR.%26date%3D2011%26volume%3D52%26issue%3D17%26spage%3D2228%26epage%3D2231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joong-Won  Park</span>, <span class="hlFld-ContribAuthor ">Richard S.  Finn</span>, <span class="hlFld-ContribAuthor ">Jun Suk  Kim</span>, <span class="hlFld-ContribAuthor ">Mark  Karwal</span>, <span class="hlFld-ContribAuthor ">Ruby K.  Li</span>, <span class="hlFld-ContribAuthor ">Fuad  Ismail</span>, <span class="hlFld-ContribAuthor ">Melanie  Thomas</span>, <span class="hlFld-ContribAuthor ">Rosemarie  Harris</span>, <span class="hlFld-ContribAuthor ">Christine  Baudelet</span>, <span class="hlFld-ContribAuthor ">Ian  Walters</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Raoul</span>. </span><span class="cited-content_cbyCitation_article-title">Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2011,</strong> <em>17 </em>
                                    (7)
                                     , 1973-1983. <a href="https://doi.org/10.1158/1078-0432.CCR-10-2011" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-10-2011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-10-2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-10-2011%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DPhase%252BII%25252C%252BOpen-Label%252BStudy%252Bof%252BBrivanib%252Bas%252BFirst-Line%252BTherapy%252Bin%252BPatients%252Bwith%252BAdvanced%252BHepatocellular%252BCarcinoma%26aulast%3DPark%26aufirst%3DJoong-Won%26date%3D2011%26date%3D2011%26volume%3D17%26issue%3D7%26spage%3D1973%26epage%3D1983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivan  Diaz-Padilla</span>, <span class="hlFld-ContribAuthor ">Lillian L  Siu</span>. </span><span class="cited-content_cbyCitation_article-title">Brivanib alaninate for cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2011,</strong> <em>20 </em>
                                    (4)
                                     , 577-586. <a href="https://doi.org/10.1517/13543784.2011.565329" title="DOI URL">https://doi.org/10.1517/13543784.2011.565329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2011.565329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2011.565329%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DBrivanib%252Balaninate%252Bfor%252Bcancer%26aulast%3DDiaz-Padilla%26aufirst%3DIvan%26date%3D2011%26date%3D2011%26volume%3D20%26issue%3D4%26spage%3D577%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenji  Takeuchi</span>, <span class="hlFld-ContribAuthor ">Fumiaki  Ito</span>. </span><span class="cited-content_cbyCitation_article-title">Receptor Tyrosine Kinases and Targeted Cancer Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Biological and Pharmaceutical Bulletin</span><span> <strong>2011,</strong> <em>34 </em>
                                    (12)
                                     , 1774-1780. <a href="https://doi.org/10.1248/bpb.34.1774" title="DOI URL">https://doi.org/10.1248/bpb.34.1774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/bpb.34.1774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fbpb.34.1774%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DReceptor%252BTyrosine%252BKinases%252Band%252BTargeted%252BCancer%252BTherapeutics%26aulast%3DTakeuchi%26aufirst%3DKenji%26date%3D2011%26volume%3D34%26issue%3D12%26spage%3D1774%26epage%3D1780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tarek  Mekhail</span>, <span class="hlFld-ContribAuthor ">Eric  Masson</span>, <span class="hlFld-ContribAuthor ">Bruce S.  Fischer</span>, <span class="hlFld-ContribAuthor ">Jiachang  Gong</span>, <span class="hlFld-ContribAuthor ">Ramaswamy  Iyer</span>, <span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">Janice  Pursley</span>, <span class="hlFld-ContribAuthor ">Daniel  Patricia</span>, <span class="hlFld-ContribAuthor ">Daphne  Williams</span>, <span class="hlFld-ContribAuthor ">Ram  Ganapathi</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism, Excretion, and Pharmacokinetics of Oral Brivanib in Patients with Advanced or Metastatic Solid Tumors. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2010,</strong> <em>38 </em>
                                    (11)
                                     , 1962-1966. <a href="https://doi.org/10.1124/dmd.110.033951" title="DOI URL">https://doi.org/10.1124/dmd.110.033951</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.110.033951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.110.033951%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DMetabolism%25252C%252BExcretion%25252C%252Band%252BPharmacokinetics%252Bof%252BOral%252BBrivanib%252Bin%252BPatients%252Bwith%252BAdvanced%252Bor%252BMetastatic%252BSolid%252BTumors%26aulast%3DMekhail%26aufirst%3DTarek%26date%3D2010%26date%3D2010%26volume%3D38%26issue%3D11%26spage%3D1962%26epage%3D1966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine Y.  Shiang</span>, <span class="hlFld-ContribAuthor ">Yuan  Qi</span>, <span class="hlFld-ContribAuthor ">Bailiang  Wang</span>, <span class="hlFld-ContribAuthor ">Vladimir  Lazar</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">W.  Fraser Symmans</span>, <span class="hlFld-ContribAuthor ">Gabriel N.  Hortobagyi</span>, <span class="hlFld-ContribAuthor ">Fabrice  Andre</span>, <span class="hlFld-ContribAuthor ">Lajos  Pusztai</span>. </span><span class="cited-content_cbyCitation_article-title">Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research and Treatment</span><span> <strong>2010,</strong> <em>123 </em>
                                    (3)
                                     , 747-755. <a href="https://doi.org/10.1007/s10549-009-0677-6" title="DOI URL">https://doi.org/10.1007/s10549-009-0677-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10549-009-0677-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10549-009-0677-6%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%2520and%2520Treatment%26atitle%3DAmplification%252Bof%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor-1%252Bin%252Bbreast%252Bcancer%252Band%252Bthe%252Beffects%252Bof%252Bbrivanib%252Balaninate%26aulast%3DShiang%26aufirst%3DChristine%2BY.%26date%3D2010%26date%3D2009%26volume%3D123%26issue%3D3%26spage%3D747%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert H.  Bradbury</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors: Approved Drugs and Clinical Candidates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 295-344. <a href="https://doi.org/10.1002/0471266949.bmc214" title="DOI URL">https://doi.org/10.1002/0471266949.bmc214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc214%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%25253A%252BApproved%252BDrugs%252Band%252BClinical%252BCandidates%26aulast%3DBradbury%26aufirst%3DRobert%2BH.%26date%3D2010%26date%3D2010%26spage%3D295%26epage%3D344%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roshani R.  Patel</span>, <span class="hlFld-ContribAuthor ">Surojeet  Sengupta</span>, <span class="hlFld-ContribAuthor ">Helen R.  Kim</span>, <span class="hlFld-ContribAuthor ">Andres J.  Klein-Szanto</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Pyle</span>, <span class="hlFld-ContribAuthor ">Fang  Zhu</span>, <span class="hlFld-ContribAuthor ">Tianyu  Li</span>, <span class="hlFld-ContribAuthor ">Eric A.  Ross</span>, <span class="hlFld-ContribAuthor ">Salewa  Oseni</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>, <span class="hlFld-ContribAuthor ">V. Craig  Jordan</span>. </span><span class="cited-content_cbyCitation_article-title">Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: A potential clinical application of angiogenesis inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Cancer</span><span> <strong>2010,</strong> <em>46 </em>
                                    (9)
                                     , 1537-1553. <a href="https://doi.org/10.1016/j.ejca.2010.02.018" title="DOI URL">https://doi.org/10.1016/j.ejca.2010.02.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejca.2010.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejca.2010.02.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Cancer%26atitle%3DExperimental%252Btreatment%252Bof%252Boestrogen%252Breceptor%252B%252528ER%252529%252Bpositive%252Bbreast%252Bcancer%252Bwith%252Btamoxifen%252Band%252Bbrivanib%252Balaninate%25252C%252Ba%252BVEGFR-2%25252FFGFR-1%252Bkinase%252Binhibitor%25253A%252BA%252Bpotential%252Bclinical%252Bapplication%252Bof%252Bangiogenesis%252Binhibitors%26aulast%3DPatel%26aufirst%3DRoshani%2BR.%26date%3D2010%26volume%3D46%26issue%3D9%26spage%3D1537%26epage%3D1553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael L.  Maitland</span>, <span class="hlFld-ContribAuthor ">Xing Jian  Lou</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Ramirez</span>, <span class="hlFld-ContribAuthor ">Apurva A.  Desai</span>, <span class="hlFld-ContribAuthor ">Dorit S.  Berlin</span>, <span class="hlFld-ContribAuthor ">Howard L.  McLeod</span>, <span class="hlFld-ContribAuthor ">Ralph R.  Weichselbaum</span>, <span class="hlFld-ContribAuthor ">Mark J.  Ratain</span>, <span class="hlFld-ContribAuthor ">Russ B.  Altman</span>, <span class="hlFld-ContribAuthor ">Teri E.  Klein</span>. </span><span class="cited-content_cbyCitation_article-title">Vascular endothelial growth factor pathway. </span><span class="cited-content_cbyCitation_journal-name">Pharmacogenetics and Genomics</span><span> <strong>2010,</strong> <em>20 </em>
                                    (5)
                                     , 346-349. <a href="https://doi.org/10.1097/FPC.0b013e3283364ed7" title="DOI URL">https://doi.org/10.1097/FPC.0b013e3283364ed7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/FPC.0b013e3283364ed7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FFPC.0b013e3283364ed7%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacogenetics%2520and%2520Genomics%26atitle%3DVascular%252Bendothelial%252Bgrowth%252Bfactor%252Bpathway%26aulast%3DMaitland%26aufirst%3DMichael%2BL.%26date%3D2010%26volume%3D20%26issue%3D5%26spage%3D346%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajeev S.  Bhide</span>, <span class="hlFld-ContribAuthor ">Louis J.  Lombardo</span>, <span class="hlFld-ContribAuthor ">John T.  Hunt</span>, <span class="hlFld-ContribAuthor ">Zhen-wei  Cai</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Susan  Galbraith</span>, <span class="hlFld-ContribAuthor ">Robert  Jeyaseelan</span>, <span class="hlFld-ContribAuthor ">Steven  Mortillo</span>, <span class="hlFld-ContribAuthor ">Barri S.  Wautlet</span>, <span class="hlFld-ContribAuthor ">Bala  Krishnan</span>, <span class="hlFld-ContribAuthor ">Daniel  Kukral</span>, <span class="hlFld-ContribAuthor ">Harold  Malone</span>, <span class="hlFld-ContribAuthor ">Anne C.  Lewin</span>, <span class="hlFld-ContribAuthor ">Benjamin J.  Henley</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>. </span><span class="cited-content_cbyCitation_article-title">The Antiangiogenic Activity in Xenograft Models of Brivanib, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinases. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2010,</strong> <em>9 </em>
                                    (2)
                                     , 369-378. <a href="https://doi.org/10.1158/1535-7163.MCT-09-0472" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-09-0472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-09-0472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-09-0472%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DThe%252BAntiangiogenic%252BActivity%252Bin%252BXenograft%252BModels%252Bof%252BBrivanib%25252C%252Ba%252BDual%252BInhibitor%252Bof%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor-2%252Band%252BFibroblast%252BGrowth%252BFactor%252BReceptor-1%252BKinases%26aulast%3DBhide%26aufirst%3DRajeev%2BS.%26date%3D2010%26date%3D2010%26volume%3D9%26issue%3D2%26spage%3D369%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Jin  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">New Indole-Containing Medicinal Compounds. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 1-29. <a href="https://doi.org/10.1007/7081_2010_37" title="DOI URL">https://doi.org/10.1007/7081_2010_37</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7081_2010_37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7081_2010_37%26sid%3Dliteratum%253Aachs%26atitle%3DNew%252BIndole-Containing%252BMedicinal%252BCompounds%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2010%26date%3D2010%26spage%3D1%26epage%3D29%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DHeterocyclic%252BScaffolds%252BII%25253A%26aulast%3DGribble%26aufirst%3DGordon%2BW.%26date%3D2010%26volume%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Punit H.  Marathe</span>, <span class="hlFld-ContribAuthor ">Amrita V.  Kamath</span>, <span class="hlFld-ContribAuthor ">Yueping  Zhang</span>, <span class="hlFld-ContribAuthor ">Celia  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">Rajeev  Bhide</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2009,</strong> <em>65 </em>
                                    (1)
                                     , 55-66. <a href="https://doi.org/10.1007/s00280-009-1002-0" title="DOI URL">https://doi.org/10.1007/s00280-009-1002-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-009-1002-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-009-1002-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DPreclinical%252Bpharmacokinetics%252Band%252Bin%252Bvitro%252Bmetabolism%252Bof%252Bbrivanib%252B%252528BMS-540215%252529%25252C%252Ba%252Bpotent%252BVEGFR2%252Binhibitor%252Band%252Bits%252Balanine%252Bester%252Bprodrug%252Bbrivanib%252Balaninate%26aulast%3DMarathe%26aufirst%3DPunit%2BH.%26date%3D2009%26date%3D2009%26volume%3D65%26issue%3D1%26spage%3D55%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takuya  Sato</span>, <span class="hlFld-ContribAuthor ">Noriko  Gotoh</span>. </span><span class="cited-content_cbyCitation_article-title">The FRS2 family of docking/scaffolding adaptor proteins as therapeutic targets of cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2009,</strong> <em>13 </em>
                                    (6)
                                     , 689-700. <a href="https://doi.org/10.1517/14728220902942330" title="DOI URL">https://doi.org/10.1517/14728220902942330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728220902942330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728220902942330%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DThe%252BFRS2%252Bfamily%252Bof%252Bdocking%25252Fscaffolding%252Badaptor%252Bproteins%252Bas%252Btherapeutic%252Btargets%252Bof%252Bcancer%252Btreatment%26aulast%3DSato%26aufirst%3DTakuya%26date%3D2009%26date%3D2009%26volume%3D13%26issue%3D6%26spage%3D689%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robin K.  Kelley</span>, <span class="hlFld-ContribAuthor ">Alan P.  Venook</span>. </span><span class="cited-content_cbyCitation_article-title">Drug development in advanced colorectal cancer: Challenges and opportunities. </span><span class="cited-content_cbyCitation_journal-name">Current Oncology Reports</span><span> <strong>2009,</strong> <em>11 </em>
                                    (3)
                                     , 175-185. <a href="https://doi.org/10.1007/s11912-009-0026-2" title="DOI URL">https://doi.org/10.1007/s11912-009-0026-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11912-009-0026-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11912-009-0026-2%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Oncology%2520Reports%26atitle%3DDrug%252Bdevelopment%252Bin%252Badvanced%252Bcolorectal%252Bcancer%25253A%252BChallenges%252Band%252Bopportunities%26aulast%3DKelley%26aufirst%3DRobin%2BK.%26date%3D2009%26date%3D2009%26volume%3D11%26issue%3D3%26spage%3D175%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm7013309&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-6%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm7013309%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=102&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/medium/jm-2007-013309_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/large/jm-2007-013309_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7013309&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/medium/jm-2007-013309_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/large/jm-2007-013309_0001.jpeg" id="rightTab-gc1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Examples of VEGFR-2 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/large/jm-2007-013309_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7013309&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/medium/jm-2007-013309_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/large/jm-2007-013309_0002.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/large/jm-2007-013309_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7013309&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF, 16 h; (b) MeMgBr, THF, 0 °C, 2–5 h, 75% yield over two steps; (c) H<sub>2</sub>O<sub>2</sub>, BF<sub>3</sub>/OEt<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −15 °C to −25 °C, 1 h, 66%; (d) <i>R</i>-(+)- propylene oxide, LiCl, NEt<sub>3</sub> (cat.), EtOH, 3 h, 81%; (e) CbzNHCR<sup>1</sup>R<sup>2</sup>COOH (<b>7</b>–<b>15</b>) or R<sup>3</sup>CO<sub>2</sub>H (<b>16</b>–<b>20</b>), HATU, DIPEA, DMAP (cat.), THF, 5 h, 51–94%; (f) HCOO<sup>−</sup>NH<sub>4</sub><sup>+</sup>, Pd/C, DMF, 69–99%.</p></p></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/medium/jm-2007-013309_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/large/jm-2007-013309_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. In vivo antitumor activity of <b>8</b> vs L2987 xenografts in athymic mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7013309/production/images/large/jm-2007-013309_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7013309&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13744" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13744" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 18 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Klagsbrun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moses, M. A.</span><span> </span><span class="NLM_article-title">Molecular angiogenesis</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_elocation-id">R217–224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&author=M.+Klagsbrunauthor=M.+A.+Moses&title=Molecular+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlagsbrun%26aufirst%3DM.%26aulast%3DMoses%26aufirst%3DM.%2BA.%26atitle%3DMolecular%2520angiogenesis%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Folkman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shing, Y.</span><span> </span><span class="NLM_article-title">Angiogenesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">10931</span><span class="NLM_x">–</span> <span class="NLM_lpage">10934</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=10931-10934&author=J.+Folkmanauthor=Y.+Shing&title=Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26aulast%3DShing%26aufirst%3DY.%26atitle%3DAngiogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D10931%26epage%3D10934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Folkman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klagsbrun, M.</span><span> </span><span class="NLM_article-title">Angiogenic factors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">235</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1987&pages=442-447&author=J.+Folkmanauthor=M.+Klagsbrun&title=Angiogenic+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26aulast%3DKlagsbrun%26aufirst%3DM.%26atitle%3DAngiogenic%2520factors%26jtitle%3DScience%26date%3D1987%26volume%3D235%26spage%3D442%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Carmeliet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">Angiogenesis in cancer and other diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1038%2F35025220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=11001068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVSls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=249-257&author=P.+Carmelietauthor=R.+K.+Jain&title=Angiogenesis+in+cancer+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in cancer and other diseases</span></div><div class="casAuthors">Carmeliet, Peter; Jain, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">6801</span>),
    <span class="NLM_cas:pages">249-257</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 75 refs.  Pathol. angiogenesis is a hallmark of cancer and various ischemic and inflammatory diseases.  Concd. efforts in this area of research are leading to the discovery of a growing no. of pro- and anti-angiogenic mols., some of which are already in clin. trials.  The complex interactions among these mols. and how they affect vascular structure and function in different environments are now beginning to be elucidated.  This integrated understanding is leading to the development of a no. of exciting and bold approaches to treat cancer and other diseases.  But owing to several unanswered questions, caution is needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPQMelW0OMYbVg90H21EOLACvtfcHk0lhoYxwvbLyStw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVSls74%253D&md5=703cbcdbd32292a9238f0394220c853c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F35025220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35025220%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DAngiogenesis%2520in%2520cancer%2520and%2520other%2520diseases%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D249%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ellis, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidler, I. J.</span><span> </span><span class="NLM_article-title">Angiogenesis and metastasis</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">32A</span><span class="NLM_x">, </span> <span class="NLM_fpage">2451</span><span class="NLM_x">–</span> <span class="NLM_lpage">2460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32A&publication_year=1996&pages=2451-2460&author=L.+M.+Ellisauthor=I.+J.+Fidler&title=Angiogenesis+and+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DL.%2BM.%26aulast%3DFidler%26aufirst%3DI.%2BJ.%26atitle%3DAngiogenesis%2520and%2520metastasis%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1996%26volume%3D32A%26spage%3D2451%26epage%3D2460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Folkman, J.</span><span> </span><span class="NLM_article-title">Angiogenesis-dependent diseases</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1016%2FS0093-7754%2801%2990021-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=11740806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A280%3ADC%252BD3MnptlOguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=536-542&author=J.+Folkman&title=Angiogenesis-dependent+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis-dependent diseases</span></div><div class="casAuthors">Folkman J</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">536-42</span>
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    </div><div class="casAbstract">There is accumulating evidence that leukemias and other hematologic diseases are angiogenesis-dependent.  Therefore, angiogenesis inhibitors may be useful adjuncts to conventional therapies in the treatment of these diseases.  When all conventional therapy has failed, an angiogenesis inhibitor may be successfully used alone, as has been demonstrated in the treatment of multiple myeloma by thalidomide.  The experimental and clinical evidence that the efficacy of thalidomide against multiple myeloma is mediated in part by its antiangiogenic activity is presented here.  In current clinical trials throughout the United States, angiogenesis inhibitors are being used against cancer in combination with conventional chemotherapy or radiotherapy.  Angiogenesis inhibitors are also being used in combination with each other.  This practice may increase as different angiogenesis inhibitors become more widely available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcxNoAnTF920EgZCMqtRBifW6udTcc2ea_V_hYtMuaCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MnptlOguw%253D%253D&md5=e5d99cc1a7ff1b7e3ee6fcdb07671b45</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2FS0093-7754%2801%2990021-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0093-7754%252801%252990021-1%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DAngiogenesis-dependent%2520diseases%26jtitle%3DSemin.%2520Oncol.%26date%3D2001%26volume%3D28%26spage%3D536%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ferrara, N.</span><span> </span><span class="NLM_article-title">VEGF and the quest for tumor angiogenesis factors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1038%2Fnrc909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=12360282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVGrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=795-803&author=N.+Ferrara&title=VEGF+and+the+quest+for+tumor+angiogenesis+factors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Timeline: VEGF and the quest for tumor angiogenesis factors</span></div><div class="casAuthors">Ferrara, Napoleone</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">795-803</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The ability of tumors to induce new blood-vessel formation has been a major focus of cancer research over the past few decades, and vascular endothelial growth factor (VEGF) is now known to be central to this process.  The quest for VEGF and other factors that promote tumor angiogenesis was initiated many decades ago, and a long and complicated path has led to the development of inhibitors of these mols. as anticancer agents.  How did this field begin, and how have we arrived at our present understanding of the role of VEGF in tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFHN1T3vtAELVg90H21EOLACvtfcHk0li8ZNV6pVu-kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVGrtbk%253D&md5=b0f6d2bde63351fae496d743a9a7e4bf</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1038%2Fnrc909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc909%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DVEGF%2520and%2520the%2520quest%2520for%2520tumor%2520angiogenesis%2520factors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D795%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Risau, W.</span><span> </span><span class="NLM_article-title">Mechanism of angiogenesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=249-257&author=W.+Risau&title=Mechanism+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRisau%26aufirst%3DW.%26atitle%3DMechanism%2520of%2520angiogenesis%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D249%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Baka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clamp, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayson, G. C.</span><span> </span><span class="NLM_article-title">A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1517%2F14728222.10.6.867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=17105373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Smt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=867-876&author=S.+Bakaauthor=A.+R.+Clampauthor=G.+C.+Jayson&title=A+review+of+the+latest+clinical+compounds+to+inhibit+VEGF+in+pathological+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis</span></div><div class="casAuthors">Baka, Sofia; Clamp, Andrew R.; Jayson, Gordon C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">867-876</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Angiogenesis plays an important role in the formation of new blood vessels and is crucial for tumor development and progression.  Imbalance between pro- and antiangiogenesis factors regulates the biol. process of angiogenesis.  The best characterized of the proangiogenic factors and the most potent is vascular endothelial growth factor (VEGF).  The binding of VEGF to one of its transmembrane tyrosine kinase receptors, which are predominantly found on endothelial cells, results in receptor dimerization, activation and autophosphorylation of the tyrosine kinase domain.  This triggers a cascade of complex downstream signalling pathways.  Several strategies targeting the VEGF signalling pathway have been developed.  These include neutralizing antibodies to VEGF (bevacizumab) or VEGF receptors (VEGFRs) (DC101), sol. VEGFR/VEGFR hybrids (VEGF-Trap), and tyrosine kinase inhibitors of VEGFRs (BAY43-9006, SU11248, ZD6474, AZD2171, PTK/ZK and others).  Several of these agents are now being investigated in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozY3D8lNZOqLVg90H21EOLACvtfcHk0li8ZNV6pVu-kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Smt7zO&md5=3cba31f6365fd5ef2749fe401c4a0406</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1517%2F14728222.10.6.867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.10.6.867%26sid%3Dliteratum%253Aachs%26aulast%3DBaka%26aufirst%3DS.%26aulast%3DClamp%26aufirst%3DA.%2BR.%26aulast%3DJayson%26aufirst%3DG.%2BC.%26atitle%3DA%2520review%2520of%2520the%2520latest%2520clinical%2520compounds%2520to%2520inhibit%2520VEGF%2520in%2520pathological%2520angiogenesis%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2006%26volume%3D10%26spage%3D867%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. A.</span><span> </span><span class="NLM_article-title">Antiangiogenic agents targeting vascular endothethial growth factor and its receptors in clinical development</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1447</span><span class="NLM_x">–</span> <span class="NLM_lpage">1465</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1517%2F13543784.11.10.1447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=12387705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFOhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=1447-1465&author=L.+Sepp-Lorenzinoauthor=K.+A.+Thomas&title=Antiangiogenic+agents+targeting+vascular+endothethial+growth+factor+and+its+receptors+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development</span></div><div class="casAuthors">Sepp-Lorenzino, Laura; Thomas, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1447-1465</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  There is ample therapeutic opportunity for the use of antiangiogenic inhibitors in the clinic, as there are several human diseases that are dependent upon angiogenesis.  However, no disease has attracted as much attention as a target for antiangiogenic therapy as malignant disorders.  There is a vast amt. of literature acting as proof-of-principle for the use of angiogenic inhibitors as effective agents for blocking tumor-induced angiogenesis and subverting tumor growth and disease dissemination.  One of the unique attractions of targeting tumor angiogenesis is that vascular endothelial cells are a genetically stable population in which acquisition of therapeutic resistance might be less efficient than in genetically unstable tumor cells [2,3].  This review covers inhibitors that target the tumor angiogenic agent vascular endothelial growth factor and its receptors as one such antiangiogenic approach.  Many agents in this class are in clin. trials with limited reports of toxicity and some early evidence of clin. benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqBbAXNb4_cLVg90H21EOLACvtfcHk0li8ZNV6pVu-kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFOhtrw%253D&md5=c2faa232a13b86a261649d6aa9840e97</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1517%2F13543784.11.10.1447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.11.10.1447%26sid%3Dliteratum%253Aachs%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DK.%2BA.%26atitle%3DAntiangiogenic%2520agents%2520targeting%2520vascular%2520endothethial%2520growth%2520factor%2520and%2520its%2520receptors%2520in%2520clinical%2520development%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D1447%26epage%3D1465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Klebl, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, G.</span><span> </span><span class="NLM_article-title">Second-generation kinase inhibitors</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1517%2F14728222.9.5.975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=16185153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVartbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=975-993&author=B.+M.+Kleblauthor=G.+Muller&title=Second-generation+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation kinase inhibitors</span></div><div class="casAuthors">Klebl, Bert M.; Mueller, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">975-993</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  An increasing no. of kinase inhibitor candidates are entering clin. development, representing an important change in the pharmaceutical industry; notably, the development of small-mol. kinase inhibitors for signal transduction therapies.  Today, kinase inhibitors garner substantial attention in cancer research.  Over the last few years, three distinct small-mol. kinase inhibitors reached the market for treatment of chronic myeloid leukemia, gastrointestinal stromal tumors, and non-small cell lung cancers.  These three drugs, imatinib, gefitinib and erlotinib, act on a distinct subset of dysregulated, and often cancer-relevant kinases.  Imatinib, gefitinib and erlotinib are considered the front-runners of targeted kinase inhibitor drugs.  The entire research field gains tremendous insights through the ongoing research and clin. trials with these three drugs and with fast following first-generation kinase inhibitors, many of which are in different phases of clin. development.  In addn., novel chemogenomic and chemoproteomic technologies are emanating from the current kinase research area, focussing efforts on the generation of spectrum-selective inhibitors for anticancer therapies as opposed to the monospecific inhibitors for the remaining therapeutic areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJli31wX5cJbVg90H21EOLACvtfcHk0lhkCtgI63k45Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVartbfN&md5=81c46202984d0fe908b7315008839b03</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1517%2F14728222.9.5.975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.9.5.975%26sid%3Dliteratum%253Aachs%26aulast%3DKlebl%26aufirst%3DB.%2BM.%26aulast%3DMuller%26aufirst%3DG.%26atitle%3DSecond-generation%2520kinase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2005%26volume%3D9%26spage%3D975%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span> </span><span class="NLM_article-title">Protein tyrosine kinase inhibitors as anticancer agents</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1517%2F13543776.14.1.35" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVequrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=35-53&author=C.+T.+Supuranauthor=A.+Scozzafava&title=Protein+tyrosine+kinase+inhibitors+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine kinase inhibitors as anticancer agents</span></div><div class="casAuthors">Supuran, Claudiu T.; Scozzafava, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-53</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  There are > 700 protein kinases and 100 protein phosphatases encoded within the human genome.  By catalyzing protein phosphorylation and dephosphorylation, they play a pivotal role in intracellular signaling and in the regulation of signal transduction pathways.  Activation of oncogenes coding for such proteins can lead to the prodn. of kinases that are continually active in the absence of a normal stimulus, leading to increased cell proliferation and/or decreased apoptosis.  Receptor and nonreceptor protein tyrosine kinases (PTKs) are essential enzymes in cellular signaling processes that regulate cell growth, differentiation, migration and metab.  Their inhibition by specific inhibitors was recently shown to constitute a new modality for cancer treatment.  A patent literature review comprising the years 2000-2003 is presented here, as the major drug houses are currently involved in the design and development of novel types of such compds. with applications as antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorjQ5uLqMRpbVg90H21EOLACvtfcHk0lhkCtgI63k45Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVequrg%253D&md5=0433a3e496ac1961f4602f7dd6ca7dfb</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1517%2F13543776.14.1.35&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.14.1.35%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DScozzafava%26aufirst%3DA.%26atitle%3DProtein%2520tyrosine%2520kinase%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2004%26volume%3D14%26spage%3D35%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kiselyov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakin, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkachenko, S. E.</span><span> </span><span class="NLM_article-title">VEGF/VEGFR signaling as a target for inhibiting angiogenesis</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=83-107&author=A.+Kiselyovauthor=K.+V.+Balakinauthor=S.+E.+Tkachenko&title=VEGF%2FVEGFR+signaling+as+a+target+for+inhibiting+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiselyov%26aufirst%3DA.%26aulast%3DBalakin%26aufirst%3DK.%2BV.%26aulast%3DTkachenko%26aufirst%3DS.%2BE.%26atitle%3DVEGF%252FVEGFR%2520signaling%2520as%2520a%2520target%2520for%2520inhibiting%2520angiogenesis%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D16%26spage%3D83%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Herbst, R. S.</span><span> </span><span class="NLM_article-title">Therapeutic options to target angiogenesis in human malignancies</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1517%2F14728214.11.4.635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=17064223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWltbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=635-650&author=R.+S.+Herbst&title=Therapeutic+options+to+target+angiogenesis+in+human+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic options to target angiogenesis in human malignancies</span></div><div class="casAuthors">Herbst, Roy S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">635-650</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The crit. role of angiogenesis in tumor growth and metastasis is now well established in the literature.  Growing tumors stimulate neovascularization through the secretion of pro-angiogenic growth factors, in particular, basic fibroblast growth factor and VEGF.  Several lines of evidence have implicated VEGF in tumorigenesis, and understanding the role of VEGF in tumor angiogenesis has facilitated the development of novel targeting agents that specifically interfere with angiogenesis.  Different approaches to disrupting tumor-induced angiogenesis encompass tyrosine kinase inhibitor, monoclonal antibodies, small-mol. inhibitors and transcription inhibitors.  However, monoclonal antibody and tyrosine kinase inhibitors are the most advanced drug classes currently being investigated in clin. trials.  So far, three anti-VEGF inhibitors, bevacizumab, sunitinib and sorafenib, have been approved for the treatment of solid human malignancies including colorectal cancer, gastrointestinal stromal tumors and renal cell carcinoma.  Other antiangiogenic drugs are being investigated in various types of cancer.  This review summarizes the current literature on the use of these agents to interfere with VEGF, VEGF receptor, the matrix breakdown or other mechanisms involved in angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCCi5NM8VbsLVg90H21EOLACvtfcHk0lhkCtgI63k45Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWltbfL&md5=d66cd5be7b8293bb797f68b7fb6d5d1a</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1517%2F14728214.11.4.635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.11.4.635%26sid%3Dliteratum%253Aachs%26aulast%3DHerbst%26aufirst%3DR.%2BS.%26atitle%3DTherapeutic%2520options%2520to%2520target%2520angiogenesis%2520in%2520human%2520malignancies%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2006%26volume%3D11%26spage%3D635%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Presta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DellʼEra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnati, M.</span><span> </span><span class="NLM_article-title">Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1016%2Fj.cytogfr.2005.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=15863032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=159-178&author=M.+Prestaauthor=P.+Dell%CA%BCEraauthor=S.+Mitolaauthor=E.+Moroniauthor=R.+Roncaauthor=M.+Rusnati&title=Fibroblast+growth+factor%2Ffibroblast+growth+factor+receptor+system+in+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis</span></div><div class="casAuthors">Presta, Marco; Dell'Era, Patrizia; Mitola, Stefania; Moroni, Emanuela; Ronca, Roberto; Rusnati, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-178</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Fibroblast growth factors (FGFs) are a family of heparin-binding growth factors.  FGFs exert their pro-angiogenic activity by interacting with various endothelial cell surface receptors, including tyrosine kinase receptors, heparan-sulfate proteoglycans, and integrins.  Their activity is modulated by a variety of free and extracellular matrix-assocd. mols.  Also, the cross-talk among FGFs, vascular endothelial growth factors (VEGFs), and inflammatory cytokines/chemokines may play a role in the modulation of blood vessel growth in different pathol. conditions, including cancer.  Indeed, several exptl. evidences point to a role for FGFs in tumor growth and angiogenesis.  This review will focus on the relevance of the FGF/FGF receptor system in adult angiogenesis and its contribution to tumor vascularization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ2Z-3PisajLVg90H21EOLACvtfcHk0lh5nyN4FOgAuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOns7c%253D&md5=9f7ce0832577f97591b7a5c3c120ff12</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cytogfr.2005.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cytogfr.2005.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DPresta%26aufirst%3DM.%26aulast%3DDell%25CA%25BCEra%26aufirst%3DP.%26aulast%3DMitola%26aufirst%3DS.%26aulast%3DMoroni%26aufirst%3DE.%26aulast%3DRonca%26aufirst%3DR.%26aulast%3DRusnati%26aufirst%3DM.%26atitle%3DFibroblast%2520growth%2520factor%252Ffibroblast%2520growth%2520factor%2520receptor%2520system%2520in%2520angiogenesis%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2005%26volume%3D16%26spage%3D159%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ozen, M. A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medrano, E. E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittmann, M. A. C.</span><span> </span><span class="NLM_article-title">Inhibition of proliferation and survival of melanoma cells by adenoviral-mediated expression of dominant negative fibroblast growth factor receptor</span> <span class="citation_source-journal">Melanoma Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1097%2F00008390-200402000-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=15091189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1agtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=13-21&issue=1&author=M.+A.+C.+Ozenauthor=E.+E.+B.+Medranoauthor=M.+A.+C.+Ittmann&title=Inhibition+of+proliferation+and+survival+of+melanoma+cells+by+adenoviral-mediated+expression+of+dominant+negative+fibroblast+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of proliferation and survival of melanoma cells by adenoviral-mediated expression of dominant negative fibroblast growth factor receptor</span></div><div class="casAuthors">Ozen, Mustafa; Medrano, Estela E.; Ittmann, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Melanoma Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-21</span>CODEN:
                <span class="NLM_cas:coden">MREEEH</span>;
        ISSN:<span class="NLM_cas:issn">0960-8931</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Melanoma is the most deadly cutaneous malignancy; its incidence has risen significantly over the last 30 yr and there is no effective treatment for advanced melanoma.  Autocrine expression of fibroblast growth factors (FGFs) is a common event in malignant melanoma.  We therefore sought to inhibit the proliferation and survival of melanoma cells as an approach to melanoma therapy by disrupting FGF signaling via adenoviral-mediated expression of a dominant neg. FGF receptor.  We tested three melanoma cell lines (A375, IIB and UCD) that express FGF2 and respond to exogenous FGF2 with increased proliferation.  In all three cell lines, there was a significant decrease in net proliferation, and in two (A375 and UCD) an increase in cell death, assocd. with expression of the dominant neg. FGF receptor.  In these two cell lines, expression of the dominant neg. FGF receptor resulted in the accumulation of p21 (WAF1/cip1), decreased cell division cycle-2 (cdc2) kinase activity, an increase in the percentage of cells in the G2 phase of the cell cycle, and inhibition of cytokinesis, with accumulation of binucleated cells.  These studies reveal that inhibition of FGF signaling can markedly decrease the net proliferation of melanoma cells by a novel mechanism involving a decrease in cdc2 kinase activity, an increase in p21 expression, inhibition of G2 progression, inhibition of cytokinesis and increased cell death.  In contrast, disruption of FGF signaling had only slight effects on normal melanocytes.  Disruption of FGF signaling via the expression of the dominant neg. FGF receptor is, therefore, a potential therapeutic approach in human melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcsEa7XwD8LbVg90H21EOLACvtfcHk0lh5nyN4FOgAuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1agtrs%253D&md5=017f21e66536bbf7113a99c73185835d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1097%2F00008390-200402000-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008390-200402000-00003%26sid%3Dliteratum%253Aachs%26aulast%3DOzen%26aufirst%3DM.%2BA.%2BC.%26aulast%3DMedrano%26aufirst%3DE.%2BE.%2BB.%26aulast%3DIttmann%26aufirst%3DM.%2BA.%2BC.%26atitle%3DInhibition%2520of%2520proliferation%2520and%2520survival%2520of%2520melanoma%2520cells%2520by%2520adenoviral-mediated%2520expression%2520of%2520dominant%2520negative%2520fibroblast%2520growth%2520factor%2520receptor%26jtitle%3DMelanoma%2520Res.%26date%3D2004%26volume%3D14%26issue%3D1%26spage%3D13%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Auguste, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gürsel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemière, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuevas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carceller, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">and Bikfalvi, A.</span><span> </span><span class="NLM_article-title">Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">–</span> <span class="NLM_lpage">1726</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=1717-1726&author=P.+Augusteauthor=D.+B.+G%C3%BCrselauthor=S.+Lemi%C3%A8reauthor=D.+Reimersauthor=P.+Cuevasauthor=F.+Carcellerauthor=J.+P.+Di+Santoauthor=A.+and+Bikfalvi&title=Inhibition+of+fibroblast+growth+factor%2Ffibroblast+growth+factor+receptor+activity+in+glioma+cells+impedes+tumor+growth+by+both+angiogenesis-dependent+and+-independent+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAuguste%26aufirst%3DP.%26aulast%3DG%25C3%25BCrsel%26aufirst%3DD.%2BB.%26aulast%3DLemi%25C3%25A8re%26aufirst%3DS.%26aulast%3DReimers%26aufirst%3DD.%26aulast%3DCuevas%26aufirst%3DP.%26aulast%3DCarceller%26aufirst%3DF.%26aulast%3DDi%2BSanto%26aufirst%3DJ.%2BP.%26aulast%3Dand%2BBikfalvi%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520fibroblast%2520growth%2520factor%252Ffibroblast%2520growth%2520factor%2520receptor%2520activity%2520in%2520glioma%2520cells%2520impedes%2520tumor%2520growth%2520by%2520both%2520angiogenesis-dependent%2520and%2520-independent%2520mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D1717%26epage%3D1726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kornmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beger, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korc, M.</span><span> </span><span class="NLM_article-title">Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis</span> <span class="citation_source-journal">Pancreas</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=169-175&author=M.+Kornmannauthor=H.+G.+Begerauthor=M.+Korc&title=Role+of+fibroblast+growth+factors+and+their+receptors+in+pancreatic+cancer+and+chronic+pancreatitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKornmann%26aufirst%3DM.%26aulast%3DBeger%26aufirst%3DH.%2BG.%26aulast%3DKorc%26aufirst%3DM.%26atitle%3DRole%2520of%2520fibroblast%2520growth%2520factors%2520and%2520their%2520receptors%2520in%2520pancreatic%2520cancer%2520and%2520chronic%2520pancreatitis%26jtitle%3DPancreas%26date%3D1998%26volume%3D17%26spage%3D169%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frebourg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfister, C.</span><span> </span><span class="NLM_article-title">Molecular profiling of bladder tumors based on the detection of FGFR3 and TP53 mutations</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">2686</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm7013309&amp;key=10.1016%2Fj.juro.2006.07.132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm7013309&amp;key=17085196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm7013309&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlantbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=2686-9&author=A.+Lamyauthor=F.+Gobetauthor=M.+Laurentauthor=F.+Blanchardauthor=C.+Varinauthor=C.+Moulinauthor=A.+Andreouauthor=T.+Frebourgauthor=C.+Pfister&title=Molecular+profiling+of+bladder+tumors+based+on+the+detection+of+FGFR3+and+TP53+mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular profiling of bladder tumors based on the detection of FGFR3 and TP53 mutations</span></div><div class="casAuthors">Lamy, A.; Gobet, F.; Laurent, M.; Blanchard, F.; Varin, C.; Moulin, C.; Andreou, A.; Frebourg, T.; Pfister, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">6, Pt. 1</span>),
    <span class="NLM_cas:pages">2686-2689</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Purpose: On a routine basis we performed systematic mol. screening for FGFR3 and TP53 mutations in 121 bladder tumors.  We then specifically analyzed the predictive value of the recurrence of FGFR3 and TP53 genotypes in superficial lesions.  Materials and Methods: The FGFR3 gene was analyzed by direct sequencing of exons 7, 10 and 15, whereas TP53 status was detd. using the p53 functional assay in yeast.  Results: We identified a missense FGFR3 mutation in 66% of pTa, 26% of pT1 and 12% of pT2 tumors.  Of activating FGFR3 mutations 54% and 85% were found in low G1 and intermediate G2 grade tumors, resp., but in only 20% of high grade G3 tumors.  We detected inactivating TP53 mutations in 10% of pTa, 42% of pT1 and 58% of pT2 tumors.  Moreover, TP53 mutations were found only in 23% of grade G1 and 3% of grade G2 tumors but in 44% of high grade G3 tumors.  When the 2 genotypes were combined, we obsd. that 58% of pTa tumors had the (mutant FGFR3, WT TP53) genotype, whereas 58% of invasive lesions harbored the inverse genotype (WT FGFR3, mutant TP53).  The (mutant FGFR3, WT TP53) genotype and the (WT FGFR3, mutant TP53) genotype were detected in 23% and 38% of pT1G3 tumors, resp.  In the subgroup of 92 patients with superficial pTa-T1 bladder tumors we did not find that the TP53 or FGFR3 genotype alone or combined had a predictive value for tumor recurrence.  Conclusions: Our data again represent solid proof for the pivotal role of FGFR3 and TP53 mutations in superficial and invasive bladder tumors, resp.  However, other mol. markers should be identified for borderline pT1G3 bladder tumors, which are probably at the crossroads of these 2 distinct mol. pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2xIzAcPgkU7Vg90H21EOLACvtfcHk0lh5nyN4FOgAuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlantbvJ&md5=d16e6a583df615ef20baeab6c3f3b851</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2006.07.132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2006.07.132%26sid%3Dliteratum%253Aachs%26aulast%3DLamy%26aufirst%3DA.%26aulast%3DGobet%26aufirst%3DF.%26aulast%3DLaurent%26aufirst%3DM.%26aulast%3DBlanchard%26aufirst%3DF.%26aulast%3DVarin%26aufirst%3DC.%26aulast%3DMoulin%26aufirst%3DC.%26aulast%3DAndreou%26aufirst%3DA.%26aulast%3DFrebourg%26aufirst%3DT.%26aulast%3DPfister%26aufirst%3DC.%26atitle%3DMolecular%2520profiling%2520of%2520bladder%2520tumors%2520based%2520on%2520the%2520detection%2520of%2520FGFR3%2520and%2520TP53%2520mutations%26jtitle%3DJ.%2520Urol.%26date%3D2006%26volume%3D176%26spage%3D2686%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bhide, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaseelan Sr., R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukral, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DʼArienzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derbin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span> </span><span class="NLM_article-title">Discovery and preclinical studies of (<i>R</i>)-1-(4-(4-fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propanol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2143</span><span class="NLM_x">–</span> <span class="NLM_lpage">2146</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051106d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2143-2146&author=R.+S.+Bhideauthor=Z.-W.+Caiauthor=Y.-Z.+Zhangauthor=L.+Qianauthor=D.+Weiauthor=S.+Barbosaauthor=L.+J.+Lombardoauthor=R.+M.+Borzilleriauthor=X.+Zhengauthor=L.+I.+Wuauthor=J.+C.+Barrishauthor=S.-H.+Kimauthor=K.+Leavittauthor=A.+Mathurauthor=L.+Leithauthor=S.+Chaoauthor=B.+Wautletauthor=S.+Mortilloauthor=R.+Jayaseelan+Sr.author=D.+Kukralauthor=J.+Huntauthor=A.+Kamathauthor=A.+Furaauthor=V.+Vyasauthor=P.+Maratheauthor=C.+D%CA%BCArienzoauthor=G.+Derbinauthor=J.+Fargnoli&title=Discovery+and+preclinical+studies+of+%28R%29-1-%284-%284-fluoro-2-methyl-1H-indol-5-yloxy%29-5-methylpyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazin-6-yloxy%29propanol+%28BMS-540215%29%2C+an+in+vivo+active+potent+VEGFR-2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm051106d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051106d%26sid%3Dliteratum%253Aachs%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DZhang%26aufirst%3DY.-Z.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DBarbosa%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%2BI.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DLeavitt%26aufirst%3DK.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DLeith%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DS.%26aulast%3DWautlet%26aufirst%3DB.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DJayaseelan%2BSr.%26aufirst%3DR.%26aulast%3DKukral%26aufirst%3DD.%26aulast%3DHunt%26aufirst%3DJ.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DD%25CA%25BCArienzo%26aufirst%3DC.%26aulast%3DDerbin%26aufirst%3DG.%26aulast%3DFargnoli%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520preclinical%2520studies%2520of%2520%2528R%2529-1-%25284-%25284-fluoro-2-methyl-1H-indol-5-yloxy%2529-5-methylpyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-6-yloxy%2529propanol%2520%2528BMS-540215%2529%252C%2520an%2520in%2520vivo%2520active%2520potent%2520VEGFR-2%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2143%26epage%3D2146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hu, L.</span><span> </span><span class="NLM_article-title">Prodrug approaches to drug delivery</span>. In  <span class="citation_source-book">Drug Delivery Principles and Applications</span>. <span class="NLM_contrib-group">Wang, B.; Siahaan, T.; Soltero, R. A.</span>, Eds.; <span class="NLM_publisher-name">John Wiley & Son, Inc.</span>: <span class="NLM_publisher-loc">New Jersey</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">125</span>#x2013; <span class="NLM_lpage">165</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=125-165&author=L.+Hu&title=Drug+Delivery+Principles+and+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DL.%26atitle%3DProdrug%2520approaches%2520to%2520drug%2520delivery%26btitle%3DDrug%2520Delivery%2520Principles%2520and%2520Applications%26aulast%3DWang%26aufirst%3DB.%26pub%3DJohn%2520Wiley%2520%2526%2520Son%252C%2520Inc%26date%3D2005%26spage%3D125%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goyal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R. S.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-<i>f</i>][1,2,4]triazine based VEGFR-2 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1433</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1429-1433&author=R.+M.+Borzilleriauthor=Z.-W.+Caiauthor=C.+Ellisauthor=J.+Fargnoliauthor=A.+Furaauthor=T.+Gerhardtauthor=B.+Goyalauthor=J.+T.+Huntauthor=S.+Mortilloauthor=L.+Qianauthor=J.+Tokarskiauthor=V.+Vyasauthor=B.+Wautletauthor=X.+Zhengauthor=R.+S.+Bhide&title=Synthesis+and+SAR+of+4-%283-hydroxyphenylamino%29pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+based+VEGFR-2+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DEllis%26aufirst%3DC.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DGerhardt%26aufirst%3DT.%26aulast%3DGoyal%26aufirst%3DB.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DTokarski%26aufirst%3DJ.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DWautlet%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-%25283-hydroxyphenylamino%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520based%2520VEGFR-2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1429%26epage%3D1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kabalka, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayana, C.</span><span> </span><span class="NLM_article-title">Sodium perborate: A convenient reagent for benzylic hydroperoxide rearrangement</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">7667</span><span class="NLM_x">–</span> <span class="NLM_lpage">7668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1993&pages=7667-7668&author=G.+W.+Kabalkaauthor=N.+K.+Reddyauthor=C.+Narayana&title=Sodium+perborate%3A+A+convenient+reagent+for+benzylic+hydroperoxide+rearrangement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKabalka%26aufirst%3DG.%2BW.%26aulast%3DReddy%26aufirst%3DN.%2BK.%26aulast%3DNarayana%26aufirst%3DC.%26atitle%3DSodium%2520perborate%253A%2520A%2520convenient%2520reagent%2520for%2520benzylic%2520hydroperoxide%2520rearrangement%26jtitle%3DTetrahedron%2520Lett.%26date%3D1993%26volume%3D34%26spage%3D7667%26epage%3D7668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukral, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of orally active 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)-pyrrolo[2,1-<i>f</i>][1,2,4]triazines as dual vascular endothelial growth factor receptor-2 (VEGFR-2) and fibroblast growth factor receptor-1 (FGFR-1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3991</span><span class="NLM_x">–</span> <span class="NLM_lpage">4008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0501275" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3991-4008&author=R.+M.+Borzilleriauthor=X.+Zhengauthor=L.+Qianauthor=C.+Ellisauthor=Z.-W.+Caiauthor=B.+Wautletauthor=S.+Mortilloauthor=R.+Jeyaseelanauthor=D.+Kukralauthor=A.+Furaauthor=A.+Kamathauthor=V.+Vyasauthor=J.+Tokarskiauthor=J.+C.+Barrishauthor=J.+T.+Huntauthor=L.+J.+Lombardoauthor=J.+Fargnoliauthor=R.+Bhide&title=Design%2C+synthesis%2C+and+evaluation+of+orally+active+4-%282%2C4-difluoro-5-%28methoxycarbamoyl%29phenylamino%29-pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazines+as+dual+vascular+endothelial+growth+factor+receptor-2+%28VEGFR-2%29+and+fibroblast+growth+factor+receptor-1+%28FGFR-1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm0501275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0501275%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DEllis%26aufirst%3DC.%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DWautlet%26aufirst%3DB.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKukral%26aufirst%3DD.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DTokarski%26aufirst%3DJ.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBhide%26aufirst%3DR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520orally%2520active%25204-%25282%252C4-difluoro-5-%2528methoxycarbamoyl%2529phenylamino%2529-pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%2520as%2520dual%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520%2528VEGFR-2%2529%2520and%2520fibroblast%2520growth%2520factor%2520receptor-1%2520%2528FGFR-1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3991%26epage%3D4008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><div class="note"><p class="first last">For detailed in vivo assay condition, see <a class="ref internalNav" href="#ref16" aria-label="Experimental Section in ref 16">Experimental Section in ref 16</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+detailed+in+vivo+assay+condition%2C+see+Experimental+Section+in+ref+16."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Chen, B.-C.; Zhao, R.; Sundeen, J. E.; Leftheris, K.; Hynes, J.; Wrobleski, S. T.</span><span> </span><span class="NLM_article-title">Process for preparing pyrrolotriazine kinase inhibitors</span>. U.S. patent application, US 2004157846,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=B.-C.+Chen&author=R.+Zhao&author=J.+E.+Sundeen&author=K.+Leftheris&author=J.+Hynes&author=S.+T.+Wrobleski&title=Process+for+preparing+pyrrolotriazine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.-C.%26atitle%3DProcess%2520for%2520preparing%2520pyrrolotriazine%2520kinase%2520inhibitors%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i24"><a href="/doi/suppl/10.1021/jm7013309">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_77613"></div></div></div></div></div><hr /></hr><p class="last">Characterization data for chiral purity determination of <b>1</b>, <b>8</b>, and <b>9</b>, prodrugs <b>7</b>–<b>20</b>, and a table of reaction yields and HPLC analysis data for key compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm7013309/suppl_file/jm7013309-file002.pdf">jm7013309-file002.pdf (177.13 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm7013309&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-6%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm7013309%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm7013309" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                243KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994ffbeff4123e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
